Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003181	u-na	mmol/l (mmol/l)	6153	8715	1.37%
3003181	u-na	— (—)	2184	2658	100.00%	Distribution not available
3003181	u-na	mmol/l____ (mmol/l)	131	157	0.00%
3003181	u-na	MMOL/L (mmol/l)	42	48	0.00%
3003181	u-na	mmol/L (mmol/l)	38	48	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Exclusions for E4_PCOS_BROAD

637

1213

5.60

319.12

1.9

1.5

73.59

63.36

mmol/l

5.24

556

980

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1867

3926

2.84

318.64

1.6

1.4

60.17

63.11

mmol/l

1.81

1458

3109

1867

3926

2.84

318.64

1.6

1.4

60.17

63.11

mmol/l

1.81

1458

3109

Explicit Sepsis, including avohilmo

1212

3356

3.38

311.79

1.7

1.4

57.86

63.87

mmol/l

4.93

948

2704

Explicit Sepsis

1195

3305

3.41

310.77

1.7

1.4

57.84

63.90

mmol/l

4.93

932

2666

Hyperkalaemia

292

229

14.21

307.76

1.7

1.2

56.71

65.99

mmol/l

2.27

229

173

Substance abuse, excluding more controls

1437

2695

4.61

307.65

1.5

1.3

54.63

65.36

mmol/l

12.99

1009

2179

Hypo-osmolality and hyponatraemia

3799

838

78.78

307.65

1.6

1.2

55.43

66.02

mmol/l

10.41

2990

646

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2124

5174

2.79

307.65

1.6

1.4

59.94

63.47

mmol/l

2.86

1655

4120

Heart failure and antihypertensive medication

628

621

6.85

307.65

1.5

1.3

55.77

67.38

mmol/l

5.32

477

479

Metabolic disorders

2981

2523

7.40

307.65

1.6

1.3

58.88

68.82

mmol/l

15.50

2319

1991

General symptoms and signs

1966

3175

3.16

307.65

1.5

1.4

60.78

64.53

mmol/l

2.58

1564

2469

Cerebrovascular diseases (FINNGEN)

691

816

6.13

307.65

1.4

68.40

66.85

mmol/l

0.26

553

632

Other disorders of fluid, electrolyte and acid-base balance

4222

1445

36.38

307.65

1.6

1.2

56.97

66.88

mmol/l

13.24

3346

1123

Condition for Implicit Sepsis (Organ dysfunction codes)

2079

4447

3.33

307.65

1.6

1.4

58.64

63.40

mmol/l

4.81

1613

3539

Bacterial Sepsis

1402

3353

3.59

307.65

1.6

1.3

56.79

63.55

mmol/l

7.08

1081

2685

Other bacterial diseases

2252

4971

3.08

307.65

1.6

1.4

58.93

63.24

mmol/l

4.29

1748

3972

Convulsions, not elsewhere classified

725

1162

6.46

307.65

1.6

1.5

65.21

65.76

mmol/l

0.09

567

919

Other bacterial diseases, including avohilmo

2213

4828

2.92

307.65

1.6

1.4

59.62

64.01

mmol/l

4.18

1710

3858

Renal tubulo-interstitial diseases

2102

5094

3.10

307.65

1.6

1.4

55.92

64.64

mmol/l

15.87

1629

4080

Influenza and pneumonia

2161

4966

2.74

307.65

1.6

1.4

60.19

63.76

mmol/l

2.84

1675

3956

Implicit bacterial Sepsis, including avohilmo

1399

3314

3.65

307.65

1.6

1.3

56.71

63.22

mmol/l

6.65

1082

2652

Pneumonias (Asthma/COPD co-morbidities)

2127

5112

2.77

307.65

1.6

1.4

59.89

63.68

mmol/l

3.22

1659

4071

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1188

2968

4.12

307.65

1.5

1.3

53.73

64.62

mmol/l

12.44

828

2394

Alcohol use disorder, ICD-based

1098

2760

4.13

307.65

1.5

1.4

53.53

64.37

mmol/l

11.35

763

2226

1474

3621

3.65

307.65

1.5

1.4

54.49

64.93

mmol/l

14.14

1032

2954

1442

3553

3.74

307.65

1.5

1.4

54.68

64.84

mmol/l

13.17

1012

2895

Pneumonia, organism unspecified

2021

4867

2.91

307.65

1.6

1.4

60.03

63.38

mmol/l

2.52

1569

3872

Bacterial infection, other or unspecified, including avohilmo

1586

4126

3.25

307.65

1.6

1.4

59.21

63.04

mmol/l

2.86

1236

3311

Fever of other and unknown origin

1185

2881

3.65

307.65

1.7

1.4

60.99

63.99

mmol/l

1.43

968

2246

All pneumoniae

2127

5123

2.75

307.65

1.6

1.4

59.91

63.66

mmol/l

3.17

1655

4082

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2075

4306

3.33

307.65

1.6

1.4

59.32

63.82

mmol/l

4.14

1611

3417

Implicit bacterial Sepsis

1290

3132

3.68

307.65

1.6

1.3

56.86

63.03

mmol/l

5.66

995

2517

Endocrine, nutritional and metabolic diseases

1289

1246

5.32

307.65

1.5

1.3

63.33

72.82

mmol/l

5.77

1013

986

Substance abuse

1437

3673

3.75

307.65

1.5

1.4

54.63

64.66

mmol/l

12.63

1009

2981

All kidney diseases

2108

5127

2.81

307.65

1.6

1.4

56.57

64.81

mmol/l

13.96

1633

4102

Malaise and fatigue

1628

2619

5.10

307.65

1.6

1.4

58.27

63.56

mmol/l

4.65

1330

2046

Hypokalaemia

618

511

13.42

307.65

1.8

1.2

60.93

67.24

mmol/l

1.88

500

392

Implicit Sepsis

2068

4399

3.58

307.65

1.6

1.3

58.15

63.11

mmol/l

5.27

1612

3501

Heart failure, not strict

1809

4043

3.10

307.65

1.5

1.4

56.75

63.74

mmol/l

8.96

1391

3238

Alcohol use disorder, Swedish definition

1403

3416

3.86

307.65

1.6

1.4

53.94

65.11

mmol/l

15.38

978

2790

Anaemias

548

152

24.00

307.65

1.8

58.40

72.27

mmol/l

2.30

416

124

Mental and behavioural disorders due to alcohol

1280

3255

3.87

307.65

1.5

1.4

54.54

64.76

mmol/l

11.86

898

2649

Mental and behavioural disorders due to psychoactive substance use

1466

3745

3.70

307.65

1.5

1.4

54.83

64.69

mmol/l

12.43

1031

3037

Bacterial infection, other or unspecified

1489

3967

3.28

307.65

1.6

1.4

59.42

62.99

mmol/l

2.42

1157

3196

Implicit Sepsis, including avohilmo

2112

4455

3.49

307.65

1.6

1.4

58.70

63.19

mmol/l

4.40

1643

3539

Benzodiazepine use

2137

5549

2.65

307.65

1.5

1.4

57.18

63.42

mmol/l

8.46

1604

4476

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2252

5257

2.96

307.65

1.6

1.4

58.72

63.48

mmol/l

5.46

1765

4186

Nausea and vomiting

838

2061

4.13

292.95

1.8

1.4

62.14

63.32

mmol/l

0.31

686

1658

Volume depletion

356

403

9.48

290.05

2.1

1.2

60.55

66.62

mmol/l

1.30

280

303

Persons encountering health services for specific procedures and health care

2068

4884

2.54

288.66

1.6

1.4

62.09

63.16

mmol/l

0.45

1651

3854

Pure hypercholesterolaemia

1191

2233

3.45

287.54

1.4

1.2

60.38

67.48

mmol/l

5.52

963

1749

Hypertensive diseases (excluding secondary)

835

1079

4.59

281.87

1.5

1.4

61.71

68.30

mmol/l

2.57

658

822

Septicaemia

1175

3426

3.24

281.22

1.7

1.4

57.41

63.48

mmol/l

5.05

917

2792

Disorders of lipoprotein metabolism and other lipidaemias

1245

2313

3.33

281.06

1.4

1.2

59.18

67.41

mmol/l

7.61

1005

1814

Constipation

1908

5186

2.54

276.18

1.5

1.4

59.40

63.20

mmol/l

3.26

1501

4153

Syncope and collapse

1009

2444

3.54

273.99

1.6

1.3

60.83

63.53

mmol/l

1.16

836

1910

Other septicaemia

1075

3162

3.32

270.65

1.7

1.4

57.43

63.33

mmol/l

4.41

839

2583

Other septicaemia, including avohilmo

1091

3223

3.29

270.30

1.7

1.4

57.34

63.37

mmol/l

4.67

854

2631

Alcohol dependence

708

1711

4.31

264.14

1.6

1.3

53.44

63.98

mmol/l

7.38

481

1395

Bleeding

1832

5215

2.52

261.41

1.6

1.4

65.15

60.46

mmol/l

3.79

1441

4143

Hypertension, essential

1308

2420

3.11

258.93

1.4

60.24

65.22

mmol/l

3.02

1029

1859

Mood disorders, excluding more controls

1734

3941

2.63

258.80

1.5

1.4

58.42

63.67

mmol/l

4.78

1321

3192

Acute tubulo-interstitial nephritis

1420

4417

2.78

257.67

1.6

1.4

57.12

64.36

mmol/l

8.70

1123

3564

Aplastic and other anaemias

1278

4159

2.91

254.18

1.6

1.4

55.79

62.48

mmol/l

7.72

1024

3367

Renal failure

1325

4102

2.84

248.93

1.5

1.4

52.11

63.13

mmol/l

20.59

1032

3307

Hypertensive diseases

1305

2484

3.02

245.50

1.4

60.78

65.77

mmol/l

2.95

1028

1914

Hypertension

1304

2482

3.01

245.25

1.4

60.78

65.74

mmol/l

2.91

1027

1912

Oxycodone

1024

2772

3.26

244.85

1.5

1.3

59.35

62.35

mmol/l

1.36

781

2218

Any mental disorder

1956

4041

2.46

243.92

1.5

1.4

60.49

63.75

mmol/l

2.21

1515

3275

Other anaemias

1199

3979

2.92

241.19

1.6

1.4

55.13

62.46

mmol/l

8.79

953

3216

Epilepsy

828

2371

3.61

240.84

1.5

66.60

63.23

mmol/l

1.26

690

1863

Other and unspecified anaemias

1190

3953

2.92

240.43

1.6

1.4

54.98

62.48

mmol/l

9.16

947

3198

Asthma, unspecified (mode), excluding more controls

984

2124

3.38

239.77

1.4

1.3

61.05

64.16

mmol/l

1.26

776

1695

Intracranial trauma

1076

2299

3.22

238.87

1.5

64.60

61.01

mmol/l

1.51

856

1773

Any death

1523

4157

2.64

236.71

1.4

58.77

61.74

mmol/l

1.72

1129

3385

Other heart diseases

722

1112

4.30

236.51

1.6

59.62

69.25

mmol/l

4.82

573

861

STROKE

1161

2639

3.03

232.04

1.5

1.3

65.66

62.06

mmol/l

1.57

945

2039

Acute renal failure

732

2009

3.83

229.80

1.5

1.4

51.31

63.86

mmol/l

13.38

545

1602

Other CVD (FINNGEN)

357

364

7.91

223.64

1.6

1.2

56.66

68.62

mmol/l

4.07

275

290

Heart failure,strict

1249

3182

2.82

220.44

1.5

1.3

55.91

63.70

mmol/l

8.91

973

2577

Hypothyroidism (congenital or acquired)

310

141

12.52

220.15

2.0

1.5

69.16

74.57

mmol/l

0.44

255

115

Cardiovascular diseases (excluding rheumatic etc)

833

1290

3.75

218.58

1.6

1.7

66.60

69.97

mmol/l

0.86

672

1002

Disorders of other endocrine glands

1072

3733

2.91

218.42

1.8

1.5

67.76

60.96

mmol/l

5.06

904

2950

All chronic kidney diseases

1268

3806

2.72

218.16

1.5

1.4

53.10

64.66

mmol/l

20.91

1019

3066

Injuries to the head

2074

5609

2.23

217.78

1.5

1.4

61.51

62.69

mmol/l

0.55

1645

4448

Diseases of arteries, arterioles and capillaries (FINNGEN)

500

652

5.46

217.04

1.4

1.3

55.86

66.66

mmol/l

4.55

392

515

Asthma, unspecified (mode)

1035

2488

3.06

215.62

1.4

1.3

61.04

62.69

mmol/l

0.55

818

1983

Symptoms and signs involving the urinary system

1620

5181

2.41

214.35

1.5

1.4

58.73

62.16

mmol/l

2.57

1294

4110

Symptoms and signs involving cognition, perception, emotional state and behaviour

1820

5361

2.31

213.42

1.5

1.4

62.19

61.85

mmol/l

0.12

1485

4203

Other antidepressants

1834

4023

2.36

211.08

1.5

1.4

61.01

63.24

mmol/l

1.19

1424

3257

Headache

1083

2925

2.91

210.92

1.6

1.4

61.12

64.78

mmol/l

1.78

901

2276

Oedema, not elsewhere classified

741

2105

3.54

209.82

1.5

1.3

57.16

63.49

mmol/l

3.52

575

1638

Hypothyroidism and >3 levothyroxin purchases

299

141

12.08

208.85

1.7

1.5

68.86

74.57

mmol/l

0.47

247

115

Hypothyroidism, levothyroxine purchases

299

141

12.08

208.85

1.7

1.5

68.86

74.57

mmol/l

0.47

247

115

Other functional intestinal disorders

1072

3506

2.85

207.29

1.7

1.4

59.40

64.07

mmol/l

3.02

866

2826

Anxiety disorders, excluding more controls

1435

3651

2.55

207.12

1.6

1.4

58.47

63.69

mmol/l

3.99

1121

2950

Implicit viral Sepsis, including avohilmo

801

2479

3.34

206.57

1.7

1.3

61.07

63.62

mmol/l

0.90

641

2004

Schizophrenia or delusion, excluding more controls

602

1546

3.95

201.43

1.4

1.3

53.78

64.12

mmol/l

6.69

441

1237

Viral Sepsis

615

1639

3.92

200.92

1.7

1.3

62.26

63.03

mmol/l

0.16

491

1308

Tramadol

1422

3416

2.54

200.49

1.5

1.3

59.59

62.88

mmol/l

1.83

1110

2722

Implicit viral Sepsis

613

1639

3.91

199.33

1.7

1.3

62.24

63.03

mmol/l

0.16

489

1308

Infections, IBD-co-morbidities

359

374

6.98

197.36

1.9

1.4

56.33

59.96

mmol/l

0.58

295

270

Depression medications

316

146

11.04

196.02

1.6

1.4

63.83

76.91

mmol/l

1.71

254

121

Other medical care

1146

3669

2.69

194.76

1.4

59.95

62.30

mmol/l

1.04

889

2933

Complications of surgical and medical care, not elsewhere classified

1876

5811

2.19

194.37

1.5

1.4

61.97

61.65

mmol/l

0.11

1494

4593

GASTRO-related operations

1192

2162

2.80

191.09

1.6

1.3

64.66

65.45

mmol/l

0.20

923

1771

Any gastric operation

1192

2162

2.80

191.09

1.6

1.3

64.66

65.45

mmol/l

0.20

923

1771

Osteopathies and chondropathies

1269

4743

2.50

190.25

1.5

1.4

59.76

61.05

mmol/l

0.52

1001

3771

First line medication for Crohn's disease

1889

4664

2.21

189.86

1.5

1.4

62.97

62.59

mmol/l

0.13

1503

3696

Use of hypnotics and sedatives

1890

5016

2.19

188.02

1.5

1.4

59.43

63.33

mmol/l

3.33

1467

4004

Anxiety (asthma-related co-morbidities)

1013

2772

2.82

186.46

1.6

1.5

55.94

65.97

mmol/l

9.26

776

2228

Psychiatric diseases

1612

3480

2.35

183.22

1.5

1.4

61.37

63.26

mmol/l

0.83

1261

2814

Concussion

877

2288

3.02

183.11

1.6

1.5

63.05

60.91

mmol/l

0.68

703

1763

Fall on same level

1906

4753

2.17

182.42

1.5

61.53

63.43

mmol/l

1.00

1495

3784

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

472

1091

4.37

181.88

1.6

1.3

57.68

65.13

mmol/l

2.23

337

873

Retention of urine

841

2272

3.09

181.26

1.5

1.3

56.05

64.04

mmol/l

7.09

678

1846

Dyspnoea

1706

5704

2.19

181.21

1.5

1.4

59.96

62.18

mmol/l

1.37

1347

4522

Non-invasive ventilation

450

848

4.69

181.21

1.5

1.4

63.54

66.60

mmol/l

0.57

374

670

Diseases of oesophagus, stomach and duodenum

1884

5260

2.14

180.67

1.5

1.4

60.26

62.94

mmol/l

1.71

1469

4151

Focal epilepsy

582

1611

3.76

179.75

1.5

69.15

63.66

mmol/l

2.02

483

1300

Diseases of liver

824

2846

2.99

176.61

1.5

1.4

54.76

63.00

mmol/l

6.37

601

2287

Heart failure, strict

1353

4045

2.38

170.91

1.5

1.3

55.62

62.64

mmol/l

8.58

1060

3261

Hyperosmolality and hypernatraemia

116

30.23

168.09

2.1

1.3

66.24

68.82

mmol/l

0.15

105

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

457

1124

4.29

167.75

1.5

1.4

51.33

62.40

mmol/l

5.74

293

913

All-cause Heart Failure

1333

3998

2.38

167.54

1.5

1.3

55.75

62.76

mmol/l

8.36

1040

3221

Nutritional anaemias

1140

4523

2.46

166.16

1.6

1.4

58.23

62.04

mmol/l

2.47

884

3656

Persons encountering health services in other circumstances

839

2985

2.84

165.71

1.5

1.4

59.45

63.76

mmol/l

2.05

640

2371

Cardiovascular diseases

711

1097

3.48

164.27

1.6

1.8

67.32

71.14

mmol/l

0.92

589

857

Focal epilepsy, strict definition

540

1512

3.72

164.11

1.5

69.40

63.66

mmol/l

2.08

449

1222

Atrial fibrillation and flutter

505

778

4.28

163.93

1.4

1.3

57.96

64.93

mmol/l

2.37

392

601

Mood disorders

1807

5629

2.08

163.81

1.5

1.4

58.96

62.96

mmol/l

3.20

1378

4499

Alcoholic liver disease

345

692

5.33

163.69

1.5

1.3

52.05

61.79

mmol/l

3.18

214

564

Mood [affective] disorders

1803

5625

2.08

163.62

1.5

1.4

58.91

62.98

mmol/l

3.29

1376

4495

Depression or dysthymia

1099

2302

2.65

163.13

1.5

1.3

60.04

63.21

mmol/l

1.40

855

1879

Diarrhoea and gastroenteritis of presumed infectious origin

1328

5292

2.28

161.74

1.7

1.4

59.97

63.53

mmol/l

2.14

1065

4193

Symptoms and signs concerning food and fluid intake

321

611

5.52

160.31

1.7

1.5

60.18

66.24

mmol/l

1.24

246

484

Certain infectious and parasitic diseases

1514

3382

2.27

159.40

1.5

1.4

60.67

64.81

mmol/l

2.67

1180

2693

Osteoporosis

812

2685

2.89

159.32

1.6

1.4

59.22

59.68

mmol/l

0.12

636

2160

Intracranial injury

1159

4598

2.39

159.22

1.5

1.4

64.46

62.83

mmol/l

0.58

924

3670

Alcohol abuse, main dg, excluding more controls

334

671

5.16

156.71

1.5

1.3

57.71

65.35

mmol/l

1.90

239

540

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1674

5094

2.10

155.92

1.6

1.4

62.12

62.65

mmol/l

0.18

1311

4040

Persons encountering health services in other circumstances, wide

1950

5019

2.02

155.18

1.5

1.4

60.81

63.02

mmol/l

1.32

1538

3984

Transplanted organ and tissue status

315

614

5.46

154.16

1.7

1.5

54.24

64.00

mmol/l

3.28

267

495

Intestinal infectious diseases

1682

6158

2.06

153.38

1.6

1.4

59.22

63.11

mmol/l

3.04

1344

4882

COPD (mode)

690

1757

3.15

153.00

1.5

1.3

54.91

62.17

mmol/l

4.36

519

1399

Covid-19 confirmed case

872

3347

2.68

152.21

1.5

1.4

59.66

62.00

mmol/l

0.89

721

2689

Asthma, excluding more controls

1087

2188

2.58

151.35

1.5

1.3

62.49

64.81

mmol/l

0.81

851

1742

Other disorders of urethra and urinary system

1247

3789

2.33

151.21

1.5

1.4

60.99

63.80

mmol/l

1.49

1010

3016

Any reimbursement code in KELA

689

1025

3.41

151.19

1.5

1.4

64.17

68.72

mmol/l

1.22

548

793

Depression

1641

5336

2.08

151.08

1.5

1.4

58.99

62.92

mmol/l

2.89

1260

4257

Disorders of mineral metabolism

223

315

7.45

150.57

2.1

1.2

59.46

69.49

mmol/l

2.26

188

249

Focal epilepsy, mode (most common among epilepsy diagnosis)

500

1413

3.69

149.86

1.5

70.67

63.00

mmol/l

3.03

416

1141

Antihypertensive medication - note that there are other indications

695

1106

3.32

149.25

1.5

1.8

64.40

72.54

mmol/l

3.22

573

855

Secondary hypertension

207

265

8.08

149.24

1.6

1.3

58.14

74.18

mmol/l

4.26

179

214

Dental caries

570

1640

3.38

148.75

1.6

1.4

61.23

61.59

mmol/l

0.06

447

1290

Iron deficiency anaemia

990

4001

2.49

148.58

1.6

1.4

57.94

62.00

mmol/l

2.46

762

3241

Erysipelas, including avohilmo

1317

4432

2.24

147.88

1.4

1.3

57.56

62.62

mmol/l

4.27

1049

3538

Early onset COPD, excluding more controls

427

1095

4.02

146.51

1.5

1.3

52.58

64.68

mmol/l

6.38

304

873

ILD medications: prednisolone, methylprednisolone, prednisone

1797

4996

2.02

146.48

1.5

1.4

60.39

63.14

mmol/l

1.78

1411

3963

Cerebrovascular diseases

1494

4952

2.13

145.94

1.4

65.17

60.24

mmol/l

3.85

1232

3908

General examination and investigation of persons without complaint and reported diagnosis

1096

2295

2.52

145.17

1.5

1.4

61.66

61.64

mmol/l

0.00

858

1791

Other disorders of electrolyte and fluid balance, not elsewhere classified

41.69

144.56

2.3

1.1

60.45

62.95

mmol/l

0.14

All anxiety disorders

1020

3268

2.46

143.77

1.6

1.4

56.01

64.62

mmol/l

7.34

782

2571

Personality disorders, excluding more controls

397

977

4.14

143.23

1.6

1.3

56.18

65.32

mmol/l

3.22

296

793

Codes for special purposes

1052

4495

2.37

142.52

1.5

1.4

59.96

62.37

mmol/l

1.05

860

3568

Provisional assignment of new diseases of uncertain etiology

1051

4490

2.37

142.48

1.5

1.4

59.96

62.39

mmol/l

1.06

860

3566

Substance use, excluding alcohol

421

1093

3.98

142.28

1.6

1.4

53.75

64.25

mmol/l

4.11

289

889

Open wound of head

1083

4433

2.34

141.38

1.6

1.4

61.26

62.21

mmol/l

0.29

844

3520

Abnormalities of breathing

1404

3711

2.19

141.35

1.5

61.90

63.97

mmol/l

0.89

1084

2943

Other heart diseases, wide

1409

3973

2.17

141.09

1.5

59.75

64.86

mmol/l

3.90

1115

3099

Other disorders of adrenal gland

209

301

7.68

140.33

1.8

1.4

69.91

61.50

mmol/l

1.56

185

246

Asthma (only as main-diagnosis), excluding more controls

999

2188

2.56

139.63

1.4

1.3

62.74

64.81

mmol/l

0.68

787

1742

Dizziness and giddiness

1345

4943

2.15

138.33

1.4

63.00

61.50

mmol/l

0.62

1105

3883

Other anxiety disorders

763

2413

2.74

136.32

1.6

1.4

54.20

64.28

mmol/l

7.99

591

1886

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

544

988

3.52

135.97

1.4

1.3

61.08

67.86

mmol/l

2.19

412

757

Caries of dentine

510

1488

3.40

135.62

1.6

1.4

61.35

61.84

mmol/l

0.08

397

1163

Other symptoms and signs involving cognitive functions and awareness

1012

3855

2.38

135.30

1.5

1.4

60.77

61.01

mmol/l

0.06

811

3064

Complications of medical and surgical care

1373

5994

2.09

135.30

1.6

1.4

61.84

61.66

mmol/l

0.05

1104

4753

Adrenocortical insufficiency

185

243

8.56

135.14

1.7

1.4

69.78

61.48

mmol/l

1.38

165

199

Atrial fibrillation and flutter with reimbursement

430

661

4.20

134.95

1.4

1.3

57.41

66.15

mmol/l

3.14

341

515

Complications of procedures, not elsewhere classified

1437

5694

2.06

133.89

1.5

1.4

61.12

61.52

mmol/l

0.12

1129

4512

Dialysis, with operation codes

364

894

4.29

133.85

1.6

1.4

51.50

65.61

mmol/l

8.49

297

722

Oral corticosteroids

1762

5336

1.96

133.15

1.5

1.4

60.73

62.40

mmol/l

0.84

1366

4241

Parasetamol

982

1980

2.54

131.49

1.4

63.13

64.73

mmol/l

0.44

788

1529

Acute alcohol intoxication

521

1637

3.27

131.46

1.5

1.4

55.54

64.10

mmol/l

4.04

365

1340

Paralytic ileus and intestinal obstruction

621

2165

2.95

130.79

2.0

1.3

58.58

63.15

mmol/l

1.69

460

1751

Asthma

1148

2561

2.34

130.76

1.5

1.3

63.20

63.26

mmol/l

0.01

904

2034

Cardiac arrhythmias

810

1964

2.68

129.56

1.4

60.68

64.65

mmol/l

1.49

644

1527

Pain, not elsewhere classified

508

1584

3.28

129.46

1.6

1.4

59.73

64.46

mmol/l

1.59

405

1243

ILD medications

1794

5040

1.94

129.19

1.5

1.4

60.89

63.45

mmol/l

1.56

1415

4005

Hyperlipidaemia, other/unspecified

578

1723

3.07

128.99

1.4

1.2

56.76

66.64

mmol/l

7.19

474

1362

Poisoning by drugs, medicaments and biological substances

470

1402

3.45

128.99

1.6

1.4

56.55

64.59

mmol/l

2.68

330

1107

Unspecified mental disorder

726

2761

2.68

128.95

1.4

53.96

63.56

mmol/l

7.39

531

2184

Anxiety disorders

1486

5108

2.02

127.06

1.6

1.4

58.75

63.17

mmol/l

3.22

1162

4035

Neurotic, stress-related and somatoform disorders

1468

5047

2.03

127.01

1.6

1.4

58.61

63.19

mmol/l

3.38

1147

3990

Poisoning by medicine

435

1248

3.59

126.93

1.5

1.4

56.66

64.15

mmol/l

2.27

302

987

Opioids

1426

3537

2.10

126.72

1.5

1.3

60.62

63.65

mmol/l

1.62

1110

2821

Asthma (only as main-diagnosis)

1066

2561

2.36

126.20

1.4

1.3

62.59

63.26

mmol/l

0.18

848

2034

Other diseases of intestines

1622

4603

1.98

125.76

1.7

1.4

60.18

64.85

mmol/l

3.78

1264

3642

ILD medications: immunosuppressive drugs

1089

4521

2.21

124.77

1.6

1.4

59.36

63.51

mmol/l

2.49

874

3590

Kela-code for severe mental illness

673

2508

2.74

124.66

1.4

53.44

63.34

mmol/l

7.23

490

1976

Alcohol withdrawal state with delirium

238

438

5.84

124.62

1.5

1.4

49.01

62.78

mmol/l

4.53

156

357

Other diseases of urinary system

1554

4398

2.01

124.38

1.5

1.4

60.06

63.83

mmol/l

2.77

1227

3479

Symptoms and signs involving the digestive system and abdomen

1562

3916

2.02

123.80

1.5

1.4

60.74

63.59

mmol/l

1.57

1229

3128

L04AD Calcineurin inhibitors

308

712

4.56

122.66

1.7

1.6

54.20

66.04

mmol/l

4.48

255

573

Schizophrenia or delusion

602

2140

2.88

122.14

1.4

53.78

62.64

mmol/l

5.49

441

1688

Excluding asthma or asthma-COPD overlap

1155

2582

2.27

121.66

1.4

1.3

60.55

63.25

mmol/l

1.15

931

2052

Cystitis

1368

3970

2.08

121.50

1.6

1.4

58.59

63.82

mmol/l

4.46

1093

3161

Stroke, including SAH

1271

4413

2.11

121.45

1.4

66.33

60.42

mmol/l

4.44

1042

3498

Schizophrenia, schizotypal and delusional disorders

605

2169

2.86

120.82

1.4

53.66

62.71

mmol/l

5.76

443

1708

Pain in throat and chest

1293

3666

2.11

120.23

1.4

61.82

63.74

mmol/l

0.79

1026

2903

COPD/asthma related infections

1553

3926

2.00

120.19

1.5

1.4

61.34

63.11

mmol/l

0.78

1247

3109

COPD/asthma/ILD related infections

1553

3926

2.00

120.19

1.5

1.4

61.34

63.11

mmol/l

0.78

1247

3109

Hypertensive heart and/or renal disease

529

1235

3.21

119.24

1.4

1.3

54.09

65.17

mmol/l

7.36

423

985

Chronic kidney disease

770

3009

2.53

119.19

1.6

1.4

50.94

63.58

mmol/l

20.88

632

2431

Inflammatory bowel disease treatment related agents

1814

5424

1.87

119.10

1.5

1.4

60.95

62.90

mmol/l

1.06

1408

4323

Kidney transplant status

196

314

6.78

118.62

1.7

1.5

51.02

67.27

mmol/l

5.01

174

262

COPD differential diagnosis

1144

2588

2.24

117.29

1.4

1.3

60.60

63.35

mmol/l

1.18

924

2050

ILD differential diagnosis

1144

2588

2.24

117.27

1.4

1.3

60.60

63.35

mmol/l

1.18

924

2050

Other and unspecified iron deficiency

766

3132

2.50

117.05

1.5

1.4

57.97

61.96

mmol/l

1.97

595

2528

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

427

540

4.01

116.59

1.4

1.6

63.60

68.19

mmol/l

0.89

363

427

Non-ischemic cardiomyopathy

733

2287

2.62

116.26

1.5

1.3

56.55

62.77

mmol/l

3.96

567

1845

Other pulmonary diagnosis

1138

2582

2.23

115.86

1.4

1.3

60.39

63.25

mmol/l

1.27

916

2052

Codeine

1330

3505

2.07

115.18

1.5

1.3

61.01

63.48

mmol/l

1.14

1046

2794

Hyperfunction of pituitary gland

171

244

7.53

115.09

2.5

1.3

75.09

62.04

mmol/l

2.51

150

208

Asthma, hospital admission 2, infections

1098

5118

2.12

114.75

1.5

61.28

62.55

mmol/l

0.45

874

4059

Asthma-related infections

1098

5118

2.12

114.75

1.5

61.28

62.55

mmol/l

0.45

874

4059

Care involving use of rehabilitation procedures

1080

4586

2.15

114.69

1.6

1.4

63.51

62.53

mmol/l

0.30

896

3631

Asthma-related pneumonia

807

3410

2.41

114.18

1.5

1.4

61.27

62.02

mmol/l

0.19

639

2727

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1280

5604

2.02

114.14

1.5

1.4

60.86

61.39

mmol/l

0.17

1025

4463

Acute alcohol intoxication, ICD10

428

1302

3.39

114.13

1.5

1.4

56.18

63.80

mmol/l

2.57

294

1055

Asthma-related pneumonia or sepsis

807

3414

2.41

113.86

1.5

1.4

61.27

61.99

mmol/l

0.18

639

2731

Asthma, hospital admissions 3, pneumonia

807

3414

2.41

113.86

1.5

1.4

61.27

61.99

mmol/l

0.18

639

2731

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1744

4988

1.88

113.83

1.5

1.4

60.41

63.07

mmol/l

1.67

1397

3965

Erysipelas

1032

4130

2.19

113.77

1.4

1.3

57.01

62.69

mmol/l

4.53

828

3297

Nephropathy related operations

340

896

3.99

113.53

1.7

1.4

51.61

63.82

mmol/l

6.18

277

727

Used for control exclusion in common control thyroid runs

1572

4111

1.95

112.90

1.6

1.4

64.08

62.61

mmol/l

0.58

1263

3235

Asthma (mode)

1089

2588

2.24

112.70

1.4

1.3

64.07

63.35

mmol/l

0.19

866

2050

Autoimmune diseases excluding thyroid diseases

1601

4563

1.92

112.63

1.6

1.4

62.35

63.32

mmol/l

0.35

1270

3614

Ascites

250

533

4.99

110.48

1.4

1.3

48.36

62.48

mmol/l

5.71

152

431

Type 2 diabetes, wide definition

1390

4497

1.98

109.45

1.4

57.45

62.24

mmol/l

4.01

1081

3574

Low back pain

1267

4272

2.03

109.00

1.5

1.4

60.83

62.22

mmol/l

0.53

1026

3351

Diseases of the digestive system

940

4304

2.21

108.50

2.0

1.4

60.12

62.42

mmol/l

0.90

733

3475

Asthma (diagnoses ohter than nonallergic)

1462

6306

1.89

107.45

1.4

1.5

61.58

62.51

mmol/l

0.36

1178

5002

Selective serotonin reuptake inhibitors

1497

4052

1.94

107.28

1.5

1.4

60.52

63.59

mmol/l

1.74

1145

3286

Hypopituitarism

226

453

5.29

107.21

2.1

1.5

75.70

67.28

mmol/l

1.42

200

370

COPD

932

3449

2.24

106.81

1.5

1.4

55.40

62.32

mmol/l

5.88

710

2768

Intestinal infectious diseases, including avohilmo, including avohilmo

1852

5810

1.79

105.87

1.5

1.4

59.50

63.04

mmol/l

2.79

1478

4608

Hard cardiovascular diseases

1386

4232

1.96

105.23

1.5

1.4

62.37

61.84

mmol/l

0.16

1099

3316

Medical observation and evaluation for suspected diseases and conditions

1002

2304

2.25

104.37

1.5

1.4

61.57

61.60

mmol/l

0.01

768

1797

Hypertensive Heart Disease

475

1178

3.14

104.37

1.4

1.3

54.67

65.16

mmol/l

6.05

377

942

Disorders of calcium metabolism

161

240

7.05

103.58

2.1

1.2

59.16

67.68

mmol/l

1.33

134

184

Other chronic obstructive pulmonary disease

896

3343

2.24

102.77

1.5

1.4

55.21

62.20

mmol/l

5.82

687

2684

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

321

868

3.81

102.49

1.5

1.4

56.64

63.36

mmol/l

1.34

218

692

Exposure to unspecified factor

1652

6261

1.81

102.41

1.5

1.4

59.29

63.05

mmol/l

3.01

1289

4991

Traumatic subdural haemorrhage

337

876

3.73

101.77

1.5

1.3

68.14

60.71

mmol/l

1.89

272

696

Falls/tendency to fall

1509

4011

1.90

101.24

1.5

60.50

63.70

mmol/l

1.90

1184

3201

Insulin, fast-acting

703

2964

2.42

100.63

1.6

1.4

56.01

63.94

mmol/l

6.35

568

2353

Autoimmune diseases

1650

4591

1.84

100.59

1.6

1.4

62.51

63.38

mmol/l

0.32

1300

3635

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

472

1635

2.95

100.37

1.6

1.4

57.68

64.07

mmol/l

1.85

337

1299

Delirium, not induced by alcohol and other psychoactive substances

382

1177

3.39

100.23

1.5

1.3

58.04

59.25

mmol/l

0.23

309

943

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1098

5436

2.01

99.05

1.6

1.4

62.85

61.68

mmol/l

0.38

881

4318

Autoimmune diseases excluding thyroid diseases, strict definition

1494

4362

1.88

98.99

1.6

1.4

61.64

62.84

mmol/l

0.45

1181

3446

Care involving dialysis

224

479

4.94

98.44

1.6

1.4

52.45

64.38

mmol/l

4.16

193

389

Other and unspecified nonorganic psychotic disorders

357

1065

3.44

98.09

1.4

53.07

63.39

mmol/l

3.85

259

844

Haemorrhage from respiratory passages

688

2553

2.43

97.33

1.6

1.4

60.76

63.13

mmol/l

0.74

539

2056

Injuries to the abdomen, lower back, lumbar spine and pelvis

824

3723

2.22

96.59

1.5

1.4

59.90

61.49

mmol/l

0.49

670

2973

Nonorganic sleeping disorders, excluding more controls

332

954

3.56

96.48

1.6

1.3

59.34

65.21

mmol/l

1.58

263

766

Suicide or other Intentional self-harm

437

1491

3.00

95.74

1.6

1.4

56.73

63.29

mmol/l

1.86

306

1185

Intestinal stricture

687

2940

2.40

95.58

2.2

1.4

59.51

61.59

mmol/l

0.57

507

2375

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1621

5861

1.79

95.51

1.7

1.4

60.73

62.98

mmol/l

1.18

1298

4650

Symptoms and signs involving the nervous and musculoskeletal systems

1044

5270

2.01

94.62

1.5

1.4

62.66

61.85

mmol/l

0.26

862

4177

Examination and observation for other reasons

894

2286

2.23

94.29

1.6

1.4

61.85

61.67

mmol/l

0.04

709

1785

Other chronic obstructive pulmonary disease, including avohilmo

1052

4328

2.03

94.28

1.5

1.4

55.96

62.61

mmol/l

5.94

802

3489

Other neurological diseases

1313

5483

1.88

93.72

1.5

1.4

65.10

60.53

mmol/l

3.32

1080

4336

Diabetes, varying definitions

1551

5001

1.82

93.47

1.5

1.4

59.78

63.75

mmol/l

3.02

1220

3959

Heart failure and bmi 25plus

679

1867

2.48

93.36

1.4

1.3

56.89

62.55

mmol/l

2.88

506

1480

Alcohol abuse, main dg

334

989

3.49

93.18

1.5

1.4

57.71

62.91

mmol/l

1.13

239

797

Insulin, fast-acting or short human

707

3092

2.33

93.07

1.6

1.4

55.94

63.57

mmol/l

5.99

572

2441

Hypotension

480

1766

2.82

92.23

1.5

1.3

58.84

61.06

mmol/l

0.62

374

1415

Certain infectious and parasitic diseases, including avohilmo

1025

2451

2.12

92.03

1.4

61.31

65.12

mmol/l

1.72

816

1947

Implicit fungal Sepsis, including avohilmo

223

503

4.69

91.95

1.6

1.3

59.62

61.32

mmol/l

0.23

182

410

Diabetes mellitus

1551

5006

1.81

91.89

1.5

1.4

59.82

63.76

mmol/l

2.97

1220

3961

Stroke, excluding SAH

1153

4325

1.96

90.60

1.4

63.82

60.77

mmol/l

1.49

937

3449

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1480

4878

1.82

90.06

1.5

1.4

57.39

63.45

mmol/l

6.42

1151

3863

Other diseases of pleura

909

3840

2.10

89.57

1.5

1.4

58.03

62.44

mmol/l

2.52

698

3114

Insulin medication

1069

4550

1.98

89.46

1.5

1.4

56.52

63.10

mmol/l

6.15

852

3621

Other or unspecified ileus, impaction or obstruction

430

1514

2.93

89.31

2.2

1.3

59.36

62.90

mmol/l

0.83

312

1227

Gastro-oesophageal reflux disease

1120

4938

1.94

88.81

1.5

1.4

61.40

62.57

mmol/l

0.40

902

3910

COPD, early/later onset

904

3692

2.10

88.29

1.5

1.4

55.30

62.92

mmol/l

7.00

693

2985

Other reaction to severe stress, and adjustment disorders

531

2087

2.58

88.06

1.6

1.4

64.30

63.17

mmol/l

0.20

410

1631

Pain in limb

1312

4525

1.86

87.39

1.5

60.54

62.83

mmol/l

1.10

1044

3563

Type 1 diabetes

449

1634

2.80

87.03

1.6

1.5

55.67

65.14

mmol/l

5.52

372

1302

Lower back pain or/and sciatica

1673

6067

1.73

87.02

1.4

61.19

61.91

mmol/l

0.27

1355

4774

Hypothyroidism, drug reimbursement

131

107

8.67

86.03

1.4

1.2

62.17

71.99

mmol/l

0.90

109

Hernia of abdominal wall, postoperative

325

984

3.36

86.02

2.1

1.3

55.15

64.85

mmol/l

3.95

238

809

Other CVD

513

2022

2.62

85.77

1.5

1.3

58.90

61.59

mmol/l

0.83

400

1624

Abdominal and pelvic pain

1418

3914

1.84

85.59

1.5

1.4

60.79

63.57

mmol/l

1.44

1123

3126

COPD, hospital admissions

888

3660

2.08

85.54

1.5

1.4

55.14

63.00

mmol/l

7.37

682

2961

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1015

5275

1.95

83.99

1.5

1.4

63.21

61.34

mmol/l

0.67

806

4199

Non-selective monoamine reuptake inhibitors

662

2818

2.30

83.63

1.5

1.3

57.21

61.15

mmol/l

1.77

513

2277

Injuries to the thorax

853

4193

2.07

83.36

1.5

1.4

60.35

61.75

mmol/l

0.42

661

3343

Diabetes medication

1589

5385

1.74

83.19

1.4

58.36

63.29

mmol/l

4.63

1248

4268

Other disorders of skin and subcutaneous tissue

1255

5869

1.83

83.05

1.5

1.4

57.32

62.16

mmol/l

4.10

1021

4651

Fracture of lumbar spine and pelvis

554

2296

2.48

82.65

1.5

1.3

58.92

60.82

mmol/l

0.50

444

1829

Dialysis

142

237

6.48

82.59

1.7

1.4

54.32

68.77

mmol/l

3.31

128

198

COPD related to multimorbidity

797

3218

2.14

81.96

1.5

1.3

55.39

62.73

mmol/l

5.90

612

2619

COPD, hospital admission 2, with asthma infections

669

2571

2.29

81.84

1.5

1.3

54.39

63.07

mmol/l

7.05

518

2085

Chronic lower respiratory diseases

1779

5598

1.69

81.71

1.4

1.5

60.54

63.18

mmol/l

1.63

1382

4453

Insulin, intermediate and long-acting

982

4919

1.96

81.69

1.5

1.4

56.09

63.04

mmol/l

6.54

779

3918

Codeine or tramadol medication

1669

5373

1.70

79.62

1.4

60.64

62.12

mmol/l

0.68

1302

4258

Bipolar affective disorders

307

950

3.30

79.53

1.5

1.3

53.66

65.42

mmol/l

4.46

229

749

Dysphagia

491

1960

2.56

79.49

1.5

1.3

58.91

64.49

mmol/l

2.09

387

1579

Other diseases of the digestive system

668

3058

2.23

79.13

1.8

1.3

57.75

62.08

mmol/l

1.97

509

2460

Chronic pancreatitis

299

918

3.39

79.12

1.7

1.4

55.11

61.82

mmol/l

1.74

229

745

Osteoporosis with pathological fracture (FG)

270

783

3.68

79.08

1.6

1.3

58.89

57.99

mmol/l

0.13

214

609

Insulin, combination of fast acting with intermediate-acting or long-acting

1073

5238

1.88

79.03

1.5

1.4

56.54

62.85

mmol/l

5.88

854

4171

Diabetes, insulin treatment (Kela reimbursement)

1580

5537

1.71

78.88

1.4

57.86

63.14

mmol/l

5.46

1236

4396

Neurological diseases, wide definition

341

492

3.52

78.80

1.5

1.7

66.96

65.35

mmol/l

0.19

296

371

Type 1 diabetes, wide definition, subgroup 1

366

1261

2.97

78.72

1.7

1.5

55.30

65.19

mmol/l

5.33

307

1016

Neurological diseases

1140

3013

1.92

78.57

1.5

63.18

61.68

mmol/l

0.48

929

2337

Use of disulfiram, acamprosate or naltrexone

208

502

4.32

78.30

1.4

50.25

61.55

mmol/l

2.67

133

409

Symptoms and signs involving the circulatory and respiratory systems

1335

3714

1.82

78.05

1.4

1.5

62.59

63.96

mmol/l

0.47

1049

2945

Fracture of rib(s), sternum and thoracic spine

628

2824

2.27

77.76

1.4

60.48

61.73

mmol/l

0.30

481

2255

Heart failure and coronary heart disease

880

3077

2.04

77.38

1.5

1.4

55.99

60.99

mmol/l

3.42

714

2471

Problems related to lifestyle

217

544

4.12

77.31

1.6

1.4

52.47

64.14

mmol/l

2.54

147

435

Valvular heart disease excluding rheumatic fever

803

2768

2.10

77.24

1.4

59.58

64.11

mmol/l

2.40

657

2207

Disorders of lens

1065

3487

1.92

77.09

1.4

58.84

61.51

mmol/l

1.25

849

2760

Non-rheumatic valve diseases

798

2746

2.11

76.95

1.4

59.51

64.00

mmol/l

2.38

651

2187

Unspecified fall

930

4754

1.95

76.89

1.5

60.97

62.26

mmol/l

0.41

731

3793

Type 2 diabetes

1454

4869

1.74

76.84

1.4

59.50

63.11

mmol/l

2.48

1144

3845

GI-bleeding

664

3069

2.21

76.76

1.8

1.3

57.51

62.10

mmol/l

2.17

509

2465

Alcohol-induced chronic pancreatitis

179

396

4.78

75.68

1.6

1.3

51.23

61.77

mmol/l

2.37

134

319

Other soft tissue disorders, not elsewhere classified

1399

4579

1.75

75.01

1.5

61.14

62.94

mmol/l

0.80

1124

3608

Gastroduodenal ulcer

530

2244

2.41

74.99

1.6

1.3

58.78

61.83

mmol/l

0.96

405

1810

Disorders of adult personality and behaviour

417

1583

2.68

74.59

1.6

1.4

55.75

63.45

mmol/l

2.80

312

1239

746

3607

2.08

74.59

1.5

61.96

62.98

mmol/l

0.28

599

2852

Recurrent or chronic depression

508

1412

2.53

74.46

1.5

1.3

57.44

63.28

mmol/l

2.19

383

1142

Abnormal findings on diagnostic imaging of lung

911

4513

1.94

74.15

1.5

1.4

59.71

61.52

mmol/l

0.69

729

3611

Other acute lower respiratory infections

911

4534

1.94

74.07

1.7

1.5

60.55

62.63

mmol/l

0.87

734

3592

Urinary track infection

809

1926

2.13

73.66

1.5

1.4

58.91

63.88

mmol/l

2.36

642

1513

Fungal Sepsis

143

271

5.65

72.66

2.0

1.3

62.50

60.24

mmol/l

0.22

118

217

Personality disorders

397

1495

2.70

72.21

1.6

1.4

56.18

63.48

mmol/l

2.42

296

1179

Other arrhythmias

908

3514

1.95

72.12

1.4

60.61

63.87

mmol/l

1.46

754

2759

Vocal cord dysfunction

185

369

4.49

71.89

1.4

1.3

64.13

68.87

mmol/l

0.57

149

300

Supplementary factors related to causes of morbidity and mortality classified elsewhere

573

2562

2.28

71.83

1.6

1.4

61.70

62.18

mmol/l

0.09

441

2046

Hypothyroidism, strict autoimmune

1053

3736

1.87

71.63

1.5

1.3

60.67

62.27

mmol/l

0.60

847

2977

Episodal and paroxysmal disorders

1560

4719

1.69

71.62

1.4

1.5

63.39

61.35

mmol/l

0.99

1262

3689

Ischemic heart diseases

1315

4513

1.75

71.05

1.5

1.4

60.22

62.09

mmol/l

0.82

1031

3551

Later onset COPD, excluding more controls

445

1328

2.62

70.84

1.5

1.3

57.21

62.00

mmol/l

1.81

363

1058

Dermatitis

1027

5543

1.83

70.68

1.4

60.51

62.40

mmol/l

0.71

801

4422

COPD, hospital admissions 3, with asthma pneumonia sepsis

564

2137

2.31

70.66

1.5

1.3

54.13

63.03

mmol/l

6.41

448

1737

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

618

2869

2.20

70.65

1.7

1.4

68.95

61.47

mmol/l

3.37

514

2278

Early onset COPD

427

1691

2.59

70.54

1.5

1.3

52.58

63.41

mmol/l

5.80

304

1362

Schizophrenia

301

992

3.12

70.43

1.4

52.65

62.38

mmol/l

3.40

214

783

Status epilepticus

128

226

6.08

70.21

1.6

1.4

68.83

66.64

mmol/l

0.17

105

175

Polyuria

437

1754

2.55

70.14

1.5

1.3

62.07

63.36

mmol/l

0.25

356

1407

Superficial injury of head

480

2010

2.44

69.95

1.4

59.52

62.32

mmol/l

0.74

381

1573

All influenza

472

1965

2.45

69.74

1.8

1.4

61.93

63.35

mmol/l

0.30

374

1572

Other external causes of accidental injury

1085

2933

1.87

69.51

1.4

61.25

64.04

mmol/l

1.17

864

2333

Type 1 diabetes, wide definition

374

1393

2.74

69.50

1.7

1.5

55.29

65.06

mmol/l

5.45

312

1117

Hypothyreosis and Thyroxine purchase for inclusion criteria

1378

5334

1.71

69.40

1.5

1.4

63.54

61.74

mmol/l

0.79

1113

4231

Polyarthropathies

1045

3657

1.86

69.16

1.4

61.07

61.76

mmol/l

0.19

812

2854

Abnormalities of heart beat

589

2618

2.21

68.85

1.4

1.3

60.23

62.79

mmol/l

0.74

478

2091

1676

5218

1.64

68.84

1.5

1.4

61.60

62.20

mmol/l

0.22

1361

4119

Accidents

1082

2933

1.86

68.74

1.4

61.16

64.04

mmol/l

1.24

866

2333

Spondylopathies

1210

4065

1.78

68.56

1.4

60.65

61.46

mmol/l

0.27

964

3181

Injuries to the hip and thigh

916

4401

1.89

68.52

1.5

1.4

57.21

62.09

mmol/l

3.48

717

3527

Organic, including symptomatic, mental disorders

1020

3933

1.85

68.06

1.4

61.34

60.69

mmol/l

0.19

821

3161

Hypothyroidism, other/unspecified

1314

5075

1.72

67.68

1.5

1.4

63.78

61.71

mmol/l

0.93

1063

4029

Bacterial pneumoniae

682

2907

2.09

67.49

1.5

1.4

57.74

63.28

mmol/l

3.03

550

2333

Glomerular diseases

370

1398

2.72

67.39

1.6

1.4

50.15

63.24

mmol/l

9.71

310

1131

Other special examinations and investigations of persons without complaint or reported diagnosis

891

2304

1.98

67.37

1.5

1.4

64.48

61.60

mmol/l

1.00

713

1797

Mental and behavioural disorders due to sedatives or hypnotics

165

376

4.59

67.00

1.8

1.4

47.76

60.65

mmol/l

2.87

114

311

Paroxysmal tachycardia

274

709

3.26

66.76

1.5

58.84

69.69

mmol/l

3.58

227

557

Ischaemic Stroke, excluding all haemorrhages

1033

4219

1.83

66.72

1.4

61.18

60.88

mmol/l

0.08

833

3375

Presence of other functional implants

1044

3960

1.83

66.69

1.4

1.3

61.83

61.34

mmol/l

0.14

853

3167

Panhypopituitarism

109

9.01

66.28

2.2

1.3

78.12

64.46

mmol/l

1.41

Diseases of arteries, arterioles and capillaries

1179

5003

1.75

65.90

1.4

58.03

61.68

mmol/l

2.41

926

4012

Type of accident

532

2392

2.27

65.87

1.6

1.4

62.74

62.33

mmol/l

0.07

409

1902

Percutaneous Coronary Intervention

1248

4428

1.73

65.05

1.5

1.4

59.80

61.94

mmol/l

1.01

988

3485

Bronchitis

1620

6061

1.62

64.98

1.5

1.4

60.55

62.33

mmol/l

0.94

1291

4800

Other and unspecified dermatitis

868

4676

1.88

64.97

1.4

60.20

62.60

mmol/l

0.90

687

3722

Missing teeth due to accident, extraction or parodontitis

1074

5483

1.77

64.89

1.4

59.71

60.99

mmol/l

0.45

812

4404

External causes of morbidity and mortality

837

2127

1.99

64.28

1.4

1.5

64.09

64.35

mmol/l

0.05

675

1695

Gastrointestinal diseases

706

1684

2.12

64.03

1.5

1.4

63.48

66.95

mmol/l

1.05

559

1340

Other symptoms and signs involving the urinary system

237

719

3.42

63.98

1.4

58.29

63.46

mmol/l

1.17

191

583

Bacterial pneumonia, not elsewhere classified

650

2779

2.09

63.90

1.5

1.4

57.25

63.08

mmol/l

3.18

523

2233

L04AA Selective immunosuppressants

409

1663

2.52

63.88

1.6

1.4

55.85

63.16

mmol/l

3.03

336

1331

Implicit fungal Sepsis

129

252

5.47

63.41

1.7

1.3

59.97

60.27

mmol/l

0.02

106

203

Candidiasis, including avohilmo

530

2422

2.23

63.05

1.6

1.4

60.97

61.92

mmol/l

0.19

430

1932

Infections of the skin and subcutaneous tissue

881

4734

1.85

62.81

1.7

1.4

59.29

64.06

mmol/l

2.64

676

3741

Other dialysis

113

198

6.22

62.76

1.7

1.3

54.83

66.79

mmol/l

2.07

103

166

Diseases of the respiratory system

876

2285

1.94

62.58

1.4

1.3

62.00

63.52

mmol/l

0.43

707

1809

Spinal stenosis

895

3571

1.87

62.56

1.4

58.78

60.35

mmol/l

0.60

724

2819

Senile cataract

973

3253

1.84

62.02

1.4

59.66

61.46

mmol/l

0.67

775

2580

Asthma/COPD (KELA code 203)

1374

5592

1.66

62.00

1.4

1.5

60.61

63.20

mmol/l

1.45

1116

4447

Dorsalgia

1365

4343

1.68

61.83

1.4

62.49

62.55

mmol/l

0.02

1117

3407

Any event in cancer register

1270

4399

1.70

61.63

1.4

64.03

61.99

mmol/l

0.78

992

3476

Coronary revascularization (ANGIO or CABG)

1234

4429

1.71

61.46

1.5

1.4

59.97

61.97

mmol/l

0.91

976

3486

Continuous positive airway pressure

267

719

3.15

61.45

1.6

65.71

66.45

mmol/l

0.08

213

566

Other and unspecified myopathies

234

725

3.37

61.34

1.5

1.3

57.82

61.94

mmol/l

0.67

170

581

Nontraumatic intracranial haemmorrhage

436

1862

2.40

61.23

1.5

1.3

80.59

60.45

mmol/l

11.67

359

1480

Acute bronchitis

714

3613

1.97

60.87

1.6

1.4

60.89

62.37

mmol/l

0.47

559

2860

Disorders of the thyroid gland

1358

5369

1.65

60.78

1.5

1.4

64.35

61.96

mmol/l

1.18

1098

4246

Invasive ventilation

193

532

3.80

60.65

1.7

1.4

58.94

63.24

mmol/l

0.57

141

432

Malignant neoplasm, including Hilmo

1233

4246

1.71

60.55

1.4

62.47

62.38

mmol/l

0.02

956

3362

Specific personality disorders

338

1284

2.68

60.54

1.6

1.4

56.95

63.93

mmol/l

1.86

252

1002

Malignant neoplasm, wide definition

1234

4259

1.70

59.98

1.4

62.70

62.33

mmol/l

0.09

954

3372

Polyneuropathies and other disorders of the peripheral nervous system

437

1903

2.35

58.73

1.5

1.3

59.16

62.29

mmol/l

0.94

361

1517

Other symptoms and signs involving the nervous and musculoskeletal systems

676

3470

1.98

58.72

1.4

63.74

62.10

mmol/l

0.47

563

2739

Diseases of the myoneural junction and muscle

288

1029

2.90

58.71

1.5

1.4

60.89

62.47

mmol/l

0.23

219

838

Disorders of gallbladder, biliary tract and pancreas

1480

5779

1.61

58.53

1.5

1.4

61.10

61.80

mmol/l

0.24

1137

4615

Fracture of femur

606

2691

2.07

58.43

1.5

1.4

55.80

61.12

mmol/l

3.07

476

2177

Major coronary heart disease event

1315

4791

1.66

58.28

1.5

1.4

59.77

61.89

mmol/l

1.03

1038

3768

Sequelae of cerebrovascular disease

694

3059

1.97

57.98

1.4

67.95

60.55

mmol/l

3.99

558

2466

Neuromuscular dysfunction of bladder

200

581

3.57

57.84

1.7

1.4

58.31

62.79

mmol/l

0.80

157

478

severe traumatic brain injury, does not include concussion

458

2047

2.29

57.82

1.5

1.4

68.38

61.03

mmol/l

2.63

369

1648

Disorders of thyroid, IBD co-morbidities

207

388

3.70

57.67

1.4

1.3

65.08

61.07

mmol/l

0.54

167

288

Diverticular disease of intestine

1089

3945

1.74

57.63

1.4

1.3

58.59

62.48

mmol/l

2.48

866

3131

Genitourinary diseases

711

1781

2.02

57.02

1.5

62.78

68.89

mmol/l

2.54

558

1403

Aneurysms, operations, SAH

343

1358

2.60

56.94

1.5

1.4

81.11

60.68

mmol/l

9.05

285

1079

Malignant neoplasm

1203

4212

1.69

56.86

1.4

62.61

62.36

mmol/l

0.06

936

3337

Ulcer of lower limb, not elsewhere classified

334

1308

2.63

56.83

1.4

1.3

54.46

62.00

mmol/l

2.94

269

1040

Malignant neoplasm

1205

4223

1.69

56.77

1.4

62.71

62.33

mmol/l

0.10

936

3348

Lung cancer and mesothelioma

351

1171

2.60

56.76

1.3

63.16

62.63

mmol/l

0.08

273

942

Gastric ulcer

368

1509

2.50

56.61

1.6

1.3

57.96

61.43

mmol/l

0.89

281

1213

Fracture of skull and facial bones

363

1477

2.51

56.55

1.5

1.4

61.75

62.83

mmol/l

0.17

279

1155

Viral hepatitis, IBD co-morbidity

114

7.38

56.01

1.7

1.2

49.58

58.43

mmol/l

0.64

Emergency coronary revascularization (for ACS)

1351

5061

1.63

55.76

1.4

60.16

61.56

mmol/l

0.60

1072

3972

Generalized anxiety disorder

225

718

3.18

55.31

1.8

1.4

60.98

64.95

mmol/l

0.57

174

571

Unspecified haematuria

689

2923

1.95

55.27

1.5

1.4

56.69

63.72

mmol/l

4.86

553

2355

Dermatitis and eczema

1620

6231

1.55

54.58

1.4

60.07

62.75

mmol/l

1.68

1259

4965

Other cataract

716

2804

1.92

54.55

1.5

1.4

59.13

61.63

mmol/l

0.90

580

2244

Ischaemic heart disease, wide definition

1214

4547

1.66

54.42

1.4

58.51

61.15

mmol/l

1.41

958

3577

Other and unspecified polyneuropathies, also in other diseases

388

1662

2.40

54.26

1.6

1.3

57.33

62.08

mmol/l

1.81

319

1339

Type 2 diabetes, definitions combined

1328

4797

1.62

54.12

1.4

59.74

62.98

mmol/l

1.92

1042

3790

Exclusions for E4_PCOS_CONSORTIUM

1043

3813

1.72

53.96

1.7

1.4

66.32

61.03

mmol/l

2.88

837

3007

Glomerular disorders in diseases classified elsewhere

249

863

2.98

53.67

1.6

1.4

47.80

64.00

mmol/l

10.51

210

695

Persons encountering health services for examination and investigation

847

2304

1.86

53.62

1.4

63.56

61.60

mmol/l

0.59

677

1797

Cirrhosis of liver, NAS

157

410

4.05

53.56

1.4

45.84

60.94

mmol/l

5.47

334

Cough

619

2956

1.98

53.56

1.4

1.5

60.51

63.02

mmol/l

0.80

486

2370

Other metabolic disorders

173

479

3.68

53.43

1.5

1.2

61.72

69.16

mmol/l

1.44

154

372

Type 2 diabetes, strict (exclude DM1)

1334

4841

1.62

53.38

1.4

59.67

62.78

mmol/l

1.82

1045

3823

Postmenopausal osteoporosis with pathological fracture

225

745

3.21

53.36

1.6

1.4

57.27

58.62

mmol/l

0.21

179

604

Fibrosis and cirrhosis of liver

199

609

3.41

53.31

1.4

49.96

60.51

mmol/l

3.27

135

493

Other degenerative diseases of the nervous system

457

1495

2.26

53.25

1.5

1.3

59.85

59.65

mmol/l

0.03

372

1177

Diseases of the skin and subcutaneous tissue

1343

4179

1.62

53.13

1.4

59.84

64.06

mmol/l

2.88

1041

3330

Factors influencing health status and contact with health services

366

708

2.62

52.78

1.4

1.3

62.38

63.93

mmol/l

0.25

298

551

Bacterial pneumonia (organism specified)

743

3670

1.86

52.74

1.5

1.4

58.69

62.45

mmol/l

1.75

603

2923

Asthma, hospital admissions , main diagnosis only

1190

6416

1.63

52.61

1.5

61.60

62.51

mmol/l

0.32

962

5077

Total colectomy operation

116

246

4.99

51.78

3.1

1.3

55.46

63.02

mmol/l

0.54

210

Total colectomy

116

246

4.99

51.78

3.1

1.3

55.46

63.02

mmol/l

0.54

210

Peripheral artery disease

813

3601

1.81

51.69

1.4

55.89

61.54

mmol/l

3.90

635

2915

Subarachnoid haemorrhage

234

802

3.02

51.53

1.6

1.4

88.08

61.18

mmol/l

9.20

192

643

Emotionally unstable personality disorder

171

482

3.62

51.47

1.6

1.4

56.70

64.56

mmol/l

1.10

125

398

Follow-up examination after treatment for conditions other than malignant neoplasms

600

2006

2.01

51.17

1.5

1.4

57.91

61.45

mmol/l

1.30

495

1568

Benign neoplasm: Pituitary gland, craniopharyngeal duct

140

348

4.23

51.03

1.7

1.4

80.98

61.88

mmol/l

3.72

127

285

Solid cancers, including Hilmo

1180

4212

1.65

50.81

1.4

62.51

62.30

mmol/l

0.05

912

3335

Coronary atherosclerosis

1034

3881

1.70

50.81

1.4

1.3

57.62

61.43

mmol/l

2.38

822

3061

Sequelae of external causes of morbidity and mortality

473

2255

2.14

50.78

1.6

1.4

59.50

61.96

mmol/l

0.62

386

1802

Other noninfective gastroenteritis and colitis

442

2050

2.20

50.75

2.1

1.4

60.50

63.27

mmol/l

0.67

349

1653

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

171

317

3.86

50.59

1.5

1.3

62.65

59.53

mmol/l

0.39

149

233

Noninfective enteritis and colitis

705

3848

1.85

50.54

2.0

1.4

61.17

62.92

mmol/l

0.48

527

3066

Pleural effusion

326

1335

2.51

50.47

1.6

1.4

55.78

62.35

mmol/l

2.37

247

1083

Transient ischemic attack

906

4204

1.74

50.44

1.4

61.17

60.95

mmol/l

0.06

745

3383

Pain (limb, back, neck, head abdominally)

957

2753

1.76

50.41

1.4

1.5

62.56

64.18

mmol/l

0.49

768

2163

Mycoses

480

2306

2.12

50.41

1.7

1.4

61.54

62.78

mmol/l

0.25

390

1844

Hypothyroidism, strict autoimmune, 3 medication purchases required

1196

5009

1.62

49.49

1.4

60.10

61.46

mmol/l

0.54

960

3970

Autoimmune diseases related-to ILD

1215

6410

1.60

49.33

1.6

1.4

59.38

62.33

mmol/l

1.61

926

5099

Candidiasis

281

1085

2.66

49.14

1.9

1.4

59.88

61.90

mmol/l

0.32

230

874

Sub-endpoint used in defining T1D endpoints

466

2198

2.12

48.95

1.6

1.5

55.53

63.83

mmol/l

4.88

386

1741

Iron deficiency anaemia secondary to blood loss (chronic)

339

1433

2.43

48.93

1.7

1.4

57.78

61.74

mmol/l

1.08

264

1165

Nerve, nerve root and plexus disorders

1517

5990

1.53

48.65

1.4

61.22

61.70

mmol/l

0.16

1213

4726

Viral pneumonia

240

859

2.86

48.60

2.3

1.4

59.95

62.83

mmol/l

0.47

196

693

Acidosis

8.76

48.48

2.3

1.2

63.94

68.16

mmol/l

0.23

Postprocedural endocrine and metabolic disorders, not elsewhere classified

158

440

3.66

48.43

1.5

1.2

61.04

68.25

mmol/l

1.29

140

342

Other dorsopathies, not elsewhere classified

1324

4358

1.59

48.37

1.4

62.86

62.60

mmol/l

0.07

1075

3421

Attention to artificial openings

121

281

4.55

48.33

3.1

1.3

60.43

63.29

mmol/l

0.23

223

Type 2 diabetes, definitions combined, including avohilmo

1301

4777

1.59

48.28

1.4

60.51

62.93

mmol/l

1.19

1012

3787

Panic disorder

201

654

3.13

48.05

1.6

1.3

56.07

64.34

mmol/l

1.56

147

523

Unspecified kidney failure

245

896

2.83

47.90

1.6

1.4

53.28

63.21

mmol/l

3.39

197

711

Liquid cancers, including Hilmo

625

2947

1.90

47.19

1.4

59.23

62.17

mmol/l

1.01

514

2369

Fracture of shoulder and upper arm

652

3556

1.86

47.08

1.6

1.4

57.29

61.99

mmol/l

2.35

512

2832

Undetermined asthma, excluding more controls

204

679

3.06

46.89

1.4

1.3

62.85

66.52

mmol/l

0.64

164

544

Acute pancreatitis

354

1552

2.33

46.86

1.6

1.4

58.05

62.21

mmol/l

0.99

264

1250

Familial hypercholesterolemia

201

665

3.08

46.76

1.3

1.2

64.04

65.95

mmol/l

0.28

170

509

Pneumonitis due to solids and liquids

196

644

3.15

46.56

1.7

1.4

62.78

60.80

mmol/l

0.23

157

512

Asthma, including avohilmo

1637

6062

1.50

46.33

1.4

1.5

62.40

62.47

mmol/l

0.02

1293

4807

Other bacterial intestinal infections

347

1517

2.34

46.28

1.9

1.4

57.39

62.21

mmol/l

1.33

283

1196

Leisure time condition

338

1461

2.37

46.28

1.6

1.4

63.30

62.77

mmol/l

0.07

257

1190

Solid cancers

1143

4177

1.62

46.05

1.4

62.64

62.19

mmol/l

0.12

884

3304

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

122

294

4.27

46.01

1.7

1.3

49.84

64.07

mmol/l

2.09

250

Spondylosis

837

3819

1.73

45.98

1.4

60.82

61.06

mmol/l

0.06

677

2999

Nonorganic sleeping disorders

332

1428

2.37

45.80

1.6

1.4

59.34

64.22

mmol/l

1.26

263

1145

Other retinal disorders

1061

5007

1.63

45.79

1.4

59.62

61.59

mmol/l

0.87

871

3961

Acute and transient psychotic disorders

208

713

2.99

45.65

1.4

55.42

63.75

mmol/l

1.73

145

563

Other bacterial intestinal infections, including avohilmo

414

1955

2.16

45.57

1.8

1.4

57.92

62.79

mmol/l

1.57

338

1535

Other disorders of glucose regulation and pancreatic internal secretion

184

590

3.23

45.52

1.8

1.4

59.19

64.39

mmol/l

0.83

149

478

Other headache syndromes

595

3178

1.89

45.41

1.5

1.4

61.07

61.00

mmol/l

0.01

506

2469

Disorders of choroid and retina

1246

5629

1.56

44.96

1.4

60.23

61.37

mmol/l

0.45

1028

4443

Other (not insulin) diabetes medications

1360

5212

1.54

44.88

1.4

59.10

62.64

mmol/l

2.28

1062

4128

Diabetic nephropathy, excluding more controls

294

969

2.54

44.75

1.5

1.4

48.49

60.65

mmol/l

7.59

247

774

Disorder of lipoprotein metabolism, unspecified

176

554

3.24

44.59

1.5

1.2

55.23

67.62

mmol/l

4.14

149

425

Artificial opening status

142

395

3.77

44.20

3.1

1.4

66.59

61.75

mmol/l

0.44

102

313

Atherosclerosis, excluding cerebral and coronary sclerosis

752

3392

1.77

44.16

1.4

55.78

61.48

mmol/l

3.69

588

2757

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

437

2064

2.09

44.12

1.3

1.4

62.17

63.26

mmol/l

0.20

325

1672

Respiratory insufficiency

162

491

3.39

43.63

1.7

1.4

61.98

61.72

mmol/l

0.02

116

404

Persons encountering health services for specific procedures, not carried out

157

469

3.44

43.45

2.1

1.4

61.71

65.53

mmol/l

0.39

117

376

COPD, hospital admissions 1, only main diagnosis

602

2806

1.87

43.44

1.5

1.4

55.12

62.63

mmol/l

5.15

465

2272

Benign neoplasm of other and unspecified endocrine glands

267

1072

2.56

43.24

1.6

1.4

71.63

61.29

mmol/l

2.97

233

870

COPD-related respiratory insufficiency

248

963

2.65

43.08

1.5

1.4

53.92

62.27

mmol/l

2.43

183

775

Mental and behavioural disorders due to tobacco

176

568

3.20

43.07

1.6

1.4

52.66

62.93

mmol/l

2.55

116

468

Neoplasms

859

2641

1.72

42.62

1.5

1.6

66.05

64.82

mmol/l

0.28

681

2080

Other gastritis (incl. Duodenitis)

384

1811

2.16

42.48

1.6

1.3

55.14

62.48

mmol/l

3.04

296

1447

Smoking dependency

176

574

3.17

42.32

1.6

1.4

52.66

63.20

mmol/l

2.65

116

472

Postprocedural disorders of digestive system, not elsewhere classified

102

231

4.70

42.18

5.8

1.4

77.48

61.82

mmol/l

2.00

193

Injury, poisoning and certain other consequences of external causes

639

1716

1.88

42.16

1.4

1.5

63.39

64.49

mmol/l

0.23

523

1366

Other diseases of blood and blood-forming organs, wide

392

1876

2.13

41.82

1.6

1.4

62.04

62.61

mmol/l

0.10

309

1510

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

350

1611

2.22

41.33

1.3

1.4

60.07

63.02

mmol/l

0.54

244

1302

Preparatory care for dialysis

120

312

4.06

41.32

1.6

1.3

52.70

62.46

mmol/l

2.17

106

254

Other diseases of the respiratory system

384

1834

2.14

41.21

1.6

1.4

61.44

61.66

mmol/l

0.03

294

1481

Other respiratory disorders and diseases

384

1834

2.14

41.21

1.6

1.4

61.44

61.66

mmol/l

0.03

294

1481

Acute pancreatitis (for exclusion)

354

1639

2.20

41.13

1.6

1.4

58.05

62.19

mmol/l

0.99

264

1317

Hypocalcemia

151

5.71

41.08

1.7

1.3

63.29

59.59

mmol/l

0.27

127

Injuries to the shoulder and upper arm

1249

6375

1.52

40.89

1.5

1.4

61.27

61.96

mmol/l

0.23

1000

5045

Hepatic failure, not elsewhere classified

111

275

4.28

40.86

1.5

1.3

49.12

61.18

mmol/l

2.32

222

Extracorporeal dialysis

145

433

3.50

40.52

1.6

1.4

56.53

63.34

mmol/l

1.27

122

351

Undetermined asthma

204

737

2.82

40.49

1.4

1.3

62.85

64.37

mmol/l

0.21

164

592

Other diseases of anus and rectum

495

2592

1.93

40.33

1.5

1.3

57.09

63.95

mmol/l

3.43

383

2092

Sciatica+with lumbago

727

3778

1.72

40.07

1.4

61.62

61.48

mmol/l

0.03

592

2958

Schizoaffective disorder

139

406

3.53

39.95

1.4

47.96

62.46

mmol/l

4.09

106

336

Manic episode

129

5.94

39.90

1.4

1.3

55.34

59.24

mmol/l

0.37

111

Abnormal findings on examination of blood, without diagnosis

729

3887

1.72

39.89

1.4

58.92

63.13

mmol/l

2.04

597

3093

Alcohol-induced acute pancreatitis

198

4.84

39.43

1.5

1.3

52.67

60.52

mmol/l

0.73

166

Diseases of the eye and adnexa

895

2708

1.67

39.42

1.5

64.35

63.79

mmol/l

0.12

727

2098

Amputation

217

827

2.70

39.18

1.4

53.50

62.26

mmol/l

2.88

174

670

Explicit bacterial Sepsis, including avohilmo

196

711

2.82

38.81

1.7

1.4

57.19

63.98

mmol/l

1.46

154

571

Explicit bacterial Sepsis

192

691

2.85

38.60

1.6

1.4

56.71

63.91

mmol/l

1.59

150

555

Hypoglycaemia, other or unspecified

149

466

3.31

38.53

1.8

1.4

60.42

64.85

mmol/l

0.55

123

378

Sequelae with surgical and medical care as external cause

371

1798

2.11

38.37

1.6

1.4

59.05

61.77

mmol/l

0.63

309

1436

KRA_PSY_EATING, excluding more controls

175

4.89

38.30

2.2

1.6

66.47

71.25

mmol/l

0.28

153

Insulin, fast-acting (human)

215

826

2.65

37.97

1.4

53.07

63.92

mmol/l

4.20

178

651

Hypoparathyroidism

112

296

4.02

37.82

1.6

1.4

63.45

58.43

mmol/l

0.58

243

Other pleural conditions

218

849

2.65

37.74

1.6

1.4

54.32

61.97

mmol/l

2.32

172

682

Colectomy operation

321

1482

2.22

37.73

2.0

1.3

55.87

61.86

mmol/l

1.40

205

1210

Other/unspecified dorsalgia

544

2974

1.83

37.51

1.5

1.4

58.64

61.34

mmol/l

0.80

441

2322

Disorders of eyelid, lacrimal system and orbit

1234

6068

1.50

37.46

1.4

60.18

62.35

mmol/l

1.07

1013

4794

Dipeptidyl peptidase 4 (DPP-4) inhibitors

908

4488

1.60

37.29

1.4

58.40

61.38

mmol/l

1.46

717

3603

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

176

617

2.94

37.28

1.6

1.5

56.35

61.60

mmol/l

0.95

141

496

Malnutrition

177

5.09

37.22

1.8

1.6

58.70

64.48

mmol/l

0.57

145

Benign neoplasms

1237

4473

1.51

37.15

1.4

1.5

63.81

62.95

mmol/l

0.26

981

3523

Enterocolitis due to Clostridium difficile

234

951

2.53

37.05

1.8

1.3

56.53

61.69

mmol/l

1.20

187

759

Cytomegalovirus infection, IBD co-morbidity

132

5.76

37.02

1.7

1.3

55.54

61.52

mmol/l

0.52

113

Obesity related asthma

503

2734

1.86

36.98

1.4

61.63

62.47

mmol/l

0.17

396

2174

Periodontitis

1379

6016

1.47

36.98

1.4

62.32

61.36

mmol/l

0.33

1073

4773

Injuries to the elbow and forearm

1018

5678

1.55

36.69

1.6

1.4

60.95

62.19

mmol/l

0.44

815

4497

Peripheral arterial reconstruction

332

1574

2.16

36.48

1.4

1.3

53.06

60.96

mmol/l

3.36

256

1279

Drug-induced adrenocortical insufficiency

120

6.06

36.48

1.9

1.5

69.29

62.20

mmol/l

0.59

104

Intestinal adhesions without obstruction

180

647

2.87

36.46

1.9

1.3

60.34

62.27

mmol/l

0.20

132

540

Other diseases of liver

302

1378

2.23

36.44

1.5

1.4

55.53

62.56

mmol/l

2.18

234

1113

Other/unspecified cytomegaloviral diseases

113

6.20

36.43

1.7

1.3

55.28

63.45

mmol/l

0.75

100

Bacterial intestinal infections, IBD co-morbidities

341

1636

2.13

36.25

1.9

1.4

56.56

62.19

mmol/l

1.71

278

1299

Other and unspecified injuries of head

163

557

3.02

36.24

1.4

60.31

62.89

mmol/l

0.30

131

440

Volvulus

184

4.84

36.22

1.8

1.3

56.24

59.78

mmol/l

0.29

152

Liquid cancers

498

2566

1.86

36.18

1.4

57.77

62.58

mmol/l

1.97

420

2067

Chronic periodontitis, including avohilmo

1373

6019

1.46

36.14

1.4

62.19

61.36

mmol/l

0.28

1070

4776

Cutaneous abscess, furuncle and carbuncle

383

1921

2.02

35.88

1.7

1.4

59.71

63.57

mmol/l

0.98

290

1528

Chronic gastritis

466

2506

1.89

35.60

1.5

1.3

58.63

61.33

mmol/l

0.77

368

1998

Other symptoms and signs involving the digestive system and abdomen

275

1219

2.30

35.56

1.6

1.4

59.72

64.14

mmol/l

0.89

215

966

Psychotic depression

104

270

3.96

35.53

1.5

1.3

54.21

64.21

mmol/l

1.36

228

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

144

5.27

35.35

1.7

1.3

48.69

63.13

mmol/l

2.73

119

Hernia

1297

5902

1.47

35.01

1.6

1.4

59.93

61.76

mmol/l

0.83

1014

4677

Cytomegaloviral disease

139

5.45

34.96

1.7

1.3

55.54

62.36

mmol/l

0.62

120

Noninfectious colitis NAS

243

1030

2.41

34.96

2.1

1.4

57.16

62.64

mmol/l

1.11

198

835

Mental and behavioural disorders due to opioids

127

5.54

34.94

2.0

1.3

60.76

66.18

mmol/l

0.29

112

Cellulitis

356

1762

2.05

34.71

1.5

1.4

57.16

63.23

mmol/l

1.93

272

1411

Mycoses, including avohilmo

1245

6481

1.47

34.64

1.5

1.4

60.56

62.46

mmol/l

0.85

1012

5113

Myalgia

349

1717

2.06

34.51

1.4

63.35

62.18

mmol/l

0.19

289

1345

Coagulation defects, purpura and other haemorrhagic conditions

319

1520

2.14

34.48

1.6

1.4

59.80

63.52

mmol/l

0.80

249

1229

Lung diseases due to external agents

262

1156

2.32

34.40

1.7

1.4

62.25

61.90

mmol/l

0.04

209

934

Cytomegaloviral disease, including avohilmo

141

5.37

34.40

1.7

1.3

55.54

62.43

mmol/l

0.64

122

Other systemic involvement of connective tissue (FG)

429

2228

1.92

34.33

1.5

1.4

60.39

60.93

mmol/l

0.10

356

1745

Persistent mood disorders

290

1333

2.21

34.31

1.5

1.3

55.02

62.35

mmol/l

2.45

224

1062

Vascular disorders of the intestines

156

538

3.00

34.17

1.5

1.3

57.15

61.95

mmol/l

0.77

122

440

Soft tissue disorders

1317

4611

1.47

34.04

1.4

1.5

62.46

63.02

mmol/l

0.17

1052

3635

Presence of cardiac and vascular implants and grafts

716

3195

1.67

34.02

1.4

1.3

59.08

61.59

mmol/l

0.98

575

2561

Streptococcal septicaemia

169

613

2.83

33.63

1.6

1.4

56.86

62.90

mmol/l

1.09

131

499

Inflammatory diseases of the central nervous system

162

575

2.90

33.61

1.4

68.32

61.11

mmol/l

1.08

129

460

Symptoms and signs involving the skin and subcutaneous tissue

1009

6329

1.52

33.57

1.4

60.42

61.99

mmol/l

0.58

812

5021

Streptococcal septicaemia, including avohilmo

173

636

2.79

33.56

1.7

1.4

57.41

63.23

mmol/l

1.03

135

519

Mixed and other personality disorders

122

367

3.41

33.48

1.5

1.4

56.90

64.43

mmol/l

0.87

304

Sleep disorders (combined)

1492

5478

1.43

33.47

1.4

61.22

61.91

mmol/l

0.25

1191

4359

L04AX Other immunosuppressants

772

4856

1.60

33.11

1.6

1.5

62.54

62.30

mmol/l

0.05

618

3852

Assault

178

668

2.71

32.98

1.6

1.4

60.18

64.79

mmol/l

0.51

123

530

Oesophageal varices

106

296

3.76

32.97

1.4

1.3

46.89

64.22

mmol/l

4.29

244

Traumatic subarachnoid haemorrhage

211

4.30

32.82

1.4

1.3

74.40

61.01

mmol/l

1.60

163

Unknown and unspecified causes of morbidity

113

329

3.52

32.65

1.6

1.3

58.52

62.74

mmol/l

0.57

253

Dorsopathies

1266

4390

1.47

32.39

1.4

1.5

62.86

62.90

mmol/l

0.01

1019

3452

197

785

2.55

32.33

1.8

1.4

68.47

65.60

mmol/l

0.31

160

619

Second line medication for Crohn's disease

784

4983

1.59

32.10

1.6

1.5

62.53

62.47

mmol/l

0.01

626

3952

Behavioural syndromes associated with physiological disturbances and physical factors

1255

5883

1.45

32.02

1.5

1.4

60.31

62.30

mmol/l

0.89

985

4661

Viral and other specified intestinal infections, including avohilmo

334

1596

2.03

31.90

2.1

1.5

63.36

67.50

mmol/l

0.85

267

1271

Functional dyspepsia

388

2038

1.93

31.84

1.6

1.3

57.89

62.72

mmol/l

1.48

321

1607

Biguanides

1301

5465

1.45

31.82

1.4

59.00

61.98

mmol/l

1.70

1010

4343

Viral and other specified intestinal infections

257

1130

2.25

31.71

2.3

1.6

63.77

66.83

mmol/l

0.46

210

904

Collagenous colitis

188

747

2.59

31.33

2.0

1.4

60.46

62.47

mmol/l

0.29

145

610

Suppurative and necrotic conditions of lower respiratory tract

123

391

3.27

31.12

1.6

1.3

54.67

63.53

mmol/l

1.53

315

Cardiomyopathy

266

1230

2.20

31.05

1.6

1.4

60.51

64.59

mmol/l

0.82

204

997

Intracerebral haemorrhage

244

1092

2.29

31.04

1.5

1.3

77.05

61.22

mmol/l

5.05

200

874

Systemic connective tissue disorders

566

3358

1.71

30.94

1.5

1.4

58.89

61.20

mmol/l

0.74

468

2668

Peripheral artery operations in Hilmo

237

1050

2.31

30.85

1.3

1.4

52.43

62.02

mmol/l

3.87

183

852

Paralytic ileus

235

4.00

30.77

2.5

1.3

60.67

61.46

mmol/l

0.05

189

Other intervertebral disc disorders

1043

4172

1.50

30.65

1.4

62.48

61.75

mmol/l

0.20

836

3264

Dental operations

864

2843

1.58

30.64

1.4

1.3

61.61

61.20

mmol/l

0.10

716

2245

ILD medications: azathioprine

212

898

2.40

30.52

1.8

1.4

59.69

65.13

mmol/l

0.98

163

712

Phobic anxiety disorders

142

491

2.92

30.51

1.7

1.5

58.36

66.60

mmol/l

1.29

107

405

Focal brain injury

112

339

3.39

30.50

1.5

1.4

71.22

62.39

mmol/l

0.99

272

Disorders resulting from impaired renal tubular function

256

3.86

30.38

1.5

1.3

55.89

62.94

mmol/l

0.97

208

Other specified and unspecified personality disorders

135

458

3.01

30.33

1.6

1.4

53.43

63.12

mmol/l

1.64

373

Acute peritonitis

137

471

3.01

30.27

1.8

1.4

54.02

62.11

mmol/l

1.44

101

377

Non-allergic asthma (mode), excluding more controls

237

1046

2.27

30.21

1.5

1.4

64.08

66.28

mmol/l

0.32

194

837

Viral infections characterized by skin and mucous membrane lesions

608

3693

1.66

30.17

1.5

61.64

62.62

mmol/l

0.24

493

2922

166

632

2.70

30.16

1.4

1.3

55.29

62.81

mmol/l

1.18

102

508

Fracture of lower leg, including ankle

792

5030

1.56

30.10

1.4

59.10

61.77

mmol/l

1.08

619

3978

Major coronary heart disease event excluding revascularizations

909

3946

1.53

30.08

1.4

1.3

58.49

61.43

mmol/l

1.38

720

3123

Intestinal malabsorption

106

315

3.50

29.93

3.3

1.4

55.98

62.62

mmol/l

0.98

259

Other diseases of intestine

258

1201

2.19

29.73

2.1

1.3

55.31

63.01

mmol/l

2.04

195

983

Conduction disorders

448

1995

1.82

29.63

1.4

56.01

64.33

mmol/l

4.34

352

1599

Pain associated with micturition

208

888

2.39

29.55

1.5

1.4

57.61

63.77

mmol/l

1.35

174

733

Open wound of lower leg

266

1258

2.16

29.47

1.5

55.74

63.04

mmol/l

2.31

206

1018

Other and unspecified drugs and medicaments

165

636

2.67

29.28

1.7

1.4

55.50

61.49

mmol/l

1.23

132

506

Decubitus ulcer and pressure area

146

530

2.85

29.24

1.6

1.3

50.78

60.33

mmol/l

2.30

123

417

Complications of internal orthopaedic prosthetic devices, implants and grafts

397

2168

1.86

29.07

1.5

1.4

59.98

60.97

mmol/l

0.21

326

1742

Diseases of oral cavity, salivary glands and jaws

820

2705

1.57

29.05

1.4

62.61

60.85

mmol/l

0.56

676

2145

Speech disturbances, not elsewhere classified

187

769

2.50

29.02

1.6

1.4

64.49

61.01

mmol/l

0.46

152

619

Agranulocytosis

206

886

2.38

28.87

1.7

1.5

65.14

62.43

mmol/l

0.42

158

726

Benign neoplasm of colon, rectum, anus and anal canal

979

5628

1.48

28.79

1.4

59.01

60.84

mmol/l

0.78

788

4489

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1282

5740

1.42

28.70

1.4

62.27

61.65

mmol/l

0.20

1008

4538

Chronic periodontitis, complicated

808

5175

1.54

28.63

1.4

59.92

61.54

mmol/l

0.50

631

4111

Amyloidosis

6.36

28.24

1.6

1.2

53.08

68.90

mmol/l

1.76

Other mental disorders due to brain damage and dysfunction and to physical disease

241

1119

2.21

28.16

1.5

1.3

60.91

59.95

mmol/l

0.13

185

901

Any dementia, excluding more controls

595

2478

1.67

28.10

1.4

1.3

62.44

60.84

mmol/l

0.46

493

2015

Heartburn

176

713

2.52

28.03

1.6

1.4

67.01

63.81

mmol/l

0.40

136

573

Finngen Rheumatological endpoints

1146

4524

1.44

27.79

1.4

62.38

62.67

mmol/l

0.08

927

3517

Diabetic nephropathy

296

1479

2.02

27.40

1.5

1.4

48.59

60.81

mmol/l

8.42

248

1169

Diagnoses used for exclusion with ILD

400

2230

1.82

27.33

1.6

1.4

60.98

61.56

mmol/l

0.09

327

1774

Diseases of peritoneum

187

790

2.43

27.32

1.7

1.4

55.36

61.76

mmol/l

1.43

140

638

Azathioprine

212

943

2.29

27.32

1.8

1.4

59.69

65.12

mmol/l

0.98

163

751

Other and unspecified mood [affective] disorders

259

3.58

27.23

1.3

49.34

61.81

mmol/l

2.27

223

Angina pectoris

829

3627

1.53

27.23

1.4

59.98

61.51

mmol/l

0.54

675

2878

Other problems related to primary support group, including family circumstances

149

548

2.69

27.14

2.7

1.8

72.02

65.30

mmol/l

0.83

127

457

Sleep disorders

1177

5729

1.42

27.14

1.5

1.4

60.51

62.06

mmol/l

0.60

935

4526

Disorders of parathyroid gland

381

2075

1.85

27.11

1.5

1.3

56.93

59.82

mmol/l

0.83

315

1655

Amyloidosis, other/unspecified

6.86

27.10

1.6

1.2

52.12

65.37

mmol/l

1.22

Purpura and other haemorrhagic conditions

228

1050

2.22

27.09

1.6

1.5

59.74

63.04

mmol/l

0.53

174

856

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

116

386

3.09

27.08

1.5

1.4

64.56

63.23

mmol/l

0.09

319

Weight loss

198

862

2.36

27.05

1.6

1.4

61.93

62.83

mmol/l

0.10

157

705

Alzheimer disease, excluding more controls

265

809

2.15

26.91

1.3

61.33

57.90

mmol/l

0.74

221

638

Abnormal weight loss

188

803

2.41

26.86

1.6

1.4

60.02

62.51

mmol/l

0.33

149

654

Alcohol abuse counselling and surveillance

6.36

26.74

1.3

1.4

54.31

58.85

mmol/l

0.25

Deforming dorsopathies

403

2264

1.80

26.74

1.4

61.80

62.00

mmol/l

0.03

323

1784

Enlarged lymph nodes

194

838

2.35

26.72

1.5

1.4

60.71

64.59

mmol/l

0.65

151

657

Fall on and from stairs and steps

402

2260

1.80

26.71

1.4

57.45

62.32

mmol/l

1.55

302

1807

Pneumonia due to other infectious organisms, not elsewhere classified

200

4.02

26.58

1.4

1.3

67.74

57.03

mmol/l

1.29

159

Chronic apical periodontitis

1426

5824

1.38

26.54

1.5

1.4

63.04

61.89

mmol/l

0.43

1107

4640

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

387

1757

1.84

26.48

1.3

1.4

62.74

62.68

mmol/l

0.01

306

1421

Sequelae of injuries of head

101

315

3.31

26.37

1.7

1.4

73.72

61.99

mmol/l

1.32

262

Abnormalities of gait and mobility

220

1011

2.23

26.37

1.4

60.25

63.14

mmol/l

0.56

185

820

Failure and rejection of transplanted organs and tissues

6.47

26.36

1.8

1.5

47.00

60.68

mmol/l

1.45

Zoster [herpes zoster]

327

1735

1.92

26.29

1.5

1.4

58.97

62.15

mmol/l

0.81

264

1388

Oesophagitis

110

362

3.14

26.28

1.7

1.3

53.93

60.80

mmol/l

1.20

286

Small cell lung cancer

159

4.42

26.14

1.5

1.3

75.62

59.24

mmol/l

2.09

126

Small cell lung cancer, including Hilmo

159

4.42

26.14

1.5

1.3

75.62

59.24

mmol/l

2.09

126

Other diseases of pancreas

164

667

2.53

26.12

1.7

1.4

57.47

62.77

mmol/l

0.90

129

543

Diseases of pulp and periapical tissues, including avohilmo

1360

5084

1.39

26.11

1.5

1.4

62.78

62.21

mmol/l

0.17

1074

4073

Other disorders of bladder

186

799

2.37

26.10

1.4

1.3

63.58

63.22

mmol/l

0.04

144

653

Acute upper respiratory infections of multiple and unspecified sites

986

4967

1.46

26.08

1.5

1.4

60.90

62.36

mmol/l

0.50

778

3906

Glomerulonephritis

173

722

2.46

25.99

1.7

1.4

54.11

63.19

mmol/l

2.38

146

581

Drug-induced osteoporosis with pathological fracture

141

4.78

25.85

1.7

1.3

61.70

62.65

mmol/l

0.05

116

Other disorders of lacrimal gland

546

3367

1.64

25.76

1.4

60.63

61.20

mmol/l

0.12

455

2660

Pneumocystosis, including avohilmo

137

4.78

25.73

1.4

1.3

67.62

59.33

mmol/l

0.77

118

Pneumocystosis

137

4.78

25.73

1.4

1.3

67.63

59.33

mmol/l

0.77

118

Haemorrhage, not elsewhere classified

233

3.69

25.58

1.5

1.3

57.92

57.97

mmol/l

0.00

182

Diseases of the musculoskeletal system and connective tissue

597

1827

1.65

25.56

1.5

1.6

63.94

65.07

mmol/l

0.23

485

1432

Charcot foot

6.18

25.55

1.3

1.2

54.56

66.78

mmol/l

1.13

Persons with potential health hazards related to communicable diseases

394

2206

1.78

25.54

1.6

66.67

65.32

mmol/l

0.22

301

1761

Transport accidents

519

2612

1.66

25.52

1.5

1.4

61.59

64.13

mmol/l

0.63

423

2070

Pacemaker

615

3631

1.59

25.42

1.4

58.43

61.46

mmol/l

1.17

490

2949

Other arthritis (FG)

432

2515

1.74

25.37

1.5

1.4

62.05

62.26

mmol/l

0.03

349

1977

Dental caries, including avohilmo

1003

3534

1.46

25.33

1.5

1.4

61.95

62.21

mmol/l

0.07

819

2812

Myocardial infarction

731

3340

1.54

25.29

1.4

58.83

61.48

mmol/l

1.02

581

2654

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1181

6611

1.40

25.18

1.4

1.5

61.91

62.34

mmol/l

0.13

961

5223

Other general symptoms and signs

214

3.74

25.10

1.8

2.1

64.76

64.67

mmol/l

0.00

172

Other diseases of lip and oral mucosa

591

3740

1.60

25.03

1.4

58.00

61.70

mmol/l

1.43

489

2951

Degeneration of the brain due to alcohol

153

4.45

24.88

2.1

1.3

54.90

61.01

mmol/l

0.46

124

Degeneration of nervous system due to alcohol

153

4.45

24.88

2.1

1.3

54.90

60.72

mmol/l

0.43

123

Other systemic involvement of connective tissue

435

2557

1.72

24.77

1.5

1.4

60.97

61.51

mmol/l

0.10

361

2034

Mental and behavioural disorders due to cannabinoids

6.14

24.77

1.5

58.52

71.79

mmol/l

0.62

Malignant neoplasm of respiratory system and intrathoracic organs

345

1559

1.86

24.70

1.4

63.62

62.69

mmol/l

0.15

276

1257

Budesonide

205

940

2.22

24.60

1.8

1.3

64.57

63.21

mmol/l

0.15

145

753

Amenorrhoea

238

3.55

24.59

2.3

1.5

68.97

64.40

mmol/l

0.28

191

Abnormal involuntary movements

216

1013

2.17

24.56

1.7

1.4

60.77

63.63

mmol/l

0.54

177

815

Small cell lung cancer, helper endpoint

167

4.20

24.53

1.5

1.3

75.62

59.52

mmol/l

2.07

144

Polycystic ovarian syndrome, consortium definition

905

3544

1.47

24.42

1.5

1.4

63.74

59.82

mmol/l

1.78

718

2807

Caries of dentine, including avohilmo

1056

3778

1.44

24.40

1.4

1.5

62.12

62.57

mmol/l

0.12

855

3024

Disorders of continuity of bone

155

633

2.50

24.37

1.5

1.4

58.79

64.51

mmol/l

0.89

121

515

Somatoform disorder

220

1042

2.14

24.30

1.6

1.3

57.54

63.44

mmol/l

1.42

181

827

Pruritus

191

859

2.27

24.11

1.4

1.5

59.87

63.85

mmol/l

0.70

156

694

Disorders of lacrimal system

643

4118

1.55

23.97

1.4

59.78

61.36

mmol/l

0.46

535

3255

Diseases of pulp and periapical tissues and dental caries

905

3166

1.48

23.97

1.4

62.46

61.92

mmol/l

0.14

739

2527

Obsessive-compulsive disorder

209

3.69

23.94

1.7

1.4

65.89

68.58

mmol/l

0.14

180

Type 1 diabetes, definitions combined

117

417

2.84

23.92

2.2

1.8

62.29

72.31

mmol/l

1.69

345

Gout

445

2266

1.71

23.89

1.5

1.3

53.28

61.20

mmol/l

4.50

344

1803

Later onset COPD

479

2323

1.68

23.85

1.5

1.3

57.40

62.22

mmol/l

2.17

391

1889

Fitting and adjustment of other devices

553

3056

1.61

23.85

1.4

59.80

62.34

mmol/l

0.82

437

2442

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

288

1491

1.93

23.85

2.2

1.6

66.42

65.99

mmol/l

0.05

236

1184

AV-block

286

1269

1.95

23.82

1.4

1.3

53.64

63.62

mmol/l

4.54

225

1033

Myocardial infarction, without ST-elevation

646

3797

1.55

23.80

1.4

57.89

61.11

mmol/l

1.51

519

3073

Other nutritional deficiencies

816

5092

1.47

23.70

1.4

62.50

62.62

mmol/l

0.02

610

4037

Disorders of oesophagus in diseases classified elsewhere

146

4.43

23.67

1.4

1.3

56.42

57.29

mmol/l

0.06

121

Other and unspecified effects of external causes

342

1900

1.82

23.63

1.8

1.5

58.65

63.06

mmol/l

1.11

267

1521

Unspecified acute lower respiratory infection

232

1134

2.08

23.63

1.5

1.4

57.58

62.69

mmol/l

1.16

198

901

Non-allergic asthma (mode)

237

1158

2.05

23.42

1.5

1.4

64.08

64.96

mmol/l

0.11

194

923

Type 1 diabetes, strict (exclude DM2)

117

422

2.81

23.41

2.2

1.8

62.29

71.97

mmol/l

1.61

352

Viral pneumonia (known virus, not influenza)

196

3.85

23.37

2.5

1.4

62.36

59.55

mmol/l

0.20

164

Other complications of surgical and medical care, not elsewhere classified

158

665

2.43

23.30

2.4

1.4

64.16

61.40

mmol/l

0.32

128

541

Fracture of forearm

780

4765

1.48

23.23

1.5

1.4

61.52

61.20

mmol/l

0.08

621

3780

Hyperaldosteronism

197

3.84

23.22

1.4

1.3

68.05

60.19

mmol/l

0.80

160

Hypertensive Renal Disease

187

3.87

23.18

1.5

1.3

52.08

63.44

mmol/l

1.84

147

Migraine with aura

264

1357

1.96

23.16

1.5

57.71

64.02

mmol/l

1.83

212

1042

Other disorders of skin and subcutaneous tissue, not elsewhere classified

239

1191

2.04

23.16

1.7

1.4

53.74

62.95

mmol/l

3.43

188

958

Visual disturbances and blindness

746

5045

1.49

23.14

1.5

1.4

65.94

61.41

mmol/l

2.02

618

4000

Other inflammatory liver diseases

122

456

2.75

23.13

1.7

1.4

55.63

61.17

mmol/l

0.87

104

371

Speech and linguistic disorders, excluding more controls

296

3.12

23.11

2.8

2.2

71.66

68.74

mmol/l

0.22

259

Polyarthrosis

362

1851

1.79

23.00

1.4

1.3

63.30

59.14

mmol/l

1.15

294

1438

Irritable bowel syndrome

343

1925

1.80

22.93

1.6

1.3

60.12

64.17

mmol/l

1.03

278

1525

Elevated blood glucose level

151

629

2.46

22.85

1.4

60.34

62.69

mmol/l

0.25

117

515

ILD, hospital admission 2, with pulmonary infections

158

672

2.40

22.77

1.4

1.3

62.87

61.41

mmol/l

0.18

141

538

Lumbar disc prolapse

787

3964

1.48

22.71

1.4

60.18

61.76

mmol/l

0.52

626

3099

Migraine

543

2656

1.60

22.66

1.6

1.5

64.33

62.60

mmol/l

0.36

434

2048

Malignant neoplasm of bronchus and lung, including Hilmo

341

1587

1.82

22.66

1.3

1.4

62.60

62.32

mmol/l

0.04

267

1282

Sequelae of injuries, of poisoning and of other consequences of external causes

318

1754

1.84

22.59

1.5

1.4

61.57

62.29

mmol/l

0.10

252

1386

Other diseases of hard tissues of teeth

770

2670

1.50

22.48

1.4

62.86

60.92

mmol/l

0.62

629

2124

Other specified/unspecified arthritis

383

2233

1.73

22.47

1.5

1.4

62.88

62.11

mmol/l

0.13

313

1763

Insomnia

1121

5658

1.39

22.35

1.4

60.16

61.90

mmol/l

0.69

895

4455

Visual disturbances

681

4560

1.51

22.34

1.5

1.4

65.95

61.71

mmol/l

1.67

564

3616

Allergic asthma (mode), excluding more controls

208

969

2.11

22.31

1.5

1.4

61.96

67.94

mmol/l

1.09

170

773

Pain in joint

660

2649

1.54

22.30

1.6

1.4

64.01

63.43

mmol/l

0.12

532

2076

Other condition

215

1046

2.09

22.23

1.7

1.4

63.68

62.38

mmol/l

0.15

164

839

Somnolence, stupor and coma

281

3.24

22.20

1.5

1.3

60.93

62.60

mmol/l

0.11

223

Calcific aortic valvular stenosis, operated

506

3061

1.61

22.13

1.4

58.19

61.35

mmol/l

1.15

416

2472

Calcific aortic valvular stenosis

506

3061

1.61

22.13

1.4

58.19

61.35

mmol/l

1.15

416

2472

Cardiac arrest

215

3.38

22.10

2.2

1.2

58.33

70.97

mmol/l

1.40

176

Other symptoms and signs involving the circulatory and respiratory systems

114

421

2.77

22.07

1.4

56.87

64.33

mmol/l

1.01

338

Other viral diseases

340

1918

1.78

22.05

1.9

1.6

66.11

64.50

mmol/l

0.23

284

1517

Malignant neoplasm of digestive organs, including Hilmo

637

3071

1.54

22.04

1.4

56.79

61.68

mmol/l

2.14

457

2463

Cerebral palsy and other paralytic syndromes

178

808

2.25

22.03

2.5

1.5

66.61

63.52

mmol/l

0.34

148

647

Endovascular or surgical operations to intracerebral aneurysms

117

440

2.74

21.98

1.5

1.4

87.85

58.95

mmol/l

6.51

348

Gingivitis and periodontal diseases

1292

4924

1.36

21.96

1.4

62.82

61.61

mmol/l

0.43

1031

3911

Autoimmune hepatitis, wide definition

273

3.25

21.89

1.7

1.4

51.88

60.53

mmol/l

1.37

222

Gout, FINNGEN

445

2703

1.65

21.84

1.5

1.3

53.28

62.50

mmol/l

6.09

344

2186

Unspecified jaundice

315

3.07

21.82

1.5

1.4

55.82

62.17

mmol/l

0.61

249

Pyothorax

316

3.09

21.79

1.5

1.3

55.32

61.12

mmol/l

0.66

257

Osteomyelitis

115

431

2.74

21.71

1.5

1.4

54.19

62.69

mmol/l

1.64

356

Osteonecrosis

119

456

2.69

21.54

1.5

1.3

57.12

58.73

mmol/l

0.17

365

Malignant neoplasm of brain, including Hilmo

302

3.10

21.49

1.5

1.4

83.70

62.31

mmol/l

3.25

242

Calcific aortic valvular stenosis, including rheumatic fever

504

3065

1.60

21.47

1.4

57.74

61.14

mmol/l

1.32

414

2475

Calcific aortic valvular stenosis, diagnosis (helper)

502

3054

1.60

21.45

1.4

57.68

61.13

mmol/l

1.35

412

2465

Operations 2 for CAVS

502

3054

1.60

21.45

1.4

57.68

61.13

mmol/l

1.35

412

2465

Secondary parkinsonism, excluding more controls

110

4.72

21.42

1.4

1.2

56.68

60.78

mmol/l

0.25

Diaphragmatic hernia

554

3588

1.56

21.36

1.5

1.4

58.74

61.54

mmol/l

0.96

449

2890

Diabetic maculopathy, excluding more controls

164

730

2.29

21.28

1.3

1.4

52.25

62.64

mmol/l

3.34

135

585

Protozoal diseases

205

3.63

21.16

1.4

1.3

66.27

61.04

mmol/l

0.46

172

Acute upper respiratory infections

1349

6069

1.34

21.07

1.5

1.4

61.55

61.93

mmol/l

0.12

1099

4803

Fentanyl

179

828

2.20

21.05

1.7

1.3

58.21

61.20

mmol/l

0.41

139

644

Superficial injury of hip and thigh

255

1345

1.93

20.96

1.6

1.3

58.14

62.48

mmol/l

0.96

207

1087

Parkinson's disease, excluding more controls

178

753

2.21

20.94

1.4

1.3

71.77

59.44

mmol/l

3.54

137

600

Congenital malformations, deformations and chromosomal abnormalities

644

4089

1.50

20.84

1.6

1.5

66.50

63.17

mmol/l

0.94

503

3217

Protozoal diseases, including avohilmo

207

3.58

20.83

1.4

1.3

66.27

61.11

mmol/l

0.46

174

Duodenal ulcer

178

827

2.19

20.83

1.6

1.3

59.78

60.69

mmol/l

0.10

130

664

Injuries to the knee and lower leg

1500

6182

1.32

20.63

1.5

1.4

60.79

62.87

mmol/l

1.12

1196

4904

Hydrocephalus

146

629

2.38

20.60

1.7

1.4

86.21

61.17

mmol/l

6.41

129

507

Benign neoplasm: Colon

811

5359

1.43

20.34

1.4

59.51

60.99

mmol/l

0.51

655

4285

Malignant neoplasm of bronchus and lung

299

1388

1.83

20.29

1.4

62.73

63.06

mmol/l

0.05

238

1118

Scoliosis

130

536

2.47

20.12

1.5

64.91

63.92

mmol/l

0.09

109

433

Eating disorder

280

3.07

20.10

2.2

1.6

66.47

70.56

mmol/l

0.24

240

Chronic ulcer of skin, not elsewhere classified

134

562

2.45

20.09

1.7

1.4

50.49

61.26

mmol/l

3.19

108

443

Emotional disorders starting during childhood or adolecense, excluding more controls

5.04

20.06

2.1

3.2

65.44

78.88

mmol/l

0.88

Diabetic retinopathy, excluding more controls

384

1260

1.73

19.92

1.4

56.96

59.93

mmol/l

0.74

313

988

Migraine without aura

186

892

2.10

19.89

1.6

66.54

65.98

mmol/l

0.05

150

692

Disturbances of skin sensation

335

1950

1.73

19.82

1.5

1.4

60.66

62.43

mmol/l

0.30

267

1548

Vascular diseases of the intestine

318

2.97

19.74

1.4

1.3

56.56

60.80

mmol/l

0.46

264

Acute sinusitis

606

3683

1.50

19.74

1.5

1.4

63.20

62.29

mmol/l

0.20

498

2868

Statin medication

746

2881

1.47

19.66

1.4

61.16

64.17

mmol/l

1.00

592

2205

Post-traumatic stress disorder

243

3.21

19.65

2.9

1.4

60.29

63.64

mmol/l

0.18

209

Monoamine oxidase A inhibitors

160

729

2.23

19.65

1.5

1.3

56.81

62.62

mmol/l

1.05

126

597

Venous thromboembolism

781

5298

1.43

19.62

1.4

61.64

60.75

mmol/l

0.25

606

4240

Hydronephrosis

172

808

2.17

19.58

1.5

1.4

57.64

66.13

mmol/l

1.73

135

661

Exposure to other specified factors

988

6204

1.37

19.42

1.5

59.49

63.21

mmol/l

2.07

764

4926

Drug-induced neutropenia

128

535

2.46

19.36

1.3

1.4

64.54

61.46

mmol/l

0.38

437

Cushing syndrome

5.76

19.36

1.6

1.4

63.15

62.82

mmol/l

0.01

Cardiomyopathy, other and unspecified

119

481

2.53

19.27

1.6

1.4

61.30

63.45

mmol/l

0.20

395

Vitamin deficiency

333

2.88

19.23

1.6

1.3

64.85

60.66

mmol/l

0.36

272

Vitamin deficiency, wide

333

2.88

19.23

1.6

1.3

64.85

60.66

mmol/l

0.36

272

Cerebral aneurysm, nonruptured

143

629

2.32

19.20

1.4

71.12

60.73

mmol/l

1.76

118

509

5-aminosalicylic acid

245

1312

1.89

19.18

2.0

1.4

60.40

64.47

mmol/l

0.72

167

1049

Cardiomyopathy (excluding other)

179

861

2.11

19.16

1.6

1.4

57.77

64.10

mmol/l

1.30

138

698

Malignant neoplasm of head and neck

137

592

2.36

19.15

1.5

1.4

61.17

60.20

mmol/l

0.08

111

472

Other viral diseases, including avohilmo

401

2443

1.64

19.13

1.8

1.6

65.20

64.79

mmol/l

0.06

336

1926

Alzheimer’s disease (Atypical or mixed), excluding more controls

145

467

2.36

19.11

1.3

58.98

58.57

mmol/l

0.05

120

369

677

4196

1.47

19.11

1.3

1.4

60.71

60.91

mmol/l

0.05

558

3376

Zoster [herpes zoster], including avohilmo

744

5040

1.44

19.08

1.4

60.48

61.25

mmol/l

0.22

604

4017

Pulmonary heart disease, diseases of pulmonary circulation

494

3203

1.56

19.02

1.4

61.40

61.09

mmol/l

0.06

376

2581

Fracture of neck

116

469

2.54

18.87

1.7

1.3

61.21

61.91

mmol/l

0.06

101

375

Allergic asthma (mode)

208

1032

1.98

18.87

1.5

1.4

61.96

66.08

mmol/l

0.65

170

817

Rheumatoid arthritis

451

2529

1.59

18.86

1.5

1.4

62.34

60.54

mmol/l

0.39

367

1976

Cardiomyopathies, Primary/intrinsic

169

801

2.14

18.81

1.6

1.4

56.37

64.30

mmol/l

1.86

131

650

Cervical disc disorders

461

2951

1.58

18.74

1.5

1.4

61.95

61.33

mmol/l

0.12

378

2310

Special screening examination for other diseases and disorders

151

684

2.23

18.73

1.4

59.57

62.44

mmol/l

0.42

125

552

Misadventures to patients during surgical and medical care

213

1100

1.97

18.73

1.6

1.4

58.59

62.09

mmol/l

0.57

172

894

Persistent delusional disorders

134

580

2.37

18.72

1.3

1.4

55.27

59.87

mmol/l

0.69

101

464

Abnormal findings on examination of urine, without diagnosis

306

2.94

18.64

1.5

1.4

59.73

62.26

mmol/l

0.24

254

Malignant neoplasm of head and neck, including Hilmo

158

734

2.19

18.55

1.5

1.4

62.25

60.76

mmol/l

0.14

124

593

Actinic keratosis

639

3989

1.47

18.49

1.3

1.4

60.67

60.56

mmol/l

0.02

528

3218

Arthropathies in other diseases classified elsewhere

224

3.28

18.36

1.4

1.3

57.27

62.31

mmol/l

0.45

178

Amputation of toe

131

570

2.36

18.13

1.4

1.3

52.61

60.94

mmol/l

1.91

103

457

Reimbursement for rheumatic diseases

744

5244

1.42

18.09

1.5

1.4

60.70

61.41

mmol/l

0.19

613

4140

ILD, hospital admissions 3, with pneumonia sepsis

140

627

2.28

18.04

1.4

1.3

64.46

60.36

mmol/l

0.59

126

514

Thrombocytopenia, unspecified

128

553

2.37

17.98

1.8

1.4

63.50

61.34

mmol/l

0.19

442

Soft tissue disorders related to use, overuse and pressure

388

2411

1.63

17.96

1.4

62.51

60.80

mmol/l

0.33

322

1908

Skin changes due to chronic exposure to nonionizing radiation

650

4075

1.46

17.94

1.3

1.4

60.76

60.74

mmol/l

0.00

536

3285

Assault by bodily force

370

2.67

17.67

1.5

1.4

66.74

66.38

mmol/l

0.02

307

All influenza (not pneumonia)

180

895

2.04

17.60

1.8

1.4

64.96

64.56

mmol/l

0.04

140

725

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

704

4517

1.43

17.53

1.5

1.4

65.38

63.09

mmol/l

0.60

551

3555

Inflammatory bowel disease

374

2317

1.63

17.50

1.9

1.4

62.50

62.83

mmol/l

0.04

252

1845

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

146

675

2.22

17.48

1.5

1.4

56.97

62.51

mmol/l

1.01

117

541

Type 1 diabetes, strict definition, subgroup 1

255

3.02

17.47

2.6

2.0

59.49

79.56

mmol/l

3.47

209

Degeneration of macula and posterior pole

758

4166

1.42

17.46

1.4

61.32

61.12

mmol/l

0.05

620

3347

Symptoms and signs involving speech and voice

460

2995

1.55

17.42

1.5

1.4

64.56

61.70

mmol/l

0.70

378

2382

Morphin

139

3.90

17.36

1.4

1.3

62.63

60.76

mmol/l

0.11

103

Asthma and allergy, excluding more controls

114

467

2.43

17.30

1.6

1.5

64.71

68.65

mmol/l

0.37

373

Encephalitis

187

3.44

17.29

1.2

1.4

65.37

63.31

mmol/l

0.13

155

Type 1 diabetes, strict definition

278

2.91

17.27

2.6

2.0

60.10

78.49

mmol/l

3.17

225

Other diseases of oesophagus

150

704

2.17

17.21

1.7

1.3

54.06

61.07

mmol/l

1.45

118

572

Infection of intervertebral disc (pyogenic)

5.22

17.13

2.0

1.4

56.93

55.25

mmol/l

0.09

Other viral diseases, not elsewhere classified

226

1227

1.86

16.86

2.1

1.6

68.65

63.99

mmol/l

0.70

188

983

Use of biperiden

346

2.70

16.82

1.5

1.3

52.92

60.56

mmol/l

1.06

279

Primary_lymphoid and hematopoietic malignant neoplasms

361

2244

1.63

16.79

1.4

58.75

61.87

mmol/l

0.80

308

1804

Faecal incontinence

158

766

2.10

16.71

1.6

1.3

61.39

62.39

mmol/l

0.12

122

625

Ulcerative colitis

293

1727

1.71

16.67

1.9

1.4

60.18

63.21

mmol/l

0.47

187

1386

Alzheimer’s disease (Late onset), excluding more controls

209

706

1.95

16.60

1.3

62.76

58.22

mmol/l

0.90

168

557

Rheumatism, unspecified

199

1048

1.93

16.58

1.5

1.4

58.65

61.18

mmol/l

0.43

165

834

Personal history of risk-factors, not elsewhere classified

5.59

16.54

1.6

1.3

65.72

70.25

mmol/l

0.17

Other eating disorders

162

3.51

16.48

2.1

1.6

62.54

75.78

mmol/l

0.84

144

Amputation of foot

209

3.26

16.44

1.4

1.3

56.28

61.96

mmol/l

0.49

169

Superficial injury of abdomen, lower back and pelvis

210

1128

1.88

16.42

1.6

1.4

58.32

63.30

mmol/l

0.89

171

912

Asthma and allergy

114

479

2.37

16.36

1.6

1.4

64.71

68.54

mmol/l

0.36

377

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

375

2.61

16.35

1.3

1.4

53.97

59.77

mmol/l

1.01

302

Other diseases of biliary tract

157

767

2.09

16.30

1.7

1.4

57.12

61.80

mmol/l

0.71

114

627

Anaemia in chronic diseases classified elsewhere

170

3.50

16.24

1.7

1.4

54.80

62.46

mmol/l

0.86

138

Cholelithiasis, broad definition with cholecystitis

1090

5510

1.32

16.17

1.5

1.4

61.53

61.65

mmol/l

0.03

850

4411

Other disorders of ear

1170

5800

1.31

16.07

1.4

63.42

61.59

mmol/l

0.76

947

4574

Erosion of teeth , including avohilmo

294

1753

1.69

16.03

1.7

1.5

61.64

63.77

mmol/l

0.32

231

1391

Other shoulder lesions

135

627

2.19

15.92

1.4

63.55

63.11

mmol/l

0.04

111

499

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

162

3.51

15.91

2.0

1.6

61.23

60.62

mmol/l

0.03

137

Stomatitis and related lesions

266

1549

1.74

15.89

1.5

1.4

64.36

62.58

mmol/l

0.30

219

1248

Other diseases of stomach and duodenum

109

464

2.40

15.89

1.8

1.4

57.12

59.78

mmol/l

0.30

370

Superficial injury of lower leg

336

2079

1.63

15.88

1.5

1.4

59.37

63.45

mmol/l

1.05

267

1663

Fissure and fistula of anal and rectal regions

285

1692

1.70

15.82

1.4

59.16

64.27

mmol/l

1.30

205

1357

Diffuse brain injury

143

3.65

15.80

1.3

1.2

73.38

61.59

mmol/l

0.70

110

Other encephalitis

173

3.42

15.77

1.2

1.4

66.64

62.77

mmol/l

0.26

145

DVT of lower extremities and pulmonary embolism

609

4263

1.43

15.72

1.4

61.79

60.91

mmol/l

0.21

461

3424

Disorders of psychological development

129

545

2.22

15.66

2.4

2.2

79.91

70.42

mmol/l

1.10

109

462

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

111

480

2.36

15.59

1.4

82.08

60.80

mmol/l

4.28

103

388

Eating disorders

103

430

2.42

15.49

2.1

1.5

63.54

65.91

mmol/l

0.15

366

Other disorders involving the immune mechanism, not elsewhere classified

180

3.33

15.46

2.1

1.5

60.29

59.19

mmol/l

0.07

154

Amputation of ankle bones

151

3.60

15.46

1.4

1.3

53.35

60.89

mmol/l

0.60

123

Vitamin B12 deficiency anaemia

173

892

1.97

15.43

1.8

1.3

59.80

61.40

mmol/l

0.21

143

727

Other and unspecified hydrocephalus

142

3.71

15.42

1.8

1.5

85.23

62.24

mmol/l

2.33

121

Adjustment and management of implanted device

271

1601

1.71

15.42

1.9

1.3

56.41

62.59

mmol/l

1.84

222

1282

Toxic effect of other and unspecified substances

6.13

15.40

1.4

1.3

71.06

59.75

mmol/l

0.35

Pure hyperglyceridaemia

4.64

15.28

1.3

1.2

56.65

67.89

mmol/l

0.77

Abnormal findings on diagnostic imaging of other body structures

215

1193

1.83

15.25

1.5

1.4

60.66

61.69

mmol/l

0.13

174

964

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

217

1208

1.82

15.21

1.3

1.4

62.92

62.66

mmol/l

0.03

174

975

Abnormal results of function studies

131

614

2.17

15.15

1.5

1.4

54.18

64.13

mmol/l

1.89

105

500

Hernia of abdominal wall

590

4155

1.43

15.11

1.8

1.4

55.18

62.69

mmol/l

4.88

448

3308

Cervicalgia

269

1595

1.70

15.06

1.5

1.4

61.50

61.57

mmol/l

0.01

228

1253

Hyperkinetic disorders, excluding more controls

262

2.76

15.04

1.6

2.2

71.70

77.46

mmol/l

0.38

222

Injuries to the neck

269

1596

1.70

15.00

1.5

1.4

62.56

63.57

mmol/l

0.14

215

1269

Visual field defects

136

650

2.13

14.99

1.6

1.4

72.82

60.94

mmol/l

1.94

117

515

Other abnormal uterine and vaginal bleeding

318

1397

1.65

14.99

1.4

66.61

58.75

mmol/l

2.36

244

1081

Other disorders of eyelid

650

4393

1.41

14.99

1.4

59.53

61.28

mmol/l

0.56

533

3511

Other sleep disorders

143

696

2.08

14.94

1.3

1.4

60.59

65.20

mmol/l

0.65

115

548

Malignant neoplasm of digestive organs

556

2948

1.45

14.93

1.4

57.63

61.78

mmol/l

1.47

389

2366

Other viral hepatitis, including avohilmo

326

2.62

14.88

1.8

1.3

47.81

65.48

mmol/l

2.37

269

Fall involving bed

329

2.65

14.82

2.0

1.4

59.49

63.00

mmol/l

0.34

267

Obesity and other hyperalimentation

719

4927

1.38

14.81

1.3

1.4

62.50

62.59

mmol/l

0.02

528

3905

Obesity due to excess calories

522

3607

1.46

14.79

1.3

1.4

62.14

63.35

mmol/l

0.24

379

2871

Blood alcohol or alcohol intoxication level

4.23

14.76

1.5

1.4

47.56

54.89

mmol/l

0.41

Parkinson's disease, strict definition, excluding more controls

153

712

2.03

14.74

1.3

72.87

59.17

mmol/l

3.96

119

566

Extrapyramidal and movement disorders

553

3870

1.44

14.72

1.4

62.60

61.81

mmol/l

0.18

439

3086

Paraplegia, diplegia of upper limbs

132

3.71

14.68

1.6

1.2

55.21

60.99

mmol/l

0.49

114

Endocarditis

212

3.06

14.67

1.7

1.3

52.67

66.55

mmol/l

1.87

177

Fracture of foot, except ankle

290

1766

1.66

14.65

1.5

1.4

62.04

62.79

mmol/l

0.11

235

1416

Pneumonia due to Streptococcus pneumoniae

234

2.93

14.58

1.5

1.3

61.84

59.25

mmol/l

0.20

187

Bronchiectasis

133

638

2.13

14.56

1.4

58.86

61.40

mmol/l

0.31

108

520

Dementia, including avohilmo

735

3660

1.38

14.45

1.4

62.94

60.18

mmol/l

1.14

594

2947

Sleep disorders, other/unspecified

162

3.35

14.43

1.7

1.5

57.58

66.02

mmol/l

0.70

139

Disorders of skin appendages

548

3819

1.44

14.39

1.4

1.5

60.89

63.71

mmol/l

0.83

431

3029

Pneumonia derived septicemia

220

3.00

14.38

1.5

57.66

63.56

mmol/l

0.55

181

Hypercalcemia

376

2.50

14.31

2.5

1.4

57.39

59.33

mmol/l

0.17

302

Obesity

711

4899

1.37

14.31

1.3

1.4

62.37

62.60

mmol/l

0.05

526

3887

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

161

717

1.97

14.26

1.8

2.2

67.39

74.49

mmol/l

0.87

125

601

509

3025

1.46

14.19

1.3

1.4

59.96

60.58

mmol/l

0.14

417

2435

Gout, idiopatic and unspecified

357

2306

1.57

14.18

1.5

1.3

53.21

61.90

mmol/l

4.38

270

1865

Injuries to the ankle and foot

800

5089

1.35

14.17

1.5

60.62

63.55

mmol/l

1.12

623

4011

Valvular operations

192

1053

1.85

14.15

1.6

1.4

61.74

64.21

mmol/l

0.37

163

856

Intentional self-harm by unspecified means

5.63

14.14

1.9

1.3

52.75

65.14

mmol/l

0.69

Diabetic neuropathy

190

1039

1.86

14.02

1.6

1.4

56.86

60.89

mmol/l

0.83

154

831

Coxarthrosis [arthrosis of hip](FG)

731

3686

1.37

14.00

1.4

61.12

60.88

mmol/l

0.05

605

2890

Certain disorders involving the immune mechanism

252

1500

1.70

13.98

1.6

1.4

61.71

62.39

mmol/l

0.09

213

1197

Tubulo-interstitial nephritis, not specified as acute or chronic

106

472

2.29

13.96

1.6

1.3

55.46

63.51

mmol/l

1.42

385

Trochanteric bursitis

219

1256

1.77

13.93

1.4

61.34

61.73

mmol/l

0.05

184

994

Glaucoma

812

5169

1.34

13.89

1.4

59.09

61.02

mmol/l

0.79

662

4138

Dementia

681

3383

1.39

13.84

1.4

63.05

59.96

mmol/l

1.27

554

2720

Viral hepatitis, including avohilmo

417

2.37

13.83

1.7

1.4

48.94

64.71

mmol/l

2.50

341

Cerebral cysts

315

2.59

13.81

2.3

1.4

76.00

66.50

mmol/l

0.73

258

Mental retardation, excluding more controls

170

3.19

13.78

3.8

2.5

75.23

66.97

mmol/l

0.57

151

Migraine without aura and triptan purchases

147

744

1.99

13.76

1.7

1.6

65.68

65.52

mmol/l

0.01

120

594

Other diseases of spinal cord

183

3.16

13.76

1.8

1.4

56.71

63.76

mmol/l

0.63

152

Chronic viral hepatitis

225

2.90

13.74

1.7

1.4

42.08

64.67

mmol/l

3.62

183

Pulmonary heart disease

434

2941

1.49

13.73

1.4

61.45

61.02

mmol/l

0.08

330

2371

Small fibre neuropathy

221

2.96

13.72

1.5

1.3

51.89

61.70

mmol/l

1.35

187

Diseases of salivary glands

411

2756

1.50

13.67

1.4

62.45

61.88

mmol/l

0.10

338

2184

Pulmonary embolism

434

2944

1.49

13.66

1.4

61.45

61.01

mmol/l

0.08

330

2373

Other postsurgical states

433

2.33

13.61

1.7

70.35

63.70

mmol/l

0.56

351

Unspecified urinary incontinence

149

764

1.99

13.60

1.3

60.04

60.39

mmol/l

0.04

114

618

Primary biliary cholangitis, wide definition

144

3.46

13.58

1.5

1.4

57.67

58.05

mmol/l

0.02

112

Ventral hernia

331

2124

1.57

13.55

1.7

1.4

55.57

61.93

mmol/l

2.27

238

1697

Meningitis

307

2.60

13.52

1.3

1.4

73.11

62.49

mmol/l

1.03

255

Other local infections of skin and subcutaneous tissue

149

765

1.98

13.50

2.3

1.5

59.01

63.14

mmol/l

0.47

111

623

Oesophageal obstruction

251

2.79

13.44

1.7

1.3

50.21

59.95

mmol/l

1.11

201

Mental and behavioural disorders due to use of other stimulants, including caffeine

4.43

13.39

2.0

1.4

59.09

71.40

mmol/l

0.42

Dependent personality disorder

112

3.81

13.35

2.1

1.3

50.00

58.66

mmol/l

1.08

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

346

2.49

13.26

1.4

51.47

60.08

mmol/l

0.97

276

Poisoning by medicine, drug-induced

4.85

13.23

1.4

63.85

62.93

mmol/l

0.03

Intentional self-harm by sharp object

4.30

13.23

2.2

1.5

61.12

69.54

mmol/l

0.40

Nonalcoholic fatty liver disease

137

688

2.02

13.23

1.5

1.4

54.25

61.78

mmol/l

1.19

106

548

Conductive and sensorineural hearing loss

1041

5370

1.29

13.19

1.5

1.4

63.12

61.15

mmol/l

0.77

838

4249

Other arthrosis

678

3320

1.38

13.19

1.3

1.4

61.87

60.61

mmol/l

0.31

550

2586

Migraine with aura and triptan purchases

148

764

1.95

13.12

1.6

1.5

59.43

65.14

mmol/l

0.94

117

605

Myocardial infarction, strict

623

3188

1.39

13.11

1.4

58.28

61.55

mmol/l

1.28

498

2532

Other and unspecified local infections of skin and subcutaneous tissue

141

718

2.00

13.10

2.3

1.5

57.78

62.95

mmol/l

0.65

107

585

Other disorders of kidney and ureter

194

1095

1.80

13.10

1.5

1.4

55.90

62.75

mmol/l

1.90

162

890

Other diseases of upper respiratory tract

1374

5728

1.25

13.06

1.5

1.4

62.46

62.06

mmol/l

0.13

1113

4517

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

145

747

1.97

13.05

2.0

1.4

57.50

62.54

mmol/l

0.81

123

606

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

199

1095

1.78

13.05

1.8

64.30

65.59

mmol/l

0.15

165

886

Nephrotic syndrome

200

2.99

13.01

1.6

52.24

65.27

mmol/l

1.59

164

Crohn's disease NAS

373

2.40

13.00

2.3

1.4

66.63

63.80

mmol/l

0.19

301

Gout, unspecified

294

1855

1.60

13.00

1.5

1.4

53.19

62.51

mmol/l

4.06

221

1505

Other viral hepatitis

308

2.54

12.88

1.8

1.4

49.18

64.81

mmol/l

1.83

254

Isolated proteinuria

171

3.14

12.67

1.4

1.3

60.64

60.99

mmol/l

0.02

147

Viral hepatitis

390

2.35

12.65

1.7

1.4

50.10

64.73

mmol/l

2.09

319

Recurrent aphthous stomatitis , including avohilmo

199

1143

1.76

12.63

1.5

1.4

64.44

63.66

mmol/l

0.10

165

933

Ulcerative colitis, NAS

168

918

1.85

12.58

1.8

1.4

63.07

64.39

mmol/l

0.10

734

Non-small cell lung cancer, including Hilmo

216

1189

1.72

12.58

1.3

1.4

58.79

62.93

mmol/l

0.80

169

958

Malignant neoplasm of oral cavity

243

2.76

12.56

1.6

1.4

60.64

58.73

mmol/l

0.10

200

Other symptoms and signs involving general sensations and perceptions

313

2.53

12.55

1.5

50.00

59.94

mmol/l

1.51

252

Molar incisor enamel hypoplasia

178

3.02

12.54

2.3

3.5

75.26

83.20

mmol/l

0.53

162

Emphysema

111

527

2.14

12.52

1.5

1.3

61.41

62.29

mmol/l

0.07

423

Assault by unspecified means

4.43

12.49

1.6

1.5

46.24

65.08

mmol/l

1.23

Other or ill-defined heart diseases

289

2.57

12.49

1.3

52.52

65.48

mmol/l

1.88

230

Gout, strict definition

262

1625

1.63

12.47

1.4

51.26

62.03

mmol/l

5.53

201

1315

Nummular dermatitis

123

608

2.06

12.47

1.4

60.14

62.60

mmol/l

0.27

496

Disorders of ocular muscles, binocular movement, accommodation and refraction

524

3708

1.41

12.45

1.7

1.5

68.17

63.05

mmol/l

1.68

423

2931

Cholelithiasis

1020

5440

1.28

12.43

1.4

61.52

61.56

mmol/l

0.01

792

4359

Other viral diseases, not elsewhere classified, including avohilmo

282

1767

1.60

12.42

1.9

1.6

66.48

63.95

mmol/l

0.37

235

1402

Protein-energy malnutrition of moderate and mild degree

4.33

12.40

1.7

1.6

61.29

64.52

mmol/l

0.16

Open wound of forearm

133

677

1.99

12.39

1.6

1.4

64.60

62.83

mmol/l

0.18

102

550

Abnormal findings on diagnostic imaging of central nervous system

309

2.51

12.34

1.7

1.3

78.50

61.37

mmol/l

1.68

257

Any dementia

636

3224

1.38

12.34

1.4

62.20

60.49

mmol/l

0.54

530

2602

Dermatitis due to substances taken internally

358

2.40

12.31

1.3

1.4

65.55

65.40

mmol/l

0.01

294

Other infectious diseases, including avohilmo

136

701

1.97

12.26

1.6

1.4

62.99

62.70

mmol/l

0.03

109

568

Unspecified privation

149

792

1.91

12.23

1.6

1.4

57.99

61.70

mmol/l

0.44

119

644

IgA nephropathy (IgA glomerulonephritis)

119

3.56

12.20

2.0

1.2

52.39

57.75

mmol/l

0.40

101

Other congenital malformations of the digestive system

285

2.57

12.19

5.0

1.8

67.02

70.08

mmol/l

0.23

242

Generalized epilepsy

207

2.86

12.18

1.5

1.7

67.63

68.72

mmol/l

0.05

174

Hepatomegaly and splenomegaly, not elsewhere classified

5.50

12.17

1.3

1.5

56.47

63.00

mmol/l

0.30

Other endocrine disorders

320

2.45

12.16

3.9

2.3

73.97

70.82

mmol/l

0.22

271

Benign neoplasm: Colon, unspecified

362

2428

1.51

12.16

1.4

61.18

61.33

mmol/l

0.02

290

1961

Need for other prophylactic measures

417

2.28

12.14

1.7

1.5

64.21

61.08

mmol/l

0.29

338

Malignant neoplasm of oral cavity, including Hilmo

312

2.50

12.13

1.6

1.4

63.79

59.23

mmol/l

0.31

251

Benign neoplasm: Adrenal gland

124

622

2.03

12.12

1.4

62.97

59.99

mmol/l

0.36

103

503

Cramp and spasm

294

2.54

12.12

1.6

1.4

61.35

64.07

mmol/l

0.24

246

Fall on same level involving ice and snow

725

5473

1.33

12.08

1.4

60.53

61.78

mmol/l

0.32

569

4331

Other diseases of pericardium

271

2.60

12.06

1.5

1.4

68.02

62.80

mmol/l

0.55

219

Assault by blunt object

4.83

12.00

1.5

1.3

45.00

63.81

mmol/l

1.18

Speech and linguistic disorders

103

462

2.16

11.92

2.9

2.3

73.76

72.91

mmol/l

0.06

390

Acute posthaemorrhagic anaemia

256

2.65

11.88

1.6

1.3

61.65

60.80

mmol/l

0.05

205

Ulcer of oesophagus

102

479

2.17

11.87

1.5

1.3

56.96

61.50

mmol/l

0.53

386

Superficial injury of thorax

198

1157

1.73

11.85

1.5

1.4

58.67

62.25

mmol/l

0.59

152

936

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

209

1202

1.71

11.83

1.7

1.8

64.38

65.81

mmol/l

0.17

173

971

Secondary uncertain malignant neoplasm

190

1099

1.75

11.82

1.3

1.4

58.98

62.05

mmol/l

0.47

152

888

Chronic hepatitis, not elsewhere classified

217

2.80

11.78

1.3

1.4

53.00

59.78

mmol/l

0.82

188

Evidence of alcohol involvement determined by blood alcohol level

4.75

11.76

1.4

48.84

63.26

mmol/l

0.70

Crohn disease

148

795

1.88

11.74

2.3

1.4

64.16

64.89

mmol/l

0.06

106

636

Sequelae of other external causes

399

2.28

11.63

1.9

1.4

60.96

63.02

mmol/l

0.14

319

Vitamin D deficiency

3.76

11.62

1.3

65.85

59.38

mmol/l

0.29

Other Crohn's disease

367

2.32

11.62

2.4

1.4

63.64

64.19

mmol/l

0.03

301

Acute gastritis

108

523

2.10

11.60

1.6

1.3

56.41

59.93

mmol/l

0.43

418

Sensorineural hearing loss

1000

5243

1.28

11.60

1.5

1.4

63.59

61.05

mmol/l

1.08

807

4153

Alkalosis

29.34

11.55

4.2

1.0

59.93

63.17

mmol/l

—

Simple and mucopurulent chronic bronchitis

283

2.53

11.55

1.5

57.71

61.56

mmol/l

0.28

227

Emotional disorders and disorders of social functioning with onset specific to childhood

160

3.04

11.51

2.2

3.9

63.62

81.45

mmol/l

1.70

143

Seropositive rheumatoid arthritis

333

2208

1.51

11.50

1.5

1.4

63.98

60.94

mmol/l

0.64

273

1725

Immunodeficiencies

314

2.44

11.49

1.6

1.5

67.35

63.41

mmol/l

0.35

262

Complications of other internal prosthetic devices, implants and grafts

333

2.40

11.47

1.8

1.4

70.09

60.38

mmol/l

0.95

274

Malignant neoplasm of urinary organs

144

774

1.89

11.47

1.4

52.70

61.25

mmol/l

2.53

114

617

Lichen simplex chronicus and prurigo

454

2.18

11.41

1.4

1.3

60.74

61.85

mmol/l

0.11

368

Retinal vascular occlusion

190

1113

1.73

11.35

1.5

1.4

62.15

61.66

mmol/l

0.06

155

893

Non-small cell lung cancer

157

859

1.83

11.35

1.2

1.4

58.26

61.78

mmol/l

0.56

121

690

Event of undetermined intent

365

2.31

11.33

1.6

1.4

62.53

63.72

mmol/l

0.07

304

Toxic effects of substances chiefly nonmedicinal as to source

139

741

1.90

11.32

1.8

1.4

58.73

62.91

mmol/l

0.47

101

603

Periapical abscess

525

3816

1.38

11.31

1.4

62.18

62.06

mmol/l

0.02

409

3006

Benign neoplasm of other and ill-defined parts of digestive system

255

1612

1.60

11.28

1.5

1.4

57.21

61.49

mmol/l

1.09

206

1306

Right hemicolectomy

102

490

2.13

11.27

1.6

1.3

55.61

60.12

mmol/l

0.47

392

Squamous cell neoplasms and carcinomas of the skin

167

945

1.79

11.25

1.3

1.4

62.87

61.65

mmol/l

0.14

137

762

Burns and corrosions

162

908

1.80

11.23

1.4

60.91

65.86

mmol/l

0.64

110

724

Other infectious diseases

115

578

2.03

11.19

1.6

1.4

63.38

62.87

mmol/l

0.05

471

Spondylolisthesis/Spondylolysis

230

1420

1.64

11.18

1.3

1.4

58.49

61.27

mmol/l

0.53

182

1123

Excessive earwax

831

5850

1.29

11.15

1.5

1.4

61.09

61.68

mmol/l

0.17

670

4659

Non-small cell lung cancer, adenocarcinoma

101

485

2.12

11.14

1.3

1.4

56.91

60.25

mmol/l

0.38

393

Tobacco use

312

2.42

11.14

1.6

1.3

46.94

62.57

mmol/l

2.33

258

Retinal vascular disorders

192

1134

1.72

11.14

1.5

1.4

62.89

61.60

mmol/l

0.17

157

910

Alcoholic gastritis

3.98

11.08

1.9

1.3

47.43

60.90

mmol/l

1.06

Late syphilis

4.06

11.00

1.2

1.3

64.12

58.48

mmol/l

0.38

Vasculitis limited to skin, not elsewhere classified

203

2.81

10.98

1.4

1.3

58.39

58.18

mmol/l

0.01

158

Chronic laryngitis and laryngotracheitis

187

1100

1.72

10.98

1.4

1.3

56.38

62.01

mmol/l

1.18

144

877

Fibromyalgia

108

534

2.05

10.95

1.4

1.3

62.54

63.14

mmol/l

0.05

415

Malignant neoplasm of skin

649

3291

1.34

10.89

1.3

1.4

61.20

61.48

mmol/l

0.06

529

2633

Mixed hyperlipidaemia

138

3.17

10.88

1.4

1.2

55.70

69.63

mmol/l

1.77

108

Other abnormal findings of blood chemistry

341

2.34

10.86

1.3

1.4

57.67

63.84

mmol/l

0.76

280

Sequelae of injuries of neck and trunk

176

2.92

10.85

1.8

1.3

54.77

61.21

mmol/l

0.42

150

Other specific joint derangements/joint disorders

780

3730

1.31

10.84

1.5

63.95

62.52

mmol/l

0.38

613

2913

Myocarditis

133

3.20

10.83

1.3

70.75

74.37

mmol/l

0.20

111

Malignant neoplasm of skin, including Hilmo

674

3404

1.33

10.81

1.3

1.4

61.29

61.54

mmol/l

0.05

542

2720

Pneumococcal septicemia

239

2.63

10.80

1.4

1.6

55.98

66.62

mmol/l

1.28

204

Immunodeficiency with predominantly antibody defects

150

3.09

10.76

1.8

1.5

67.31

62.59

mmol/l

0.33

131

Primary biliary cholangitis (PBC)

140

3.18

10.73

1.5

1.4

58.03

58.06

mmol/l

0.00

108

Diabetic retinopathy, strict definition

241

1346

1.61

10.73

1.4

52.24

60.17

mmol/l

3.17

204

1057

Chronic sinusitis

485

3509

1.39

10.69

1.4

61.35

62.16

mmol/l

0.17

400

2739

Other congenital malformations of the digestive system, including avohilmo

353

2.30

10.69

4.6

2.0

64.25

69.81

mmol/l

0.52

295

Other noninfective disorders of lymphatic vessels and lymph nodes

252

2.56

10.68

1.3

58.16

61.77

mmol/l

0.29

212

Other skin changes

274

1783

1.55

10.68

1.4

59.23

62.44

mmol/l

0.66

218

1426

Social phobias

293

2.41

10.64

1.8

1.6

56.06

67.33

mmol/l

1.35

250

Other malignant neoplasms of skin (=non-melanoma skin cancer)

615

3116

1.35

10.61

1.3

1.4

60.28

61.40

mmol/l

0.29

502

2502

Dissocial personality disorder

4.48

10.60

1.5

1.3

66.62

55.32

mmol/l

0.30

Hyperparathyroidism

285

1854

1.54

10.58

1.4

1.3

54.49

59.44

mmol/l

1.76

237

1471

Viral encephalitis, not elsewhere classified/unspecified

131

3.25

10.57

1.4

82.09

59.34

mmol/l

2.05

112

Agoraphobia

3.69

10.55

1.4

1.3

53.60

63.35

mmol/l

0.70

Other specified/unspecified systemic involvement of connective tissue

390

2.22

10.55

1.5

1.4

56.34

60.21

mmol/l

0.42

322

Anorexia (incl.atypical)

241

2.56

10.51

2.1

1.4

58.56

65.47

mmol/l

0.39

206

Abscess of lung

3.73

10.50

2.0

1.3

49.04

60.24

mmol/l

0.99

Adverse effects, not elsewhere classified

222

1381

1.62

10.48

1.9

1.5

56.63

63.36

mmol/l

1.79

183

1113

Arthropathies

969

3865

1.27

10.42

1.5

62.88

62.92

mmol/l

0.01

778

3025

Barrett oesophagus

341

2.31

10.42

1.6

1.3

55.97

59.66

mmol/l

0.35

275

Other and unspecified vasculitis limited to skin

175

2.90

10.42

1.4

1.3

59.10

57.60

mmol/l

0.09

139

372

2413

1.45

10.42

1.4

59.91

59.85

mmol/l

0.01

308

1946

Malignant neoplasm of urinary organs, including Hilmo

159

908

1.77

10.42

1.4

52.18

61.36

mmol/l

3.22

126

727

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

101

498

2.07

10.41

1.4

49.78

60.95

mmol/l

1.85

391

Nonischemic cardiomyopathy

137

748

1.86

10.39

1.4

1.3

60.78

62.69

mmol/l

0.21

106

607

Asthma and opportunity respiratory infection

387

2.23

10.38

1.5

1.3

59.44

60.77

mmol/l

0.11

310

Hallux valgus (acquired)

432

2189

1.42

10.37

1.4

63.96

60.13

mmol/l

1.07

333

1702

Shoulder lesions

894

4207

1.28

10.37

1.4

64.07

61.34

mmol/l

1.09

735

3295

Use of pramipexole

310

2085

1.50

10.37

1.4

59.31

61.55

mmol/l

0.51

249

1667

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

629

3190

1.34

10.36

1.3

1.4

60.46

61.57

mmol/l

0.29

510

2555

Other (seronegative) rheumatoid arthritis, wide

265

1725

1.55

10.35

1.5

1.4

58.76

61.14

mmol/l

0.42

209

1388

Mental disorders, not otherwise specified

386

2.20

10.33

1.6

1.4

59.79

63.48

mmol/l

0.30

325

Salpingitis and oophoritis

212

1310

1.64

10.32

1.6

1.4

60.79

61.49

mmol/l

0.08

165

1024

Other and unspecified intracranial injuries

198

2.75

10.31

1.3

65.42

62.27

mmol/l

0.19

161

Extreme obesity with alveolar hypoventilation

293

2.41

10.31

1.5

1.3

62.07

59.93

mmol/l

0.11

242

Postprocedural musculoskeletal disorders, not elsewhere classified

116

605

1.96

10.22

1.5

1.4

62.08

60.02

mmol/l

0.26

492

Dissociative [conversion] disorders

165

2.90

10.22

1.3

66.32

66.26

mmol/l

0.00

140

Acute alcohol intoxication ICD-9

189

2.76

10.07

1.8

1.3

54.27

63.72

mmol/l

0.88

162

Other epidermal thickening

340

2.29

10.07

1.6

1.4

56.61

63.87

mmol/l

0.94

270

Other and unspecified nerve root and plexus disorders, also in other diseases

243

1560

1.57

10.06

1.4

61.07

62.06

mmol/l

0.15

203

1245

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

135

3.15

10.06

1.4

82.09

59.42

mmol/l

2.04

116

Other extrapyramidal and movement disorders in other diseases

332

2277

1.47

10.06

1.3

1.4

62.33

62.21

mmol/l

0.02

263

1816

Hyperplasia of prostate

396

1552

1.45

10.06

1.4

62.22

62.80

mmol/l

0.09

324

1221

Contact with and exposure to communicable diseases

247

1583

1.56

10.03

1.6

1.7

67.74

66.28

mmol/l

0.18

186

1255

Ovarian dysfunction

235

2.54

10.01

2.4

1.3

71.87

63.37

mmol/l

0.52

201

Late syphilis, including avohilmo

105

3.47

10.00

1.2

1.3

65.79

58.60

mmol/l

0.51

Olecranon bursitis

392

2.18

10.00

1.4

63.69

60.90

mmol/l

0.19

313

Corns and callosities

101

506

2.03

9.98

1.4

58.54

61.64

mmol/l

0.33

402

Amputation of thigh

255

2.50

9.97

1.5

1.3

57.25

60.80

mmol/l

0.28

206

Malignant neoplasm of kidney, except renal pelvis

128

695

1.87

9.95

1.5

1.4

52.44

60.77

mmol/l

2.23

101

559

Thyrotoxicosis, other and/or unspecified

240

1541

1.57

9.94

1.5

1.4

62.86

61.08

mmol/l

0.26

189

1226

Maltreatment syndromes

207

2.65

9.93

1.7

1.5

57.82

67.65

mmol/l

0.83

179

Non-Hodgkin lymphoma, all, including Hilmo

177

1056

1.70

9.93

1.4

59.33

62.22

mmol/l

0.46

148

847

Other disorders of eye and adnexa

178

1063

1.69

9.92

1.6

1.4

58.72

62.80

mmol/l

0.69

145

858

Syphilis

152

2.98

9.91

1.2

1.3

66.09

59.08

mmol/l

0.56

127

Syphilis, including avohilmo

152

2.98

9.91

1.2

1.3

66.09

59.08

mmol/l

0.56

127

Ill-defined and unknown causes of mortality

157

908

1.76

9.90

1.4

1.3

58.90

61.67

mmol/l

0.40

118

726

Lesion of ulnar nerve

169

996

1.72

9.90

1.4

58.18

62.01

mmol/l

0.56

135

805

Complications of genitourinary prosthetic devices, implants and grafts

153

2.96

9.80

1.3

55.34

62.80

mmol/l

0.70

132

Other disorders starting during childhood or adolecense, excluding more controls

124

3.11

9.80

3.0

3.4

74.03

77.92

mmol/l

0.20

116

Lung transplant status

5.59

9.78

1.4

62.63

64.23

mmol/l

0.04

Lung transplantation

5.59

9.78

1.4

62.63

64.23

mmol/l

0.04

Abnormal blood-pressure reading, without diagnosis

281

2.39

9.78

1.7

1.3

67.27

64.57

mmol/l

0.18

233

Other respiratory diseases principally affecting the interstitium

256

1676

1.54

9.77

1.5

1.4

62.93

61.40

mmol/l

0.25

227

1348

Sicca syndrome [Sjögren]

128

700

1.86

9.75

1.5

1.4

58.37

60.03

mmol/l

0.19

111

572

Other abnormalities of plasma proteins

117

3.30

9.75

1.4

1.3

54.55

62.47

mmol/l

0.51

101

Pericarditis

204

2.66

9.73

1.3

61.42

62.78

mmol/l

0.08

166

Other meningitis

3.61

9.73

1.3

1.4

68.15

59.72

mmol/l

0.42

Papulosquamous disorders

475

3489

1.37

9.70

1.4

61.59

61.88

mmol/l

0.05

357

2768

Other ill-defined and unspecified causes of mortality

145

825

1.79

9.70

1.4

1.3

58.53

61.50

mmol/l

0.42

112

664

Psoriasis

329

2269

1.46

9.67

1.5

1.4

59.46

62.62

mmol/l

0.65

244

1803

Other surgical follow-up care

176

2.78

9.67

2.3

1.4

61.03

62.38

mmol/l

0.08

142

Myeloproliferative diseases

126

688

1.86

9.66

1.2

1.4

56.22

60.31

mmol/l

0.69

102

553

Basal cell carcinoma, including Hilmo

610

3125

1.33

9.66

1.3

1.4

60.14

61.54

mmol/l

0.37

498

2506

Methotrexate

173

1034

1.69

9.63

1.8

1.4

61.14

62.30

mmol/l

0.14

152

829

Myeloproliferative diseases (CML excluded)

118

632

1.90

9.62

1.2

1.4

56.55

60.04

mmol/l

0.52

505

Trigeminal neuralgia

425

2.11

9.62

1.3

1.4

68.26

60.25

mmol/l

1.19

346

Chronic rhinitis, nasopharyngitis and pharyngitis

362

2544

1.43

9.59

1.6

1.4

58.26

62.69

mmol/l

1.40

296

2005

Cervicobrachial syndrome

242

1570

1.55

9.58

1.5

1.4

61.85

61.89

mmol/l

0.01

209

1229

L01XE Protein kinase inhibitors

434

2.10

9.54

1.4

58.20

59.35

mmol/l

0.10

346

Chronic nephritic syndrome

242

2.50

9.52

1.7

1.3

51.13

61.36

mmol/l

1.56

197

SLE (Finngen)

195

2.67

9.50

1.4

47.64

58.62

mmol/l

1.20

156

Malignant neoplasm of tongue

140

3.04

9.48

1.6

1.4

61.25

59.90

mmol/l

0.05

115

Disorders of vestibular function (Vertigo)

631

4721

1.31

9.44

1.4

63.47

60.05

mmol/l

1.43

513

3758

Pain in thoracic spine

174

1047

1.68

9.43

1.6

1.4

61.87

62.80

mmol/l

0.10

149

811

Presence of other devices

335

2293

1.45

9.42

1.5

1.4

60.01

61.57

mmol/l

0.32

261

1857

Degenerative diseases of the nervous system

577

3134

1.33

9.41

1.4

60.61

60.31

mmol/l

0.07

471

2530

Unspecified misadventure during surgical and medical care

438

2.07

9.29

1.6

1.4

60.89

60.95

mmol/l

0.00

355

Coxarthrosis

645

3188

1.31

9.29

1.4

60.48

60.60

mmol/l

0.03

529

2498

Primary Sclerosing Cholangitis, IBD and UDCA required

115

3.22

9.28

2.3

1.4

45.61

73.30

mmol/l

3.33

Pemphigoid

228

2.54

9.25

1.5

1.3

55.66

59.72

mmol/l

0.33

183

Haemorrhoids and perianal venous thrombosis

404

2892

1.40

9.25

1.4

1.3

59.68

63.48

mmol/l

1.25

325

2316

Urticaria and erythema

392

2817

1.40

9.16

1.6

1.5

63.53

63.11

mmol/l

0.07

305

2245

Thyroiditis, ILD-related definition

143

824

1.76

9.13

1.3

1.4

58.38

63.63

mmol/l

0.93

121

666

Hypoplasia of dental enamel , including avohilmo

174

2.70

9.10

2.1

3.1

77.07

83.30

mmol/l

0.36

157

Burns and corrosions of external body surface, specified by site

128

715

1.81

9.08

1.4

1.5

61.24

65.79

mmol/l

0.49

579

Crohn's disease of small intestine

394

2.11

9.08

2.3

1.4

66.97

63.63

mmol/l

0.20

322

Cholecystitis

191

1190

1.62

9.07

1.7

1.4

57.08

62.26

mmol/l

1.09

153

952

Disease of hard tissues of teeth, NOS

638

2550

1.32

9.05

1.4

62.48

61.04

mmol/l

0.37

519

2019

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

138

790

1.77

9.04

1.4

52.58

61.05

mmol/l

2.54

109

632

Coxarthrosis, primary

820

5423

1.26

9.00

1.4

59.77

60.67

mmol/l

0.28

677

4320

Seronegative rheumatoid arthritis

157

933

1.70

8.99

1.5

1.3

58.59

61.66

mmol/l

0.40

125

734

Basal cell carcinoma

590

3063

1.32

8.99

1.3

1.4

59.41

61.35

mmol/l

0.58

483

2460

Excessive attrition of teeth

631

4830

1.30

8.96

1.4

60.93

63.26

mmol/l

0.70

505

3812

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

193

1197

1.61

8.95

1.3

1.4

62.08

61.66

mmol/l

0.05

157

972

Intracranial and intraspinal abscess and granuloma

3.94

8.91

1.7

1.4

68.00

59.85

mmol/l

0.37

Disorders of sclera, cornea, iris and ciliary body

634

4915

1.30

8.91

1.4

62.86

62.13

mmol/l

0.16

514

3880

Drug-induced hypoglycaemia without coma

103

3.32

8.88

2.0

1.2

50.22

62.69

mmol/l

1.72

Irregular menses

439

2410

1.37

8.87

1.6

1.4

65.43

61.44

mmol/l

0.98

354

1904

Diabetic retinopathy

487

2241

1.36

8.82

1.4

57.01

58.85

mmol/l

0.48

397

1765

Viral infections of the central nervous system

460

2.01

8.80

1.3

1.4

73.31

60.66

mmol/l

1.82

374

D07AA Corticosteroids, weak (group I)

161

966

1.68

8.80

1.4

1.8

59.60

64.70

mmol/l

0.71

129

781

Poisoning by narcotics and psychodysleptics [hallucinogens]

4.22

8.78

2.2

1.4

86.67

62.82

mmol/l

0.69

Flat foot [pes planus] (acquired)

130

738

1.78

8.77

1.2

1.4

66.12

62.56

mmol/l

0.41

581

Benign neoplasm: Cerebral meninges

146

858

1.73

8.77

1.3

1.4

70.40

60.21

mmol/l

1.95

117

698

Diffuse large B-cell lymphoma

381

2.12

8.74

1.6

1.4

64.44

60.78

mmol/l

0.35

305

Diffuse large B-cell lymphoma, helper endpoint

381

2.12

8.74

1.6

1.4

64.44

60.78

mmol/l

0.35

305

Diffuse large B-cell lymphoma, including Hilmo

381

2.12

8.74

1.6

1.4

64.44

60.78

mmol/l

0.35

305

Schizotypal disorder

3.62

8.73

1.3

60.25

63.35

mmol/l

0.12

Disorders of conjunctiva

960

6040

1.23

8.72

1.4

1.5

59.17

62.96

mmol/l

2.14

777

4776

Diseases of inner ear

704

5301

1.28

8.72

1.4

63.84

60.62

mmol/l

1.38

570

4227

Diseases of male genital organs

508

1898

1.35

8.72

1.5

62.31

65.52

mmol/l

0.81

409

1472

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

577

4268

1.31

8.71

1.4

61.50

62.35

mmol/l

0.19

468

3329

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

368

2.13

8.70

1.3

1.4

51.96

60.85

mmol/l

1.02

289

Other aneurysm

388

2.10

8.70

1.4

64.08

61.97

mmol/l

0.15

318

Varicose veins

769

4605

1.27

8.68

1.4

63.00

61.14

mmol/l

0.66

628

3669

Disorders of synovium and tendon

596

3890

1.30

8.65

1.4

60.50

61.78

mmol/l

0.31

462

3058

Other salmonella infections

211

2.52

8.61

1.8

1.3

47.95

62.23

mmol/l

2.18

172

Blepharochalasis

405

2964

1.38

8.58

1.4

57.93

60.82

mmol/l

0.89

336

2355

Colonic or urogenital fistula

310

2168

1.44

8.53

1.4

59.95

62.74

mmol/l

0.59

221

1736

Disorders of speech understanding and production

300

2.23

8.47

3.5

2.0

72.68

69.98

mmol/l

0.17

251

Other and unspecified psoriasis

488

1.96

8.46

1.5

1.4

55.19

60.95

mmol/l

0.66

403

Endocrine disorders, other/unspecified

122

3.05

8.45

1.4

1.3

70.74

61.56

mmol/l

0.52

109

Diplopia

173

1072

1.63

8.45

1.5

1.4

70.23

62.08

mmol/l

1.46

146

863

Malignant neoplasm of tongue, including Hilmo

178

2.66

8.44

1.5

1.4

60.66

58.41

mmol/l

0.10

144

Inflammatory diseases of female pelvic organs

695

3733

1.28

8.41

1.5

1.4

59.73

60.99

mmol/l

0.33

548

2972

Other and unspecified vascular occlusions

147

877

1.70

8.36

1.6

1.3

60.23

61.64

mmol/l

0.18

120

699

Other disorders of the musculoskeletal system and connective tissue

199

1279

1.57

8.34

1.4

60.38

61.37

mmol/l

0.14

161

1033

Strabismus

291

2015

1.45

8.33

1.5

72.65

63.10

mmol/l

2.57

229

1624

Malignant neoplasm of liver and intrahepatic bile ducts

221

2.46

8.32

1.3

53.37

62.01

mmol/l

0.63

175

Emotional disorders starting during childhood or adolescence

165

2.67

8.32

2.0

2.5

67.73

82.08

mmol/l

1.08

144

Convalescence

315

2.19

8.32

1.6

1.4

56.35

61.97

mmol/l

0.58

247

Hepatocellular carcinoma, including Hilmo

197

2.55

8.31

1.3

1.4

51.45

61.06

mmol/l

0.79

158

L01XX Other antineoplastic agents

499

1.94

8.31

1.3

1.4

51.56

60.50

mmol/l

2.25

400

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

346

2445

1.40

8.29

1.4

1.5

64.49

64.62

mmol/l

0.02

257

1944

ILD, hospital admissions

210

1369

1.55

8.27

1.5

1.4

63.37

61.73

mmol/l

0.25

186

1109

Cystic kidney disease, including avohilmo

234

2.41

8.26

1.7

1.4

54.22

63.86

mmol/l

1.05

190

Postzoster neuralgia

135

2.93

8.26

1.5

1.3

56.58

58.12

mmol/l

0.11

109

Obesity, other/unspecified

333

2372

1.41

8.25

1.2

1.4

62.94

mmol/l

0.00

256

1894

Benign neoplasm of meninges

156

949

1.67

8.25

1.2

1.4

71.88

60.13

mmol/l

2.53

126

772

Viral infections of the central nervous system, including avohilmo

499

1.93

8.25

1.3

1.4

74.15

60.57

mmol/l

2.07

408

Personal history of other diseases and conditions

517

1.90

8.22

2.7

1.8

67.39

69.35

mmol/l

0.13

427

Unstable angina pectoris

493

2924

1.33

8.22

1.4

1.3

59.66

61.37

mmol/l

0.50

402

2341

Other joint disorders

914

3852

1.24

8.19

1.6

1.5

64.90

62.88

mmol/l

0.67

713

3014

Atopic dermatitis, strict definition with reimbursement

254

1653

1.48

8.18

1.6

1.7

61.52

66.98

mmol/l

1.11

186

1317

Exclusion endpoint for clefts

108

3.14

8.18

4.0

3.0

80.04

73.13

mmol/l

0.28

Acquired absence of limb

4.18

8.18

1.7

1.3

54.69

67.93

mmol/l

0.62

IBD patients in KELA-register

221

1458

1.53

8.17

1.8

1.4

64.31

63.53

mmol/l

0.08

139

1167

Urethral stricture

337

2.14

8.17

1.2

1.3

58.61

64.49

mmol/l

0.69

271

Other interstitial pulmonary diseases

214

1405

1.54

8.17

1.5

1.4

63.21

61.70

mmol/l

0.23

189

1134

Type1 diabetes, definitions combined, early onset

252

2.32

8.15

3.2

2.1

63.58

82.65

mmol/l

2.74

215

Other diseases of blood and blood-forming organs

530

1.90

8.15

1.3

1.4

55.75

61.24

mmol/l

0.84

426

Iridocyclitis

267

1833

1.47

8.15

1.4

62.54

61.86

mmol/l

0.10

215

1462

Injury of other and unspecified intrathoracic organs

432

2.00

8.14

1.6

1.3

56.48

60.32

mmol/l

0.37

349

Psoriasis vulgaris

215

1414

1.53

8.11

1.6

1.4

58.10

61.97

mmol/l

0.72

153

1134

Interstitial lung disease endpoints

214

1408

1.54

8.09

1.5

1.4

63.21

61.67

mmol/l

0.24

189

1137

Interstitial lung disease

214

1408

1.54

8.09

1.5

1.4

63.21

61.67

mmol/l

0.24

189

1137

Childhood asthma (age<16)

249

2.17

8.03

1.5

1.6

80.83

75.46

mmol/l

0.32

198

Childhood asthma (age<16), excluding more controls

244

2.19

8.02

1.5

1.6

79.43

75.46

mmol/l

0.22

194

Excessive, frequent and irregular menstruation

403

1564

1.38

8.02

1.8

1.4

62.84

60.29

mmol/l

0.55

326

1212

Crohn's disease of large intestine

281

2.24

8.01

2.1

1.5

61.48

63.21

mmol/l

0.09

235

Cholangitis (primary sclerosing, PSC)

492

1.92

7.95

1.9

1.4

54.59

62.47

mmol/l

1.10

395

Anterior Iridocyclitis

237

1598

1.50

7.94

1.4

62.17

62.03

mmol/l

0.02

195

1279

Rheumatoid arthritis, including avohilmo

479

3638

1.32

7.94

1.5

1.4

61.41

61.18

mmol/l

0.04

390

2884

Viral warts

113

635

1.80

7.93

1.5

61.91

64.62

mmol/l

0.26

518

Injury of eye and orbit

139

828

1.69

7.91

1.8

1.4

60.36

64.24

mmol/l

0.43

111

642

Portal vein thrombosis

111

3.08

7.88

1.4

1.3

52.87

64.21

mmol/l

1.13

Discitis, unspecified

3.47

7.88

1.4

1.3

50.68

55.33

mmol/l

0.26

Fibroblastic disorders

275

1912

1.45

7.86

1.4

57.68

61.83

mmol/l

1.11

219

1515

Diseases of the ear and mastoid process

1269

5332

1.20

7.81

1.4

1.5

62.78

61.99

mmol/l

0.26

1009

4196

Viral pneumonia (unknown virus, not influenza)

432

1.97

7.79

2.1

1.4

66.66

63.97

mmol/l

0.21

345

Polymyalgia rheumatica

209

1382

1.53

7.76

1.4

1.3

61.22

59.80

mmol/l

0.22

172

1108

Progressive vascular leukoencephalopathy

407

2.02

7.74

1.4

53.15

58.92

mmol/l

0.90

327

Other embolism and thrombosis

165

1034

1.61

7.74

1.4

1.3

58.39

62.68

mmol/l

0.76

119

835

Congenital malformations of the circulatory system

162

981

1.62

7.70

1.8

75.96

65.71

mmol/l

1.72

131

805

Malignant neoplasm, without specification of site, including Hilmo

366

2.06

7.67

1.3

52.69

60.33

mmol/l

0.92

280

Localized swelling, mass and lump of skin and subcutaneous tissue

372

2737

1.37

7.65

1.5

1.4

60.16

63.30

mmol/l

0.81

307

2188

Communicating hydrocephalus

164

2.65

7.63

1.6

1.4

99.89

59.27

mmol/l

3.56

135

Drug-induced cataract

158

2.67

7.62

2.2

1.3

57.38

61.54

mmol/l

0.28

139

Brain meningioma

381

2.03

7.62

1.3

1.4

75.06

59.41

mmol/l

2.34

306

In situ neoplasms

512

3949

1.30

7.60

1.3

1.4

60.38

61.61

mmol/l

0.27

421

3154

Bullous disorders

480

1.91

7.55

1.4

63.11

59.98

mmol/l

0.30

389

Assault by sharp object

3.74

7.51

1.3

71.60

61.96

mmol/l

0.26

Cutaneous lupus erythematosus

177

2.56

7.51

1.5

1.3

50.39

59.68

mmol/l

1.19

145

Conjunctivitis

844

5540

1.23

7.51

1.5

59.40

62.67

mmol/l

1.49

687

4391

Other hammer toe(s) (acquired)

253

1587

1.46

7.51

1.3

61.69

58.87

mmol/l

0.58

206

1242

Open wound of ankle and foot

124

728

1.72

7.50

1.5

1.4

55.05

64.54

mmol/l

1.40

587

Other congenital malformations

508

1.87

7.49

2.3

1.9

78.86

65.89

mmol/l

1.44

433

Unspecified event, undetermined intent

125

2.86

7.49

1.3

1.4

49.24

65.17

mmol/l

1.55

111

Personality and behavioural disorders due to brain disease, damage and dysfunction

3.29

7.47

1.6

1.2

50.78

63.78

mmol/l

0.76

Thyrotoxicosis

305

2182

1.41

7.47

1.5

1.4

60.44

61.47

mmol/l

0.17

244

1745

Radiculopathy

197

1296

1.53

7.47

1.3

1.4

61.77

61.21

mmol/l

0.07

159

1019

Covid-19 suspected case

205

1359

1.52

7.46

1.6

1.4

62.33

64.17

mmol/l

0.24

162

1088

Other neurotic disorders

330

2.10

7.45

1.8

1.3

58.18

59.86

mmol/l

0.12

263

Primary ovarian failure

3.50

7.44

3.7

1.3

69.10

60.56

mmol/l

0.41

Malignant neoplasm of tonsil and base of tongue, including Hilmo

166

2.60

7.43

1.7

1.4

62.82

60.58

mmol/l

0.09

132

Cardiodefibrillation

468

3569

1.32

7.42

1.4

59.81

61.98

mmol/l

0.58

378

2879

Sleep apnoea

1093

5749

1.20

7.42

1.4

62.60

61.43

mmol/l

0.41

872

4543

Non-small cell lung cancer, adenocarcinoma, helper endpoint

101

562

1.83

7.41

1.3

1.4

56.91

60.89

mmol/l

0.47

449

Other drug-induced secondary parkinsonism

3.65

7.40

1.3

1.4

50.88

59.26

mmol/l

0.42

Other ulcerative colitis

331

2.08

7.37

2.0

1.4

62.74

64.40

mmol/l

0.09

274

Vitreous haemorrhage

137

831

1.67

7.36

1.4

55.54

61.40

mmol/l

1.05

118

668

Palmar fascial fibromatosis [Dupuytren]

185

1206

1.55

7.32

1.4

57.92

61.78

mmol/l

0.77

145

967

Problems related to social environment

191

2.46

7.32

1.3

1.4

54.09

62.97

mmol/l

0.82

161

Brain meningioma, including Hilmo

394

1.99

7.31

1.2

1.4

74.40

59.17

mmol/l

2.27

316

Arthrosis

798

3534

1.24

7.30

1.4

61.66

61.08

mmol/l

0.14

648

2748

Specific development disorders of speech and language

352

2.03

7.29

3.3

2.2

69.60

69.26

mmol/l

0.02

293

Secondary parkinsonism

217

2.37

7.25

1.4

56.68

59.99

mmol/l

0.21

177

Clear cell adenocarcinoma of kidney

341

2.06

7.22

1.5

1.4

49.90

58.95

mmol/l

1.52

276

Benign neoplasm of mouth and pharynx

140

859

1.65

7.20

1.5

1.4

57.77

61.23

mmol/l

0.45

109

700

Cluster headache, wide

180

2.48

7.20

1.5

1.3

61.66

65.13

mmol/l

0.19

152

Acute and subacute iridocyclitis

222

1511

1.48

7.15

1.4

62.32

61.89

mmol/l

0.05

184

1200

Pyogenic arthritis

481

1.88

7.15

1.4

56.75

63.89

mmol/l

0.85

383

Alcohol induced polyneuropathy

3.77

7.13

1.5

1.2

69.47

60.59

mmol/l

0.32

Abscess of anal and rectal regions

467

1.88

7.11

1.6

1.4

59.40

65.94

mmol/l

0.53

383

Bacterial meningitis

200

2.40

7.10

1.3

1.4

72.84

61.37

mmol/l

0.88

175

Single delivery by forceps and vacuum extractor

422

0.34

7.08

1.3

1.5

75.47

65.73

mmol/l

0.34

323

Sleep apnoea, including avohilmo

1142

5808

1.19

7.07

1.4

62.75

61.50

mmol/l

0.44

910

4584

Dislocation of lens

102

3.04

7.05

1.3

1.4

63.91

61.86

mmol/l

0.09

Other maltreatment syndromes

118

2.84

7.04

1.8

1.3

50.05

64.67

mmol/l

0.92

101

Secondary parkinsonism+Parkinsonism in other disease

220

2.33

7.04

1.4

56.68

60.75

mmol/l

0.27

179

Neuralgia and neuritis, unspecified

317

2.08

7.03

1.3

62.53

59.35

mmol/l

0.21

250

Other fall from one level to another

240

1663

1.45

7.02

1.5

66.04

64.49

mmol/l

0.19

184

1335

Left bundle-branch block

520

1.83

7.02

1.3

56.24

61.99

mmol/l

0.79

424

Malignant neoplasm of tonsil and base of tongue

136

2.73

6.99

1.8

1.3

61.57

62.31

mmol/l

0.03

113

Other strabismus

226

1545

1.47

6.97

1.5

1.6

72.10

64.08

mmol/l

1.51

176

1235

Mental retardation

257

2.20

6.93

3.8

2.6

74.63

70.35

mmol/l

0.26

227

Paracetamol or NSAID medication

161

504

1.62

6.92

2.0

1.7

64.32

69.11

mmol/l

0.63

139

399

Carrier of infectious disease

137

2.69

6.87

2.0

1.4

71.48

61.80

mmol/l

0.61

123

Infective dermatitis

133

817

1.64

6.82

1.4

60.77

62.92

mmol/l

0.24

653

Injury of intra-abdominal organs

126

2.76

6.82

1.7

1.3

57.86

61.13

mmol/l

0.17

111

Other disorders of white blood cells

390

1.96

6.82

1.7

1.4

59.86

60.82

mmol/l

0.08

314

Other specified and unspecified retinal disorders

275

2.16

6.81

1.3

57.69

60.34

mmol/l

0.19

223

Other abnormal findings in urine

121

2.82

6.81

1.8

1.3

57.61

60.66

mmol/l

0.18

105

Other congenital malformations, including avohilmo

129

786

1.65

6.80

2.1

1.8

73.46

65.12

mmol/l

0.93

102

642

Other salmonella infections, including avohilmo

242

2.22

6.79

1.8

1.3

47.50

63.97

mmol/l

2.77

195

Cluster headache, strict

161

2.52

6.79

1.5

1.3

63.29

66.69

mmol/l

0.18

137

Disorders of optic nerve and visual pathways

108

629

1.74

6.77

1.9

1.4

64.00

63.00

mmol/l

0.08

514

Pediculosis, acariasis and other infestations

342

2.01

6.77

1.8

1.3

65.59

65.12

mmol/l

0.03

282

Congenital malformations of the urinary system

391

1.95

6.76

1.7

1.5

55.29

66.31

mmol/l

1.64

320

Other/unspecified rheumatoid arthritis

171

1118

1.55

6.75

1.5

1.3

62.72

60.46

mmol/l

0.28

136

897

Ulcerative ileocolitis

205

2.33

6.71

1.8

1.4

64.29

61.94

mmol/l

0.09

177

Multiple myeloma, including Hilmo

344

2.01

6.71

1.3

1.4

53.32

60.12

mmol/l

1.08

274

Benign neoplasm: Stomach

138

862

1.62

6.66

1.4

56.82

60.80

mmol/l

0.71

120

695

Lesion of lateral popliteal nerve

324

2.04

6.66

1.5

1.3

57.37

60.93

mmol/l

0.27

262

Complications of labour and delivery

387

2839

0.75

6.63

1.5

1.4

60.75

62.12

mmol/l

0.26

305

2257

ILD, hospital admissions 1, main diag only

183

1219

1.52

6.63

1.4

64.29

61.67

mmol/l

0.42

161

987

Inflammatory bowel disease, strict (require KELA)

221

1528

1.45

6.58

1.8

1.4

64.31

63.46

mmol/l

0.09

139

1222

Carcinoma in situ of skin of other and unspecified parts of face

142

897

1.61

6.57

1.3

55.72

60.75

mmol/l

0.84

117

720

Inguinal hernia

660

3529

1.25

6.57

1.4

63.96

62.72

mmol/l

0.31

526

2787

Open wound of abdomen, lower back and pelvis

152

2.54

6.56

2.3

1.3

68.24

64.02

mmol/l

0.21

133

Bullous pemphigoid

177

2.45

6.55

1.5

1.3

55.23

59.25

mmol/l

0.25

146

Malignant neoplasm of oropharynx, including Hilmo

135

2.67

6.54

1.8

1.4

72.59

59.06

mmol/l

0.75

114

Cervicocranial syndrome

124

758

1.65

6.50

1.3

1.4

56.25

61.34

mmol/l

0.96

107

583

Other necrotizing vasculopathies (FG)

490

1.82

6.49

1.5

1.3

54.01

60.18

mmol/l

1.00

385

Congenital malformations of the urinary system, including avohilmo

425

1.89

6.49

1.6

1.5

56.59

65.97

mmol/l

1.21

350

Familial hypercholesterolemia, with ischemic heart disease

129

798

1.64

6.49

1.3

65.72

62.10

mmol/l

0.50

106

642

Rotator cuff syndrome

714

4000

1.23

6.45

1.3

1.4

64.31

61.14

mmol/l

1.16

588

3140

Seropositive rheumatoid arthritis, wide

333

2480

1.35

6.44

1.5

1.4

63.98

61.07

mmol/l

0.60

273

1984

Other pulmonary heart/vessel disease

399

1.92

6.42

1.5

1.4

61.63

62.06

mmol/l

0.03

325

Secondary right heart disease

357

1.97

6.42

1.5

1.4

63.04

60.37

mmol/l

0.20

286

Malignant neoplasm of other and unspecified parts of tongue

103

2.91

6.35

1.5

1.4

67.78

58.96

mmol/l

0.37

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

149

2.55

6.35

1.5

1.4

59.72

59.83

mmol/l

0.00

121

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

3.24

6.35

2.0

2.8

70.83

71.51

mmol/l

0.02

Diseases of spleen

120

2.75

6.33

1.6

1.4

58.09

59.20

mmol/l

0.05

103

Idiopathic pulmonary fibrosis

111

666

1.69

6.31

1.4

1.3

68.54

60.76

mmol/l

1.28

101

528

Subjective visual disturbances

291

2129

1.38

6.30

1.4

60.98

62.05

mmol/l

0.16

239

1708

Herpesviral [herpes simplex] infections

132

827

1.61

6.28

1.6

1.4

67.18

63.58

mmol/l

0.52

110

666

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

570

4368

1.25

6.28

1.4

1.5

58.14

62.76

mmol/l

1.97

463

3450

187

2.36

6.26

1.4

1.3

60.38

61.22

mmol/l

0.04

153

Menorrhagia

362

1508

1.34

6.25

1.4

61.45

59.48

mmol/l

0.38

284

1164

Retinal detachments and breaks

447

3483

1.29

6.24

1.4

57.62

62.44

mmol/l

2.07

368

2765

Burn and corrosion of shoulder and upper limb, except wrist and hand

115

2.76

6.24

1.4

1.5

73.61

61.73

mmol/l

0.58

Speech therapy

320

2383

1.35

6.21

1.6

1.4

60.18

61.68

mmol/l

0.29

278

1904

Cardiac murmurs and other cardiac sounds

563

1.74

6.20

1.6

58.69

65.27

mmol/l

0.74

457

Other crystal arthropathies

151

2.52

6.20

1.2

1.4

56.30

58.46

mmol/l

0.16

121

Dermatophytosis, including avohilmo

711

5719

1.22

6.18

1.4

60.11

62.62

mmol/l

0.93

581

4492

Dilated cardiomyopathy

142

910

1.58

6.17

1.6

1.4

58.06

61.54

mmol/l

0.48

107

731

Cholangitis (primary sclerosing, PSC), with reimbursement 202

116

2.75

6.16

1.6

1.5

48.35

68.90

mmol/l

1.71

101

Necrosis of pulp, including avohilmo

576

4574

1.25

6.14

1.6

1.4

62.64

62.72

mmol/l

0.01

447

3588

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

118

725

1.65

6.12

1.4

59.31

61.20

mmol/l

0.18

583

Herpesviral [herpes simplex] infections, including avohilmo

251

1801

1.40

6.12

1.5

1.4

66.00

63.28

mmol/l

0.47

210

1417

Burns and corrosions of multiple and unspecified body regions

122

2.68

6.11

1.9

1.3

62.73

62.12

mmol/l

0.02

107

Mucosal proctocolitis

123

763

1.62

6.10

1.9

1.4

61.24

64.58

mmol/l

0.28

612

Early complications of trauma

294

2.04

6.09

1.2

1.3

56.93

63.18

mmol/l

0.56

239

!Aliquae complicationes praecoces traumatis

294

2.04

6.09

1.2

1.3

56.93

63.18

mmol/l

0.56

239

Allergic conjunctivitis

593

4604

1.24

6.07

1.4

1.5

58.27

62.88

mmol/l

1.99

482

3639

Prurigo nodularis

171

2.40

6.05

1.5

1.3

59.42

60.81

mmol/l

0.09

147

Other and unspecified visual disturbances

129

813

1.60

6.02

1.6

1.4

65.21

61.53

mmol/l

0.46

107

657

Other disorders of veins

483

3756

1.27

6.00

1.4

61.30

61.00

mmol/l

0.06

394

2990

Other/unspecified seropositive rheumatoid arthritis

327

2457

1.34

5.99

1.5

1.4

64.24

61.09

mmol/l

0.66

267

1964

Dermatophytosis

167

1117

1.51

5.97

1.3

1.4

62.01

61.55

mmol/l

0.05

133

909

Hemiplegia

352

1.93

5.95

1.7

1.3

70.78

62.11

mmol/l

0.61

280

Secondary and unspecified malignant neoplasm of lymph nodes

101

601

1.70

5.93

1.4

59.38

61.64

mmol/l

0.23

486

Mental retardation, wide definition

281

2.05

5.92

3.8

2.4

74.43

69.70

mmol/l

0.30

247

Glaucoma suspect

481

3807

1.27

5.92

1.4

59.76

60.93

mmol/l

0.29

402

3038

Colitis, primary sclerosing

3.37

5.92

2.4

1.5

36.30

68.89

mmol/l

—

Infections with a predominantly sexual mode of transmission

238

1698

1.40

5.91

1.4

61.48

64.06

mmol/l

0.39

190

1327

Thoracic aortic aneurysm

167

1120

1.50

5.90

1.4

64.91

62.26

mmol/l

0.37

137

907

Disorders of tooth development and eruption

155

826

1.54

5.90

1.5

70.94

62.32

mmol/l

1.44

126

644

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

541

1.74

5.89

1.3

1.4

69.37

60.15

mmol/l

1.16

432

Other necrotizing vasculopathies

102

611

1.69

5.87

1.5

1.4

51.95

60.42

mmol/l

1.91

494

Deficiency of other B group vitamins

149

2.48

5.85

1.3

69.13

61.31

mmol/l

0.53

124

Contact with heat and hot substances

319

1.97

5.85

1.5

63.78

67.04

mmol/l

0.19

267

Other/unspecified synovitis and tenosynovitis

127

803

1.60

5.85

1.4

62.01

63.28

mmol/l

0.12

636

3.17

5.84

1.8

1.3

50.38

58.52

mmol/l

0.71

Exposure to smoke, fire and flames

137

2.53

5.83

1.3

1.4

56.36

60.15

mmol/l

0.21

118

Pain and other conditions associated with female genital organs and menstrual cycle

171

959

1.50

5.82

1.5

1.4

62.83

62.77

mmol/l

0.01

139

729

Non-Hodgkin lymphoma, all

327

1.96

5.82

1.6

1.3

64.51

60.58

mmol/l

0.31

260

Carpal tunnel syndrome

700

4998

1.22

5.82

1.4

62.18

60.90

mmol/l

0.35

548

3955

Unspecified dementia

174

1057

1.49

5.80

1.4

1.3

63.90

59.40

mmol/l

0.84

140

834

Haemolytic anaemias

239

2.13

5.80

1.5

1.3

57.72

63.72

mmol/l

0.48

194

Gonarthrosis [arthrosis of knee](FG)

843

4047

1.20

5.79

1.3

1.4

62.08

61.03

mmol/l

0.31

683

3154

Benign neoplasm: Rectum, anus and anal canal

257

1873

1.38

5.77

1.4

56.32

61.85

mmol/l

1.73

204

1504

Redundant prepuce, phimosis and paraphimosis

186

1258

1.46

5.76

1.7

1.4

63.60

66.13

mmol/l

0.36

151

966

Intussusception

144

2.49

5.76

1.6

1.4

57.00

57.57

mmol/l

0.04

119

Atopic dermatitis

542

3461

1.25

5.76

1.6

1.5

58.77

64.96

mmol/l

2.81

417

2745

Other disorders of nervous system

487

1.77

5.74

1.4

62.27

60.23

mmol/l

0.19

391

Acute pharyngitis

126

790

1.59

5.73

2.4

1.6

71.05

66.66

mmol/l

0.49

100

628

Chondrocostal junction syndrome [Tietze]

267

2.06

5.73

1.4

1.3

68.25

58.42

mmol/l

0.74

219

Bell's palsy

137

887

1.56

5.71

1.5

1.4

62.68

62.44

mmol/l

0.02

113

714

Other coagulation defects

510

1.75

5.70

1.5

1.4

60.61

62.82

mmol/l

0.18

414

Ulcerative enterocolitis

163

2.37

5.70

2.1

1.3

40.48

64.34

mmol/l

4.41

136

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

320

2419

1.33

5.66

1.5

1.4

64.96

61.01

mmol/l

0.89

260

1937

Hypogonadotropic hypogonadism

145

2.45

5.66

1.3

1.4

77.50

60.98

mmol/l

1.11

118

Injuries to unspecified part of trunk, limb or body region

124

787

1.59

5.65

1.6

1.5

56.93

62.76

mmol/l

0.80

641

Drug-induced osteoporosis

105

2.77

5.60

1.5

1.3

65.45

60.82

mmol/l

0.18

Disturbance of activity and attention

434

1.78

5.59

1.6

2.4

73.11

76.91

mmol/l

0.24

363

Car occupant injured in other and unspecified transport accidents

180

1239

1.46

5.57

1.4

57.31

64.05

mmol/l

1.19

141

981

Embolic stroke

353

1.90

5.57

1.4

59.77

60.66

mmol/l

0.07

279

Prolonged pregnancy

494

0.36

5.57

1.4

1.5

66.06

66.72

mmol/l

0.02

385

Hypotension due to drugs

111

2.70

5.56

1.7

1.2

50.33

59.99

mmol/l

1.06

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

597

1.68

5.56

1.6

1.4

55.83

61.33

mmol/l

0.74

481

6-mercaptopurine

134

2.49

5.55

1.3

2.0

76.72

64.55

mmol/l

0.72

115

Left ventricular outflow tract obstruction (LVOTO), broad definition

108

666

1.64

5.54

1.6

1.5

63.37

63.18

mmol/l

0.01

535

Need for immunization against other single viral diseases

111

2.68

5.54

1.5

1.4

53.73

60.91

mmol/l

0.37

Gingival hyperplasia

264

2.05

5.53

1.6

1.8

66.86

63.22

mmol/l

0.18

230

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

3.42

5.49

1.9

1.2

56.50

66.53

mmol/l

—

Hyperprolactinaemia

141

2.45

5.48

1.5

1.3

73.00

64.69

mmol/l

0.47

121

Aortic valve malfunction, age under 60 years

101

615

1.66

5.46

1.6

1.4

61.29

63.26

mmol/l

0.16

495

Other noninflammatory disorders of uterus, except cervix

278

1369

1.36

5.46

1.4

62.43

58.25

mmol/l

0.98

227

1057

Systemic lupus erythematosus

252

2.06

5.44

1.4

47.64

60.55

mmol/l

1.58

208

Entropion and trichiasis of eyelid

120

764

1.59

5.43

1.5

1.4

58.24

59.93

mmol/l

0.18

103

619

Labour and delivery complicated by fetal stress [distress]

584

0.49

5.41

1.2

1.5

59.21

68.39

mmol/l

0.58

453

Diabetic maculopathy

162

1038

1.49

5.41

1.3

1.4

52.25

60.43

mmol/l

2.42

135

809

Fistulae involving female genital tract

101

2.75

5.40

1.8

1.4

65.00

58.42

mmol/l

0.27

Rare circulating lymphoid malignancy, including Hilmo

200

2.19

5.37

1.5

1.9

74.00

63.73

mmol/l

0.51

168

Restless leg syndrome

170

1168

1.47

5.36

1.3

1.4

64.88

61.95

mmol/l

0.38

136

938

Lymphoid leukaemia

453

1.77

5.36

1.4

1.6

65.06

62.24

mmol/l

0.20

365

Other congenital malformations of circulatory system

168

2.31

5.36

1.7

1.3

82.66

58.81

mmol/l

1.78

144

Vascular dementia

151

977

1.51

5.35

1.4

1.3

56.96

59.20

mmol/l

0.34

132

771

Ovarian cyst

346

1506

1.32

5.35

1.5

1.4

60.29

59.87

mmol/l

0.06

284

1164

Hepatocellular carcinoma

162

2.34

5.34

1.2

1.4

60.61

61.29

mmol/l

0.03

129

Malignant neoplasm, without specification of site

247

2.06

5.34

1.3

1.4

51.19

58.37

mmol/l

0.62

195

Non-follicular lymphoma

125

807

1.57

5.33

1.5

1.4

57.73

61.76

mmol/l

0.59

101

654

Acute bronchiolitis

258

1.98

5.32

3.3

2.8

72.00

76.87

mmol/l

0.35

230

Vasomotor and allergic rhinitis

352

2655

1.30

5.31

1.5

65.64

64.17

mmol/l

0.24

273

2092

Scabies, including avohilmo

127

822

1.55

5.30

1.8

1.6

64.95

65.41

mmol/l

0.04

104

659

Other intracranial haemorrhages

248

2.06

5.30

1.5

1.3

64.10

62.10

mmol/l

0.12

196

Infection due to other mycobacteria

114

2.62

5.28

1.6

1.4

61.43

57.66

mmol/l

0.20

Other bursopathies

151

1017

1.50

5.27

1.5

1.3

65.41

61.95

mmol/l

0.39

120

806

Atypical facial pain

353

1.87

5.27

1.4

1.3

58.98

60.36

mmol/l

0.11

291

Respiratory tuberculosis, confirmed

114

2.61

5.27

1.5

1.3

59.13

57.24

mmol/l

0.08

Atopic dermatitis, strict definition

234

1666

1.38

5.26

1.6

1.8

61.75

66.91

mmol/l

0.95

176

1327

Pneumothorax

470

1.74

5.26

1.5

1.4

59.33

63.37

mmol/l

0.43

383

Other and unspecified disorders of white blood cells

283

1.98

5.25

1.7

1.3

55.98

59.42

mmol/l

0.27

233

Mild mental retardation

132

2.47

5.25

3.7

1.8

67.70

67.66

mmol/l

0.00

117

Coeliac disease

127

825

1.55

5.25

1.5

1.4

66.16

63.99

mmol/l

0.22

105

673

Symptoms and signs involving emotional state

163

2.31

5.24

1.5

1.4

62.21

66.93

mmol/l

0.28

134

Superficial injury of forearm

103

637

1.63

5.24

1.9

1.4

55.68

64.62

mmol/l

1.39

522

Other noninflammatory disorders of vulva and perineum

100

614

1.64

5.24

1.7

1.4

49.61

60.36

mmol/l

2.55

479

Spontaneous rupture of synovium and tendon

102

630

1.64

5.24

1.4

1.3

55.87

61.78

mmol/l

0.71

495

Sulfasalazine

278

2083

1.34

5.23

1.4

62.05

63.10

mmol/l

0.16

229

1639

Malignant neoplasm of oropharynx

109

2.64

5.20

1.8

1.3

75.26

60.01

mmol/l

0.72

Polycythaemia vera

257

2.02

5.18

1.3

58.20

59.25

mmol/l

0.07

205

Respiratory tuberculosis, confirmed, including avohilmo

115

2.58

5.18

1.5

1.3

59.13

57.30

mmol/l

0.08

Respiratory tuberculosis, bacteriologically and histologically confirmed

121

2.54

5.18

1.5

1.3

58.75

57.71

mmol/l

0.04

100

Benign neoplasm of other and unspecified female genital organs

335

1.88

5.14

1.3

1.4

68.18

60.27

mmol/l

0.63

268

Other peripheral vascular diseases

564

1.67

5.14

1.5

1.4

61.95

62.77

mmol/l

0.07

465

Ulcerative proctitis

327

1.89

5.14

1.8

1.4

63.82

64.71

mmol/l

0.05

275

Lesion of radial nerve

251

2.02

5.12

1.4

1.3

45.48

60.46

mmol/l

2.58

204

Hyperkinetic disorders

475

1.71

5.11

1.6

2.4

71.74

77.26

mmol/l

0.40

394

Malignant neoplasm of tonsil, including Hilmo

110

2.62

5.11

1.8

1.3

69.74

58.80

mmol/l

0.46

Thyrotoxicosis with diffuse goitre

143

960

1.50

5.08

1.3

1.4

65.97

60.55

mmol/l

0.76

116

767

Outcome of delivery

438

0.45

5.07

1.3

1.4

76.54

62.61

mmol/l

0.65

325

Generalized epilepsy, mode (most common among epilepsy diagnosis)

147

2.35

5.04

1.7

1.6

61.63

67.77

mmol/l

0.31

123

Other hearing loss

384

2927

1.28

5.04

1.6

1.4

60.30

60.96

mmol/l

0.13

318

2354

Secondary thrombocytopenia

2.82

5.02

1.5

1.3

60.00

60.59

mmol/l

0.02

Other specified and unspecified disorders of eye and adnexa

267

1.98

5.01

1.3

1.4

55.72

60.38

mmol/l

0.37

216

Visual impairment including blindness (binocular or monocular)

608

1.63

4.98

1.8

1.4

65.06

61.38

mmol/l

0.35

489

Benign paroxysmal vertigo

377

2970

1.28

4.94

1.4

61.91

60.69

mmol/l

0.26

313

2367

Other secondary coxarthrosis

241

2.03

4.94

1.6

1.3

71.58

59.59

mmol/l

1.02

197

Use of antiglaucoma preparations and miotics

119

775

1.55

4.93

1.3

62.02

60.74

mmol/l

0.13

610

Left hemicolectomy

175

2.23

4.91

1.3

59.56

60.79

mmol/l

0.06

146

Malignant neoplasm of small intestine

162

2.27

4.91

1.9

1.4

60.74

59.35

mmol/l

0.07

131

SLE, strict definition

228

2.05

4.90

1.3

1.4

48.46

62.47

mmol/l

1.54

188

SLE, ICD10

228

2.05

4.90

1.3

1.4

48.46

62.47

mmol/l

1.54

188

Aortic aneurysm

258

1895

1.34

4.90

1.4

62.59

62.95

mmol/l

0.05

208

1542

Seropositive rheumatoid arthritis, strict definition

178

1257

1.43

4.89

1.5

1.4

67.12

60.81

mmol/l

1.27

145

1011

Rash and other nonspecific skin eruption

114

736

1.56

4.89

1.4

58.77

64.07

mmol/l

0.77

590

Crystal arthropathies, rheuma endpoint

169

2.25

4.89

1.2

1.3

56.30

57.17

mmol/l

0.06

133

Generalized skin eruption due to drugs and medicaments

284

1.93

4.87

1.4

1.5

68.23

63.11

mmol/l

0.40

234

Pre-eclampsia or poor fetal growth

213

1543

1.38

4.86

1.5

62.81

64.02

mmol/l

0.16

175

1198

Inflammatory diseases of prostate (prostatitis)

128

849

1.52

4.84

1.4

60.71

63.42

mmol/l

0.27

102

672

Oligomenorrhoea

156

2.27

4.84

1.6

1.5

58.78

63.49

mmol/l

0.26

126

Open wound of shoulder and upper arm

113

2.53

4.83

1.8

1.3

60.90

61.67

mmol/l

0.04

Other renal tubulo-interstitial diseases

144

2.34

4.82

2.0

1.3

54.89

62.79

mmol/l

0.54

121

Acute generalized exanthematous pustulosis

321

1.87

4.80

1.4

66.00

64.95

mmol/l

0.07

264

Conjunctivitis (acute, non atopic)

283

2146

1.32

4.79

1.5

60.31

64.24

mmol/l

0.88

228

1707

Infection due to other mycobacteria, including avohilmo

120

2.48

4.78

1.6

1.3

61.43

58.54

mmol/l

0.14

Hypermobility syndrome

223

2.04

4.77

2.2

1.5

67.21

67.77

mmol/l

0.03

192

Hypersomnia

3.01

4.76

1.1

1.4

71.50

65.14

mmol/l

0.21

Noninflammatory disorders of female genital tract

397

1566

1.28

4.75

1.4

60.94

60.22

mmol/l

0.12

322

1214

Scabies

258

1.96

4.75

2.0

1.4

58.93

63.75

mmol/l

0.34

214

Lactose intolerance

2.63

4.74

1.5

2.3

76.90

75.87

mmol/l

0.03

Other diseases of arteries and capillaries

106

680

1.57

4.69

1.4

60.48

62.03

mmol/l

0.12

562

Nonalcoholic steatohepatitis

3.44

4.66

1.1

1.3

51.70

67.56

mmol/l

—

L04AC Interleukin inhibitors

360

1.80

4.66

1.9

1.5

65.39

62.97

mmol/l

0.13

306

Other and unspecified mononeuropathies of upper limb

172

2.19

4.66

2.0

1.3

73.37

62.17

mmol/l

0.55

147

Dystonia

390

1.77

4.66

1.4

55.26

61.09

mmol/l

0.58

318

Nail disorders

581

1.62

4.61

1.4

1.5

58.57

63.20

mmol/l

0.55

480

Pleural plaque

113

739

1.54

4.61

1.4

1.3

59.55

62.37

mmol/l

0.35

599

Hypertrophic cardiomyopathy

326

1.84

4.60

1.9

1.4

60.92

62.13

mmol/l

0.10

267

Moderate visual impairment, binocular

269

1.93

4.59

1.4

1.5

68.17

59.95

mmol/l

0.64

217

Persons encountering health services in circumstances related to reproduction

370

3122

0.79

4.59

1.5

1.6

67.27

62.34

mmol/l

1.20

298

2396

Other and unspecified coagulation defects

304

1.86

4.59

1.6

1.4

69.40

62.82

mmol/l

0.44

256

Overexertion and strenuous or repetitive movements

103

660

1.57

4.59

1.8

1.4

58.06

61.78

mmol/l

0.45

535

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

166

2.19

4.58

3.6

2.5

85.52

77.20

mmol/l

0.40

143

Urticaria

286

2198

1.31

4.56

1.4

1.5

65.71

63.30

mmol/l

0.42

228

1764

Conduct disorder

2.76

4.54

1.4

2.7

42.25

74.57

mmol/l

3.72

Disorders of refraction and accommodation

263

1992

1.32

4.53

2.1

1.6

66.43

62.72

mmol/l

0.70

217

1585

Schizoid personality disorder

2.70

4.53

1.7

1.3

41.87

56.99

mmol/l

0.85

Respiratory conditions due to other external agents

155

2.25

4.53

1.6

1.3

55.89

61.90

mmol/l

0.41

130

Toxic liver disease

2.65

4.52

2.2

1.3

55.22

64.52

mmol/l

0.40

Other specified/unspecified spondylopathies

155

2.24

4.51

1.2

1.4

53.00

56.15

mmol/l

0.20

123

Right bundle-branch block

222

2.01

4.48

1.4

1.3

53.26

62.10

mmol/l

0.85

181

Malignant neoplasm of oesophagus, including Hilmo

243

1.97

4.48

1.2

1.3

54.06

60.15

mmol/l

0.52

197

Other disorders of bone

182

1311

1.40

4.48

1.3

1.4

61.02

62.38

mmol/l

0.16

141

1047

Certain conditions originating in the perinatal period

328

1.77

4.47

3.2

2.5

82.09

76.51

mmol/l

0.32

281

Infections with a predominantly sexual mode of transmission, including avohilmo

293

2068

1.30

4.47

1.4

61.68

64.69

mmol/l

0.55

233

1616

Personal history of certain other diseases

2.97

4.46

1.6

1.3

38.70

80.04

mmol/l

—

Umbilical hernia

276

2119

1.31

4.46

1.5

1.4

56.78

62.66

mmol/l

1.58

220

1681

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

307

2390

1.29

4.46

1.4

64.41

62.52

mmol/l

0.31

244

1896

Malignant neoplasm of endocrine gland, including Hilmo

571

1.61

4.45

1.4

62.79

61.18

mmol/l

0.12

466

Pedestrian injured in transport accident

494

1.66

4.44

1.4

58.84

60.43

mmol/l

0.12

401

Coxarthrosis, primary, with hip surgery

615

4784

1.20

4.42

1.4

60.17

60.84

mmol/l

0.17

513

3825

Other disorders of optic [2nd] nerve and visual pathways

465

1.68

4.39

1.8

1.4

67.22

64.43

mmol/l

0.20

383

Hypothermia

125

2.37

4.39

1.7

1.3

74.22

59.82

mmol/l

0.53

104

Other and unspecified disorders of skin and subcutaneous tissue

473

1.67

4.38

1.6

1.4

57.58

61.36

mmol/l

0.34

376

Biological medication for rheuma

158

1115

1.42

4.38

1.8

1.4

66.96

64.41

mmol/l

0.27

126

887

Acetic acid derivatives and related substances

319

1276

1.30

4.38

1.3

1.4

60.38

60.11

mmol/l

0.04

261

1012

Other and unspecified abdominal hernia

324

1.82

4.38

3.3

1.3

56.02

63.39

mmol/l

0.82

266

Crohn disease (strict definition, require KELA)

338

1.79

4.37

2.2

1.5

66.98

64.36

mmol/l

0.14

285

Malignant neoplasm of ovary, including Hilmo

520

1.64

4.37

1.3

1.4

59.30

60.31

mmol/l

0.09

419

Other/unspecified enthesopathies of lower limb, excluding foot

420

1.71

4.36

1.4

58.83

62.46

mmol/l

0.32

337

Injury of urinary and pelvic organs

107

2.48

4.34

1.6

1.3

68.90

61.57

mmol/l

0.32

Benign neoplasm: Rectum

221

1653

1.35

4.33

1.4

54.81

61.79

mmol/l

2.27

176

1328

Secondary polycythaemia

145

2.25

4.32

1.4

1.3

63.36

60.07

mmol/l

0.19

123

Colorectal cancer, including Hilmo

329

2417

1.27

4.31

1.4

58.14

62.19

mmol/l

0.96

233

1951

Chronic myeloproliferative disease

114

2.45

4.31

1.2

1.3

62.29

60.82

mmol/l

0.08

Supervision of normal pregnancy

570

0.57

4.30

1.3

1.4

73.23

62.79

mmol/l

0.74

422

Benign neoplasm: Transverse colon

137

947

1.46

4.30

1.4

57.05

61.59

mmol/l

0.77

106

771

Special screening examination for neoplasms

392

1.72

4.29

1.5

1.4

66.69

61.46

mmol/l

0.39

301

Arterial embolism and thrombosis

453

1.67

4.28

1.6

1.3

52.80

61.52

mmol/l

1.17

374

Dronedarone medication

192

2.07

4.28

1.5

1.3

61.63

61.43

mmol/l

0.01

156

Behavioural disorders

2.73

4.27

1.4

2.8

43.73

77.18

mmol/l

3.70

Injury of nerves and spinal cord at neck level

133

2.30

4.26

1.5

1.3

59.76

59.93

mmol/l

0.01

112

Autonomic disorders

146

2.23

4.25

1.3

77.96

62.37

mmol/l

0.97

125

Fracture at wrist and hand level

340

2689

1.26

4.24

1.5

60.85

63.21

mmol/l

0.55

262

2132

Other specified/unspecified dorsopathies

213

2.00

4.24

1.2

1.3

57.76

59.18

mmol/l

0.06

172

423

1.69

4.22

1.8

1.3

58.81

58.89

mmol/l

0.01

331

Postpartum haemorrhage

978

0.61

4.21

1.2

1.5

67.58

66.67

mmol/l

0.06

763

Single spontaneous delivery

338

2251

0.79

4.21

1.3

1.4

61.30

59.60

mmol/l

0.33

279

1797

Other and unspecified mononeuropathies, also in other diseases

214

2.00

4.20

1.4

1.3

57.22

58.35

mmol/l

0.07

173

Gestational diabetes (for exclusion)

100

1045

0.66

4.20

1.3

1.5

62.63

67.98

mmol/l

0.55

823

Seborrhoeic dermatitis

107

707

1.53

4.19

1.3

1.5

59.35

62.91

mmol/l

0.44

580

Congenital malformations of cardiac septa

419

1.68

4.18

2.0

2.1

74.10

67.94

mmol/l

0.47

360

Follicular cysts of skin and subcutaneous tissue

193

1422

1.37

4.17

1.4

58.30

62.62

mmol/l

0.79

150

1138

Acquired haemolytic anaemia

174

2.11

4.16

1.6

1.3

57.93

61.86

mmol/l

0.25

145

Diseases of external ear

394

3188

1.24

4.16

1.4

61.79

62.88

mmol/l

0.20

303

2558

Degenerative macular diseases

163

1172

1.40

4.13

1.4

1.3

61.18

60.85

mmol/l

0.04

136

935

Vascular dementia (subcortical)

353

1.76

4.12

1.3

61.96

59.10

mmol/l

0.28

283

Other and unspecified types of non-Hodgkin lymphoma, hilmo

338

1.77

4.12

1.5

1.3

59.14

60.49

mmol/l

0.10

276

Psoriatic and enteropathic arthropathies

118

799

1.49

4.11

1.3

64.30

62.92

mmol/l

0.11

627

Multiple myeloma and malignant plasma cell neoplasms

421

1.69

4.11

1.4

52.68

61.36

mmol/l

1.64

340

Malignant neoplasm of tonsil

2.51

4.10

1.8

1.3

69.63

59.92

mmol/l

0.34

Orchitis and epididymitis

591

1.57

4.09

1.4

57.49

64.71

mmol/l

1.01

474

Superficial injury of shoulder and upper arm

128

882

1.46

4.08

1.4

67.06

62.84

mmol/l

0.54

104

717

Burn and corrosion of trunk

182

2.07

4.07

1.3

1.5

60.43

64.79

mmol/l

0.25

156

Other erythematous conditions

266

1.87

4.07

3.4

1.4

53.76

59.46

mmol/l

0.57

220

Delivery

342

2260

0.79

4.07

1.3

1.4

61.53

59.58

mmol/l

0.40

285

1804

Malignant neoplasm of bone and articular cartilage, including Hilmo

117

2.36

4.06

2.0

1.6

49.76

61.72

mmol/l

0.90

101

Essential (haemorrhagic) thrombocythaemia

281

1.84

4.05

1.1

1.4

54.95

59.35

mmol/l

0.40

223

Tuberculosis, IBD comorbidity

562

1.58

4.04

1.5

1.3

56.12

60.26

mmol/l

0.46

449

Sequelae of injuries of upper limb

101

665

1.53

4.04

1.4

56.84

61.64

mmol/l

0.56

533

Cholecystectomy

815

5982

1.16

4.03

1.6

1.4

61.93

61.05

mmol/l

0.24

650

4765

Chronic mastoiditis

197

2.02

4.02

1.3

1.4

68.24

61.55

mmol/l

0.49

164

Dementia in other diseases classified elsewhere

393

1.70

4.02

1.5

1.4

65.63

60.11

mmol/l

0.48

312

Spondyloarthritis

176

1286

1.38

4.02

1.6

1.3

60.37

62.61

mmol/l

0.31

144

1037

Specific development disorders of scholastic skills

159

2.11

4.01

1.9

2.7

85.28

76.67

mmol/l

0.38

139

Malignant neoplasm of colon

190

1407

1.36

4.01

1.4

53.17

61.16

mmol/l

2.31

133

1136

Contraceptive management

210

1946

0.75

4.00

1.3

1.4

63.26

61.59

mmol/l

0.19

160

1474

Crohn disease (strict definition, require KELA, min 2 HDR)

333

1.76

3.99

2.2

1.5

66.78

64.62

mmol/l

0.11

281

Pediculosis, acariasis and other infestations, including avohilmo

151

1077

1.41

3.98

1.7

1.6

66.44

65.06

mmol/l

0.14

124

867

Anankastic personality disorder

170

2.08

3.97

1.4

66.37

68.02

mmol/l

0.07

145

Temporomandibular joint disorders, including avohilmo

391

3075

1.23

3.97

1.5

63.27

62.84

mmol/l

0.07

332

2415

Psoriasis (vulgaris), strict definition

198

2.00

3.95

1.4

58.88

61.24

mmol/l

0.14

169

Benign neoplasm: Vagina

2.57

3.94

1.2

1.4

68.14

59.93

mmol/l

0.42

Undefined dementia

175

1183

1.38

3.93

1.4

1.3

63.96

59.59

mmol/l

0.83

141

932

Benign thyroid growths and nodules

383

2889

1.24

3.92

1.4

1.3

59.57

59.98

mmol/l

0.07

299

2302

Impetigo

248

1.87

3.90

2.2

1.6

57.41

69.22

mmol/l

1.05

209

Arterial embolism and thrombosis of lower extremity artery

270

1.84

3.90

1.7

1.4

52.77

59.45

mmol/l

0.71

227

Chronic tubulo-interstitial nephritis

263

1.85

3.88

1.7

1.3

51.69

58.44

mmol/l

0.76

211

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

366

1.71

3.88

2.2

1.5

65.64

65.29

mmol/l

0.02

305

Congenital malformations of heart and great arteries

128

864

1.45

3.88

1.8

70.89

66.45

mmol/l

0.47

101

708

malignant neoplasm of female genital organs, including Hilmo

231

1685

1.31

3.87

1.4

59.06

60.52

mmol/l

0.23

177

1360

Asthma mixed form (mode), excluding more controls

227

1.91

3.87

1.5

1.4

63.06

66.11

mmol/l

0.20

188

Otitis externa, unspecified

114

777

1.48

3.87

1.5

67.24

64.18

mmol/l

0.27

634

Keratitis

374

3036

1.24

3.86

1.5

1.4

62.02

61.92

mmol/l

0.01

306

2402

Coronary artery bypass grafting

308

1806

1.27

3.86

1.4

1.3

60.81

62.16

mmol/l

0.27

250

1458

Striking against or struck by other objects

310

2461

1.26

3.85

1.6

1.5

60.92

64.65

mmol/l

0.73

241

1961

Toxic effect of ethanol

186

2.01

3.84

3.3

1.3

57.46

66.85

mmol/l

0.43

154

Autoimmune hyperthyroidism

360

1.71

3.83

1.3

67.06

60.62

mmol/l

0.49

284

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

237

1.87

3.83

2.8

2.9

70.46

80.84

mmol/l

0.82

218

Erythema intertrigo

187

2.02

3.82

1.5

1.4

53.96

60.66

mmol/l

0.49

157

Unspecific neurodegenerative disorder

599

3471

1.19

3.82

1.3

1.4

64.33

59.94

mmol/l

2.01

482

2801

Other spirochaetal diseases, including avohilmo

233

3011

0.77

3.81

1.4

59.13

62.54

mmol/l

0.70

182

2407

Ocular pain

586

1.55

3.81

1.7

1.4

58.49

63.56

mmol/l

0.72

473

DVT of lower extremities

218

1661

1.32

3.81

1.4

63.46

62.34

mmol/l

0.14

162

1325

Artrosis, including avohilmo

879

4183

1.15

3.80

1.4

61.58

61.80

mmol/l

0.05

702

3245

Spirochaetal infections, other/unspecified, including avohilmo

229

2963

0.77

3.78

1.3

1.4

59.31

62.67

mmol/l

0.67

179

2366

Otitis externa

233

1793

1.31

3.78

1.4

63.47

63.53

mmol/l

0.01

187

1447

Benign neoplasm: Pancreas

223

1.92

3.78

1.3

53.26

59.57

mmol/l

0.62

184

Wet age-related macular degeneration

265

2000

1.29

3.77

1.3

60.20

59.35

mmol/l

0.14

208

1612

Idiopathic gout

113

774

1.47

3.77

1.4

50.01

61.65

mmol/l

2.96

626

Primary gonarthrosis, bilateral

662

4744

1.17

3.77

1.4

61.76

60.08

mmol/l

0.54

544

3762

Other spirochaetal diseases

230

2972

0.77

3.76

1.4

59.22

62.72

mmol/l

0.72

181

2374

Malignant neoplasm of small intestine, including Hilmo

216

1.93

3.76

1.8

1.4

59.81

59.37

mmol/l

0.02

171

Maternal care related to the fetus and amniotic cavity and possible delivery problems

203

1574

0.75

3.76

1.5

65.25

63.81

mmol/l

0.17

170

1220

Other female pelvic inflammatory diseases

166

1217

1.37

3.76

1.6

1.4

61.37

61.63

mmol/l

0.03

131

974

Anuria and oliguria

3.12

3.75

1.4

56.70

53.20

mmol/l

—

Inguinal hernia, bilateral

110

750

1.48

3.75

1.3

1.4

67.83

63.62

mmol/l

0.51

603

Special screening examination for infectious and parasitic diseases

139

715

1.42

3.74

1.4

1.3

63.96

63.46

mmol/l

0.04

107

550

Long labour

994

0.64

3.73

1.5

58.27

66.54

mmol/l

0.94

773

Malignant neoplasm of colon, including Hilmo

226

1729

1.31

3.72

1.5

1.4

56.10

61.85

mmol/l

1.34

162

1400

Postmenopausal bleeding

333

1389

1.26

3.72

1.4

62.75

58.23

mmol/l

1.19

252

1067

Toxic effect of alcohol

109

2.33

3.72

4.1

1.3

66.06

64.27

mmol/l

0.06

Amiodarone users

122

851

1.45

3.71

1.5

1.4

65.55

61.60

mmol/l

0.55

102

683

Habit and impulse disorders

2.83

3.71

1.4

46.36

60.85

mmol/l

1.07

Acute nephritic syndrome

122

2.26

3.71

1.4

1.3

52.00

57.75

mmol/l

0.44

106

Other and unspecified urticaria

190

1426

1.34

3.69

1.5

65.77

63.93

mmol/l

0.23

159

1150

Lyme disease, including avohilmo

228

2939

0.77

3.67

1.3

1.4

59.31

62.70

mmol/l

0.68

179

2345

Lyme disease

228

2939

0.77

3.67

1.3

1.4

59.31

62.70

mmol/l

0.68

179

2345

Enteropathic arthropathies

116

2.28

3.67

1.4

64.27

63.71

mmol/l

0.02

Other disorders starting during childhood or adolescence

222

1.89

3.66

3.0

3.1

74.06

80.14

mmol/l

0.39

201

Colorectal cancer

290

2209

1.27

3.66

1.4

57.47

62.22

mmol/l

1.11

202

1786

Xerosis cutis

136

2.18

3.66

1.7

1.3

46.20

63.03

mmol/l

2.10

110

Primary coxarthrosis, bilateral

379

3106

1.23

3.63

1.4

62.90

61.08

mmol/l

0.40

322

2478

Malignant neoplasm of endocrine gland

498

1.58

3.62

1.4

64.67

61.56

mmol/l

0.24

405

Unspecified chronic bronchitis

233

1.87

3.62

1.2

1.3

61.48

58.25

mmol/l

0.18

188

Pleural plaque with presence of asbestos

530

1.56

3.62

1.4

60.47

64.03

mmol/l

0.37

434

Complications of cardiac and vascular prosthetic devices, implants and grafts

150

2.11

3.61

2.0

1.3

65.08

59.78

mmol/l

0.26

128

Other noninflammatory disorders of vagina

538

1.56

3.60

1.5

1.4

59.95

59.67

mmol/l

0.02

418

Oter anti-inflammatory and antirheumatic agents, non-steroids

271

1164

1.28

3.58

1.4

59.88

59.32

mmol/l

0.08

220

932

Tuberculosis, wide, including avohilmo

604

1.52

3.56

1.5

1.3

56.20

59.53

mmol/l

0.36

485

Secondary malignant neoplasm of other and unspecified sites

138

2.15

3.54

1.3

1.4

61.04

59.30

mmol/l

0.07

115

Status post-ami

307

1863

1.26

3.54

1.4

1.3

59.77

61.71

mmol/l

0.39

237

1508

Malignant neoplasm of breast, including Hilmo

453

2411

1.21

3.53

1.4

61.51

60.50

mmol/l

0.19

349

1922

Other peripheral vertigo

115

802

1.45

3.52

1.5

1.4

71.72

61.02

mmol/l

1.80

647

Gonarthrosis

700

3404

1.16

3.52

1.4

62.31

60.79

mmol/l

0.45

566

2655

Malignant neoplasm of breast, HER2-negative, including Hilmo

453

2412

1.21

3.52

1.4

61.51

60.53

mmol/l

0.18

349

1923

Cerebral atherosclerosis

112

2.28

3.51

1.2

1.3

64.58

62.09

mmol/l

0.10

Inguinal or femoral hernia, bilateral

111

769

1.45

3.51

1.3

1.4

67.96

63.37

mmol/l

0.58

619

Disorders of muscles

103

704

1.47

3.49

1.3

1.4

54.20

64.01

mmol/l

1.51

555

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

215

1.89

3.48

1.3

1.4

55.88

59.03

mmol/l

0.27

175

Multiple myeloma

215

1.89

3.48

1.3

1.4

55.88

59.03

mmol/l

0.27

175

Benign neoplasm of middle ear and respiratory system

567

1.53

3.48

1.5

1.4

55.79

60.23

mmol/l

0.54

454

Malignant neoplasm of nasal cavity and sinuses

3.09

3.47

1.0

1.4

67.79

62.76

mmol/l

0.21

Other disorders of Eustachian tube

201

1.92

3.46

1.4

79.56

59.07

mmol/l

1.53

166

Voice disturbances

284

2268

1.26

3.46

1.4

64.38

62.19

mmol/l

0.38

236

1810

Spasmodic torticollis

194

1.93

3.46

1.4

1.3

58.58

58.80

mmol/l

0.01

166

Congenital iodine-deficiency syndrome/hypothyroidism

230

1.86

3.46

1.5

1.4

58.20

60.57

mmol/l

0.14

184

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

159

1177

1.36

3.41

1.7

1.4

64.45

63.17

mmol/l

0.12

941

Post-traumatic wound infection, not elsewhere classified

174

1.98

3.41

1.1

1.3

57.60

60.71

mmol/l

0.17

146

Diseases of tongue

466

1.58

3.41

1.5

1.3

56.03

57.79

mmol/l

0.16

365

Allergic purpura

174

1.98

3.41

1.1

1.3

56.46

64.13

mmol/l

0.50

144

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

147

2.09

3.41

1.3

58.72

62.74

mmol/l

0.25

124

Myelodysplastic syndrome, including Hilmo

224

1.86

3.40

1.3

1.4

46.65

59.58

mmol/l

1.27

179

Tuberculosis, wide

595

1.51

3.39

1.5

1.3

55.96

59.78

mmol/l

0.42

476

False labour

804

0.67

3.37

1.3

1.5

73.93

67.22

mmol/l

0.61

623

Thiazolidinediones

134

970

1.39

3.34

1.4

58.14

60.94

mmol/l

0.33

105

790

Delayed milestone in childhood

126

2.11

3.34

5.1

4.1

90.92

84.31

mmol/l

0.26

116

Other and unspecified glaucoma

672

1.47

3.31

1.4

1.3

61.10

60.96

mmol/l

0.01

532

Other specified disorders of muscle

169

1.98

3.31

1.3

48.26

59.84

mmol/l

0.91

135

Allergic contact dermatitis

122

870

1.41

3.30

1.5

61.69

63.86

mmol/l

0.22

697

Polyarthritis, unspecified

248

1.80

3.30

1.4

49.94

60.98

mmol/l

1.29

199

Ganglion

189

1443

1.32

3.30

1.4

63.02

61.99

mmol/l

0.12

154

1138

Foreign body in alimentary tract

400

1.62

3.29

1.5

1.4

57.23

64.09

mmol/l

0.55

323

Septal defects

399

1.61

3.28

2.1

2.2

71.07

69.82

mmol/l

0.08

342

Dislocation, sprain and strain of joints and ligaments of thorax

212

1.86

3.28

1.4

1.3

66.65

62.40

mmol/l

0.19

176

Etanercept

377

1.63

3.27

1.7

1.5

70.63

63.37

mmol/l

0.61

312

Use of other anti-dementia drugs

409

2742

1.21

3.27

1.3

1.4

62.59

59.74

mmol/l

0.81

331

2233

Use of memantine

409

2742

1.21

3.27

1.3

1.4

62.59

59.74

mmol/l

0.81

331

2233

Other demyelinating diseases of the central nervous system

170

1.96

3.25

1.4

47.76

67.05

mmol/l

2.79

147

ILD-related respiratory insufficiency

287

1.74

3.25

1.4

1.3

63.91

62.60

mmol/l

0.08

230

Alzheimer disease, including avohilmo

533

3141

1.18

3.25

1.3

1.4

62.60

60.19

mmol/l

0.80

435

2538

Dementia in Alzheimer disease

258

1716

1.26

3.23

1.3

62.21

59.22

mmol/l

0.65

207

1383

Chorioretinal inflammation

178

1.94

3.22

1.5

1.3

56.21

60.27

mmol/l

0.25

154

Other maternal disorders predominantly related to pregnancy

336

2563

0.82

3.21

1.4

63.04

61.78

mmol/l

0.19

268

2007

Intermittent heterotropia

340

1.66

3.20

1.6

1.9

68.18

68.30

mmol/l

0.01

293

Rosacea

129

935

1.39

3.20

1.3

1.4

62.84

63.42

mmol/l

0.05

100

745

Malignant neoplasm of bladder, including Hilmo

125

890

1.39

3.18

1.3

53.86

63.40

mmol/l

2.36

107

720

Pre-eclampsia or eclampsia

165

1243

1.33

3.18

1.4

1.5

63.30

63.18

mmol/l

0.01

132

970

Giant cell arteritis

381

1.62

3.18

1.5

1.4

56.16

59.33

mmol/l

0.31

308

Spinal instabilities

144

2.04

3.17

1.4

1.3

72.00

58.21

mmol/l

0.92

126

Other and unspecified diseases of blood and blood-forming organs

179

1.93

3.17

1.3

54.41

61.68

mmol/l

0.46

148

HSIL lesion of the cervix uteri, vagina or vulva

129

936

1.38

3.16

1.6

1.4

54.56

65.85

mmol/l

2.40

108

742

Heterophoria

507

1.53

3.16

1.6

74.36

62.98

mmol/l

1.16

410

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

252

2008

1.26

3.16

1.4

1.5

63.66

63.46

mmol/l

0.02

198

1588

Other follicular disorders

412

1.59

3.15

1.5

1.4

68.90

65.82

mmol/l

0.20

343

Acute suppurative otitis media

180

1279

1.31

3.15

2.1

1.7

71.56

66.81

mmol/l

0.56

139

1027

Other deformities of toe(s)

267

1.75

3.15

1.4

1.3

67.21

61.01

mmol/l

0.44

216

Tumor necrosis factor alpha inhibitors

133

972

1.37

3.13

1.9

1.5

68.73

63.89

mmol/l

0.54

107

775

Other and unspecified rosacea

663

1.46

3.13

1.4

61.47

61.82

mmol/l

0.03

536

Ptosis of eyelid

137

1008

1.37

3.12

1.3

1.4

62.00

60.24

mmol/l

0.23

116

810

Other abnormal products of conception

100

936

0.70

3.12

1.3

1.5

69.01

64.97

mmol/l

0.38

723

Other obstructive and reflux uropathy

238

1.78

3.10

1.5

1.3

53.29

68.15

mmol/l

1.67

193

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

275

1.72

3.10

1.7

1.5

68.59

66.17

mmol/l

0.11

222

Myopia

101

706

1.44

3.08

2.5

1.5

66.16

62.98

mmol/l

0.26

564

Other specified/unspecified inflammatory spondylopathies

202

1.85

3.08

1.7

1.4

62.48

63.97

mmol/l

0.07

168

Premature rupture of membranes

679

0.64

3.07

1.2

1.5

72.59

66.88

mmol/l

0.41

533

Torsion of testis

2.61

3.06

1.5

1.6

52.00

74.51

mmol/l

1.03

Other benign neoplasms of skin

425

3585

1.19

3.05

1.4

59.17

61.74

mmol/l

0.69

346

2853

Systemic atrophies primarily affecting the central nervous system

323

1.66

3.05

1.5

1.4

57.76

60.98

mmol/l

0.25

263

Dislocation, sprain and strain of joints and ligaments of head

203

1.84

3.04

1.5

54.10

67.36

mmol/l

1.29

173

Malignant neoplasm of breast

442

2401

1.19

3.03

1.4

62.18

60.46

mmol/l

0.35

340

1913

Benign neoplasm: Tongue

211

1.83

3.03

1.6

1.3

54.13

59.29

mmol/l

0.33

177

Disorder of pancreatic internal secretion, other and/or unspecified

2.84

3.03

1.5

1.4

58.56

59.23

mmol/l

—

Additional codes for the location of defect, injury or illness

417

1.57

3.02

1.3

1.4

66.11

61.38

mmol/l

0.37

337

Otalgia

619

1.46

3.01

1.4

1.5

57.19

65.87

mmol/l

1.33

500

Oxicams

267

1213

1.25

3.00

1.3

1.4

63.02

59.73

mmol/l

0.64

211

966

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

141

1049

1.35

2.99

1.8

1.4

63.05

63.91

mmol/l

0.08

835

Injury of unspecified body region

588

1.47

2.98

1.6

1.5

55.50

63.16

mmol/l

1.08

475

Other orthopaedic follow-up care

348

1.62

2.97

1.3

1.4

59.28

60.84

mmol/l

0.12

273

Raynaud syndrome

580

1.48

2.97

1.3

1.4

66.02

62.15

mmol/l

0.33

471

Malignant neoplasm of breast, HER2-negative

441

2401

1.19

2.97

1.4

62.18

60.46

mmol/l

0.35

340

1913

Systemic lupus erythematosus, unspecified

198

1.84

2.96

1.4

47.68

62.06

mmol/l

1.37

168

Hydrocele

109

779

1.41

2.96

1.4

57.28

65.16

mmol/l

1.30

623

Malignant neoplasm of mesothelium and soft tissue

295

1.68

2.96

1.4

66.80

59.20

mmol/l

0.53

235

Postprocedural disorders of nervous system

302

1.67

2.95

1.3

1.5

75.26

65.26

mmol/l

0.68

255

Memory loss

117

848

1.39

2.95

1.4

58.16

59.14

mmol/l

0.10

683

Alzheimer’s disease (undefined)

0.00

2.94

0.0

1.3

—

55.25

—

Bulimia nervosa (incl. atypical)

2.29

2.94

2.6

1.8

80.93

78.95

mmol/l

0.04

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

2.35

2.93

4.9

1.5

59.57

74.09

mmol/l

0.86

Other and unspecified injuries of lower leg

476

1.52

2.93

1.6

1.5

63.03

64.77

mmol/l

0.14

396

malignant neoplasm of male genital organs, including Hilmo

271

1311

1.25

2.91

1.3

1.4

61.57

63.34

mmol/l

0.30

218

1045

Use of donepezil

203

2448

0.79

2.91

1.2

1.4

63.58

59.96

mmol/l

0.67

153

1980

Vertigo of central origin

122

2.09

2.91

1.5

1.4

57.00

59.71

mmol/l

0.18

102

Vulvovaginal ulceration/inflammation in other diseases

350

1.61

2.90

1.9

1.5

57.36

64.00

mmol/l

0.64

286

Meniscus derangement

588

3377

1.16

2.90

1.5

1.4

63.87

60.85

mmol/l

1.03

476

2628

Other specified/unspecified soft tissue disorders

359

1.60

2.88

1.7

1.3

56.16

61.64

mmol/l

0.50

283

Benign neoplasm: Sigmoid colon

222

1766

1.26

2.88

1.5

1.4

61.06

61.36

mmol/l

0.04

179

1432

Acne vulgaris

273

1.69

2.88

1.5

1.8

73.47

74.44

mmol/l

0.04

237

Atypical mycobacterium lung infection

2.25

2.88

1.6

1.3

56.13

58.71

mmol/l

0.10

Other corneal oedema

2.42

2.87

1.5

1.3

51.06

56.29

mmol/l

0.25

Other disorders of the genitourinary system

160

1222

1.32

2.87

1.6

1.4

60.47

60.10

mmol/l

0.04

139

983

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

145

1091

1.33

2.86

1.4

57.30

63.10

mmol/l

1.05

109

862

Crohn disease (strict definition, all UC cases excluded)

275

1.69

2.85

1.6

1.4

70.41

64.60

mmol/l

0.37

233

Parkinson's disease, including avohilmo

194

1522

1.28

2.84

1.3

1.4

71.94

61.04

mmol/l

3.23

151

1232

Allergic rhinitis

243

1930

1.25

2.83

1.5

1.7

65.19

65.45

mmol/l

0.03

184

1525

Viral warts, including avohilmo

195

1530

1.28

2.83

1.5

61.95

64.85

mmol/l

0.39

161

1228

Deviated nasal septum

313

2584

1.21

2.83

1.4

62.72

61.80

mmol/l

0.14

258

2001

Abnormal serum enzyme levels

309

2461

1.22

2.82

1.4

58.80

63.66

mmol/l

1.47

260

1971

Alzheimer’s disease (Atypical or mixed)

166

1261

1.31

2.82

1.3

1.4

58.20

60.36

mmol/l

0.37

137

999

Malignant neoplasm of ovary

401

1.56

2.82

1.3

1.4

59.54

59.45

mmol/l

0.01

327

Other and unspecified erythematous conditions

246

1.73

2.82

3.7

1.4

55.94

58.92

mmol/l

0.22

204

Malignant neoplasm of oesophagus

187

1.84

2.81

1.2

1.4

61.70

59.08

mmol/l

0.15

154

Glaucoma secondary to other eye disorders

315

1.64

2.81

1.3

53.38

61.75

mmol/l

0.88

255

Ingrowing nail

338

1.61

2.81

1.5

1.4

63.12

64.28

mmol/l

0.08

275

Other enthesopathies

282

2310

1.22

2.79

1.4

64.10

61.40

mmol/l

0.46

230

1806

Burn and corrosion of hip and lower limb, except ankle and foot

124

2.04

2.78

1.6

1.3

81.17

64.68

mmol/l

0.69

110

Coxibs

302

1295

1.23

2.78

1.4

63.82

60.63

mmol/l

0.62

250

1030

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

225

1.76

2.77

1.4

56.00

59.97

mmol/l

0.29

182

Other inflammation of eyelid

153

1167

1.32

2.77

1.4

61.19

62.13

mmol/l

0.10

129

919

Cluster headache, wide,, including avohilmo

293

1.65

2.76

1.4

1.3

61.07

64.14

mmol/l

0.19

250

Dyshidrosis [pompholyx]

2.40

2.74

1.3

86.50

63.38

mmol/l

—

Other diseases of peritoneum

325

1.62

2.74

1.5

1.4

57.93

59.44

mmol/l

0.12

261

Pedestrian injured in collision with pedal cycle

196

1.81

2.74

1.5

1.4

53.21

60.58

mmol/l

0.46

159

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.47

2.74

1.7

1.5

62.73

64.05

mmol/l

0.04

Ulcerative colitis (strict definition, require KELA)

144

1092

1.32

2.72

1.8

1.4

62.89

63.51

mmol/l

0.05

873

Acquired absence of organs, not elsewhere classified

2.33

2.71

2.1

1.3

58.46

67.74

mmol/l

0.42

Panniculitis affecting regions of neck and back

204

1.78

2.70

1.3

65.07

59.59

mmol/l

0.23

162

malignant neoplasm of female genital organs

202

1569

1.27

2.69

1.4

59.00

60.29

mmol/l

0.19

157

1261

Neovascular glaucoma

319

1.62

2.68

1.3

1.4

53.38

61.36

mmol/l

0.82

259

Superficial injury of wrist and hand

183

1436

1.28

2.67

1.5

68.36

64.17

mmol/l

0.58

143

1147

Perineal laceration during delivery

516

0.59

2.67

1.4

1.5

71.76

68.05

mmol/l

0.14

401

Antenatal screening

586

0.68

2.67

1.4

72.69

62.48

mmol/l

0.97

436

Inflammatory disease of uterus

108

786

1.38

2.67

1.4

56.57

63.50

mmol/l

0.94

624

Burns and corrosions of multiple body regions

2.99

2.64

1.3

75.00

56.14

mmol/l

—

Open wound of wrist and hand

404

3322

1.18

2.64

1.5

1.4

64.82

63.25

mmol/l

0.27

310

2615

Impingement syndrome of shoulder

231

1868

1.24

2.62

1.5

1.4

64.53

61.70

mmol/l

0.43

193

1483

Nonsuppurative otitis media

176

1193

1.28

2.61

1.9

1.7

67.13

66.75

mmol/l

0.04

134

973

Other misadventures during surgical and medical care

170

1.85

2.61

1.9

1.3

76.78

62.21

mmol/l

0.65

145

Female genital prolapse

313

1440

1.21

2.61

1.4

63.91

58.73

mmol/l

1.41

255

1110

Injury of blood vessels at neck level

4.15

2.60

1.4

1.3

35.63

58.30

mmol/l

—

Renal cell carcinoma of kidney

237

1.71

2.60

1.4

55.06

59.20

mmol/l

0.35

191

Adalimumab

547

1.45

2.60

2.1

1.4

65.55

64.49

mmol/l

0.06

440

Myositis

163

1.87

2.59

1.2

1.4

58.25

58.41

mmol/l

0.01

129

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

2.41

2.59

1.1

1.4

66.25

58.53

mmol/l

0.39

Endometriosis

311

1498

1.21

2.58

1.4

58.37

59.47

mmol/l

0.19

254

1156

Disorders of aromatic amino-acid metabolism

7.39

2.57

15.8

2.3

92.40

63.00

mmol/l

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

2.68

2.57

1.1

1.4

71.38

61.89

mmol/l

0.44

Chronic conjunctivitis

208

1.75

2.56

1.2

1.4

62.04

64.72

mmol/l

0.14

172

therapeutic use

246

1.69

2.56

1.5

1.3

69.90

59.37

mmol/l

0.91

202

Congenital malformations of aortic and mitral valves

269

1.65

2.54

1.3

1.5

74.19

67.26

mmol/l

0.37

228

Other disorders of conjunctiva

158

1227

1.29

2.54

1.3

62.93

mmol/l

0.00

122

981

Alzheimer’s disease (Early onset)

409

0.51

2.54

1.3

76.86

59.86

mmol/l

0.78

320

Optic neuritis

201

1.76

2.53

2.2

1.4

57.27

62.20

mmol/l

0.32

172

Abrasion of teeth

359

3041

1.18

2.53

1.4

58.63

62.10

mmol/l

0.88

288

2424

Asthma mixed form (mode)

262

1.65

2.51

1.5

1.4

63.06

65.87

mmol/l

0.18

213

Contact with other hot fluids

187

1.78

2.50

1.3

1.5

60.48

66.00

mmol/l

0.26

160

Other secondary gonarthrosis

413

1.52

2.50

1.4

57.67

59.75

mmol/l

0.19

328

Injuries involving multiple body regions

232

1.70

2.50

1.4

1.3

48.89

62.26

mmol/l

1.30

195

Superficial injury of ankle and foot

100

728

1.38

2.49

1.8

1.5

54.83

65.58

mmol/l

2.30

586

All dysplastic lesions of the cervix uteri, vagina or vulva

193

1500

1.26

2.49

1.5

1.4

56.73

64.96

mmol/l

2.03

160

1178

Other and unspecified tonsillitis

226

1520

1.24

2.49

2.1

1.5

62.93

65.26

mmol/l

0.31

179

1165

Oral leukoplakia, including avohilmo

195

1.77

2.49

1.5

1.3

62.32

60.92

mmol/l

0.07

160

Congenital malformations and deformations of the musculoskeletal system

508

1.46

2.48

2.6

1.9

70.08

70.00

mmol/l

0.00

430

Primary open-angle glaucoma

419

3465

1.17

2.47

1.4

60.29

60.31

mmol/l

0.00

339

2770

Enthesopathies of lower limb, excluding foot

201

1613

1.25

2.47

1.3

1.4

61.37

62.40

mmol/l

0.14

159

1256

Lichen simplex chronicus

218

1.72

2.46

1.5

1.3

55.23

62.84

mmol/l

0.76

182

Temporal arteritis

335

1.57

2.46

1.5

1.3

59.95

59.87

mmol/l

0.01

274

Dislocation, sprain and strain of joints and ligaments at neck level

118

884

1.34

2.46

1.4

62.83

64.61

mmol/l

0.17

699

Other benign neoplasm of uterus: Other parts/unspecified

465

1.48

2.45

1.4

63.61

57.96

mmol/l

0.56

379

Cluster headache, strict, including avohilmo

272

1.63

2.44

1.5

1.3

62.53

64.51

mmol/l

0.11

232

Osteonecrosis due to drugs

117

2.01

2.44

1.3

57.00

59.14

mmol/l

0.10

101

Metatarsalgia

664

1.39

2.43

1.4

1.3

64.42

62.55

mmol/l

0.15

524

Parapsoriasis

110

2.03

2.43

1.4

62.12

59.82

mmol/l

0.08

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

506

1.45

2.43

1.3

1.4

64.66

60.24

mmol/l

0.35

405

Superficial injuries involving multiple body regions

160

1.83

2.41

1.6

1.4

43.38

62.08

mmol/l

2.30

142

Malignant neoplasm of pancreas, including Hilmo

726

1.37

2.39

1.4

61.27

60.27

mmol/l

0.08

584

Intercostal neuropathy

2.68

2.39

1.5

1.3

70.00

56.90

mmol/l

—

Retinal detachment with retinal break

139

1072

1.30

2.38

1.5

1.4

50.04

62.06

mmol/l

4.75

116

857

Carcinoma in situ of skin of lower limb, including hip

221

1.71

2.38

1.4

57.23

58.97

mmol/l

0.07

179

Phlebitis and thrombophlebitis (not including DVT)

233

1909

1.23

2.38

1.4

62.78

62.42

mmol/l

0.04

188

1521

Colon adenocarcinoma

145

1125

1.30

2.38

1.3

1.4

53.80

60.83

mmol/l

1.42

900

Benign neoplasm: Small intestine

338

1.56

2.37

1.7

1.3

59.61

59.73

mmol/l

0.01

274

Other specified/unspecified bacterial intestinal infections

517

1.44

2.37

2.6

1.4

53.89

61.80

mmol/l

0.88

420

Other enthesopathy of foot (+metatarsalgia)

710

1.37

2.36

1.4

64.63

62.05

mmol/l

0.23

564

Abnormalities of forces of labour

464

0.56

2.36

1.4

1.5

63.55

66.35

mmol/l

0.13

360

Malignant neoplasm of other and unspecified female genital organs

126

1.94

2.34

1.5

1.4

55.00

57.56

mmol/l

0.14

100

Radial styloid tenosynovitis [de Quervain]

315

1.57

2.33

1.3

58.57

62.70

mmol/l

0.33

251

Sarcoidosis

135

1041

1.30

2.32

1.4

59.29

61.33

mmol/l

0.24

115

842

Synovial cyst of popliteal space [Baker]

561

1.42

2.32

1.4

1.3

62.80

60.75

mmol/l

0.15

445

Gonarthrosis, primary, with knee surgery

718

4993

1.12

2.32

1.3

1.4

62.99

60.22

mmol/l

1.13

598

3967

Malignant neoplasm of prostate, including Hilmo

263

1282

1.21

2.30

1.3

1.4

61.80

63.72

mmol/l

0.33

213

1024

Embolic stroke with flimmer

200

1.72

2.30

1.4

1.3

65.18

64.10

mmol/l

0.05

163

Giant cell arteritis with polymyalgia rheumatica

341

1.54

2.30

1.5

1.3

59.95

60.30

mmol/l

0.03

276

Alzheimer disease

465

2894

1.15

2.26

1.3

1.4

60.94

60.10

mmol/l

0.20

380

2346

Scar conditions and fibrosis of skin

263

1.61

2.24

1.6

1.4

62.69

64.62

mmol/l

0.10

216

Osteosarcoma

5.82

2.24

3.4

1.9

75.80

67.56

mmol/l

—

Other and unspecified haemorrhagic conditions

107

2.00

2.23

1.1

1.5

56.44

60.22

mmol/l

0.14

Postpartum hemorraghe, all women as controls

997

0.71

2.22

1.2

1.5

67.58

66.50

mmol/l

0.07

779

Astigmatism

432

1.47

2.22

1.7

66.28

65.69

mmol/l

0.04

353

Macular pucker

187

1511

1.24

2.22

1.4

60.78

61.87

mmol/l

0.14

157

1212

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

2.17

2.21

1.9

1.4

43.18

58.63

mmol/l

1.42

Carcinoma in situ of skin of upper limb, including shoulder

265

1.61

2.21

1.3

1.4

55.86

59.91

mmol/l

0.19

211

Dislocation, sprain and strain of joint and ligaments of hip

296

1.57

2.21

1.7

1.3

60.94

61.09

mmol/l

0.01

244

Non-small cell lung cancer, squamous

320

1.54

2.20

1.2

1.4

60.77

60.92

mmol/l

0.01

256

Acute lymphadenitis

320

1.54

2.19

2.3

1.5

65.05

65.62

mmol/l

0.03

260

Glucosamine medication

603

4275

1.13

2.19

1.3

1.4

62.10

59.67

mmol/l

0.86

474

3433

Presbycusis

194

1556

1.24

2.19

1.4

1.3

60.69

59.69

mmol/l

0.15

159

1256

Other chondrocalcinosis

115

1.96

2.19

1.3

1.4

48.41

57.74

mmol/l

1.07

HSIL lesion of the cervix uteri

104

780

1.34

2.18

1.6

1.5

55.19

66.30

mmol/l

1.91

616

Otitis media, unspecified

607

1.37

2.18

2.0

73.39

70.34

mmol/l

0.24

505

Subacute thyroiditis

234

1.64

2.18

1.2

1.4

66.09

58.18

mmol/l

0.51

191

Trigger finger

135

1051

1.29

2.18

1.3

1.4

56.37

63.01

mmol/l

1.24

103

834

Sequelae of injuries of lower limb

610

1.38

2.18

1.4

55.77

61.68

mmol/l

0.77

495

Maternal care for other known or suspected fetal problems

576

0.70

2.17

1.7

1.5

67.88

69.03

mmol/l

0.06

442

Left ventricular outflow tract obstruction, narrow definition

321

1.54

2.17

1.4

1.8

71.54

67.55

mmol/l

0.20

271

Paralytic strabismus

552

1.41

2.17

1.4

72.83

61.67

mmol/l

1.26

441

Other and unspecified injuries of forearm

2.67

2.16

1.1

1.4

53.00

55.42

mmol/l

—

Pre-eclampsia

144

1132

1.28

2.15

1.4

63.35

63.04

mmol/l

0.03

115

885

Algoneurodystrophy

159

1.78

2.14

1.3

53.48

62.96

mmol/l

0.60

136

conjunctival degenerations and deposits

152

1.80

2.14

1.3

57.10

60.00

mmol/l

0.17

122

All dysplastic lesions of the vulva

291

1.56

2.12

2.0

1.4

49.69

60.32

mmol/l

1.37

234

Fenamates

164

888

1.26

2.12

1.4

60.17

59.65

mmol/l

0.05

137

711

Dental pulpitis, including avohilmo

850

4928

1.11

2.11

1.5

1.4

63.09

62.58

mmol/l

0.12

666

3875

Single delivery by caesarean section

528

0.70

2.10

1.2

1.5

64.89

64.77

mmol/l

0.01

401

Parkinson's disease

178

1440

1.24

2.10

1.4

1.3

71.77

60.87

mmol/l

3.04

137

1167

Traumatic ischaemia of muscle

2.17

2.10

1.2

1.3

69.91

55.43

mmol/l

0.45

Malignant neoplasm of breast, ER-negative, including Hilmo

249

1949

1.20

2.08

1.5

1.4

64.99

60.03

mmol/l

0.97

201

1557

Injuries to the wrist and hand

1071

6506

1.09

2.07

1.5

1.4

63.53

62.39

mmol/l

0.36

843

5171

Maternal care for known or suspected abnormality of pelvic organs

831

0.75

2.06

1.3

1.5

62.01

65.97

mmol/l

0.36

646

Residual foreign body in soft tissue

269

1.57

2.06

1.8

1.5

64.58

63.79

mmol/l

0.04

215

Psoriatic arthropathies

694

1.35

2.05

1.3

1.4

63.99

63.96

mmol/l

0.00

545

Other and unspecified injuries of shoulder and upper arm

207

1.66

2.05

1.7

1.3

77.15

64.82

mmol/l

0.46

175

Malignant neoplasm of prostate

254

1254

1.20

2.05

1.3

1.4

62.87

64.07

mmol/l

0.18

206

1002

Other benign neoplasms of uterus

559

1.39

2.05

1.3

1.4

61.67

58.70

mmol/l

0.27

454

Glaucoma, exfoliation

142

1124

1.27

2.04

1.3

55.93

59.74

mmol/l

0.68

115

889

UC patients in KELA-register (code 208), prior to 1994

294

1.55

2.04

2.2

1.4

62.45

59.94

mmol/l

0.13

242

Lateral epicondylitis

110

842

1.31

2.04

1.3

1.4

63.44

61.83

mmol/l

0.13

661

Other/unspecified disorders of vestibular function

351

1.50

2.04

1.5

1.3

65.86

58.53

mmol/l

0.64

286

Benign neoplasm: Other and unspecified parts of mouth

247

1.60

2.03

1.4

64.00

60.44

mmol/l

0.16

201

Congenital malformations of eye, ear, face and neck

359

1.49

2.02

1.9

1.7

63.29

69.23

mmol/l

0.47

304

Gonarthrosis,primary

1034

5712

1.09

2.01

1.3

1.4

62.46

60.22

mmol/l

1.00

838

4510

Effects of foreign body entering through natural orifice

217

1801

1.21

2.00

1.4

1.5

59.97

63.91

mmol/l

0.64

168

1429

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

127

993

1.28

2.00

1.4

1.5

62.40

65.05

mmol/l

0.24

102

777

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

201

1.66

1.99

1.5

53.00

63.93

mmol/l

0.54

171

Benign neoplasm: Descending colon

587

1.37

1.99

1.5

1.4

69.05

60.18

mmol/l

1.07

472

Acne

399

1.45

1.99

1.6

2.1

71.94

72.32

mmol/l

0.02

340

Tuberculosis

494

1.41

1.98

1.5

1.3

58.74

60.19

mmol/l

0.12

392

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

668

1.34

1.98

2.4

1.9

67.89

68.46

mmol/l

0.04

557

Demyelinating diseases of the central nervous system

435

1.43

1.98

1.6

1.4

54.17

64.21

mmol/l

1.47

357

Glaucoma-related operations

571

1.38

1.98

1.3

1.4

58.41

59.18

mmol/l

0.06

457

119

1.87

1.98

1.5

1.4

94.12

61.12

mmol/l

1.36

100

Central retinal artery occlusion

179

1.70

1.97

1.6

1.3

73.50

62.55

mmol/l

0.67

146

Exposure to other and unspecified inanimate mechanical forces

503

1.40

1.97

1.8

1.4

70.09

63.42

mmol/l

0.35

410

Tonsillectomy and adenotomy

305

2477

0.86

1.96

1.5

1.6

65.94

65.74

mmol/l

0.03

247

1937

ILD medications: nintedanib

2.81

1.96

1.3

61.67

60.04

mmol/l

—

Disorders of puberty, all

2.21

1.95

6.6

2.1

96.86

79.08

mmol/l

0.76

Delivery, wide proxy

313

1937

0.85

1.94

1.3

1.4

62.16

59.66

mmol/l

0.50

255

1550

Maternal care for known or suspected malpresentation of fetus

496

0.67

1.94

1.7

1.6

74.00

68.92

mmol/l

0.25

378

Benign lipomatous neoplasm of other sites/unspecified

728

1.33

1.93

1.5

1.4

54.31

60.42

mmol/l

1.08

586

malignant neoplasm of male genital organs

256

1296

1.19

1.93

1.3

1.4

62.80

63.41

mmol/l

0.09

206

1038

Other and unspecified degenerative diseases of nervous system

243

1.58

1.92

1.5

1.4

61.82

61.21

mmol/l

0.03

196

Benign neoplasm: Skin of other and unspecified parts of face

114

886

1.29

1.92

1.4

60.06

61.36

mmol/l

0.13

713

Other inflammation of eyelid, including avohilmo

400

3502

1.14

1.92

1.4

61.25

63.14

mmol/l

0.38

331

2733

Paranoid personality disorder

2.02

1.91

1.1

1.3

77.22

61.39

mmol/l

—

Follow-up examination after treatment for malignant neoplasms

101

773

1.31

1.90

1.3

54.33

61.04

mmol/l

0.88

606

Pollen allergy

122

943

1.28

1.90

1.7

1.9

65.89

69.04

mmol/l

0.27

765

Other predominantly sexually transmitted diseases, not elsewhere classified

108

834

1.30

1.89

1.4

1.5

63.34

63.78

mmol/l

0.03

663

Other and unspecified atrophic disorders of skin

2.73

1.89

1.2

1.4

59.67

59.17

mmol/l

—

ILD medications: pirfenidone

2.13

1.89

1.6

1.3

71.87

59.07

mmol/l

0.62

Benign neoplasm: Rectosigmoid junction

341

1.48

1.88

1.6

1.3

56.29

58.64

mmol/l

0.19

276

Medical abortion

647

3146

1.11

1.88

1.4

59.88

60.16

mmol/l

0.06

504

2510

Alzheimer’s disease (undefined), excluding more controls

0.00

1.87

0.0

1.1

—

59.17

—

Male infertility

197

1.63

1.87

1.3

1.4

73.57

63.46

mmol/l

0.46

150

Bicuspidal aortic valve syndrome

229

1.59

1.85

1.4

65.40

64.03

mmol/l

0.06

192

Dermatographic urticaria

408

1.43

1.85

1.2

1.4

59.45

62.45

mmol/l

0.25

337

Multiple delivery

528

0.64

1.85

1.6

1.5

64.25

60.52

mmol/l

0.23

400

Thyroiditis

484

1.39

1.85

1.2

1.4

65.78

61.09

mmol/l

0.39

398

Malignant neoplasm of stomach, including Hilmo

442

1.41

1.84

1.3

1.4

52.40

60.24

mmol/l

1.32

348

Burn and corrosion of wrist and hand

198

1.63

1.84

1.7

1.4

58.68

66.19

mmol/l

0.39

170

Colorectal adenocarcinoma

225

1867

1.19

1.84

1.4

58.85

62.41

mmol/l

0.57

154

1511

Unspecified/other endometriosis

400

1.43

1.83

1.4

59.94

64.07

mmol/l

0.34

305

Obstructed labour due to maternal pelvic abnormality

1075

0.75

1.82

1.4

53.60

61.90

mmol/l

1.37

831

Galactorrhea

2.61

1.81

1.1

1.3

69.78

87.97

mmol/l

—

Malignant neoplasm of thyroid gland, including Hilmo

503

1.38

1.81

1.2

1.4

63.68

61.16

mmol/l

0.17

412

Calculus of kidney and ureter

216

2565

0.84

1.80

1.4

64.85

62.71

mmol/l

0.29

168

2065

Atrial septal defect

253

1.55

1.80

1.4

2.3

77.38

69.48

mmol/l

0.35

221

Graves disease, strict definition

658

1.33

1.80

1.4

69.69

63.05

mmol/l

0.62

532

Mesothelioma

2.21

1.80

1.6

1.5

92.88

58.12

mmol/l

—

Gonococcal infection, including avohilmo

184

1.64

1.79

1.7

1.4

51.05

59.71

mmol/l

0.64

155

Benign neoplasm: Duodenum

200

1.62

1.79

1.8

1.3

60.79

59.61

mmol/l

0.05

169

Postpartum hemorraghe, parous women as controls

821

0.74

1.77

1.2

1.4

67.58

66.24

mmol/l

0.08

647

Other and unspecified follicular disorders

232

1.56

1.77

1.6

1.3

69.79

67.99

mmol/l

0.08

198

Seborrhoeic keratosis

281

2417

1.17

1.77

1.4

59.45

62.05

mmol/l

0.50

234

1921

Pedal cyclist injured in transport accident

200

1672

1.20

1.76

1.6

1.4

66.63

63.15

mmol/l

0.47

165

1328

Amblyopia ex anopsia

289

1.50

1.75

1.3

1.6

60.75

68.88

mmol/l

0.66

241

Carcinoma in situ of skin

107

837

1.29

1.75

1.2

1.4

63.22

60.02

mmol/l

0.32

680

Injury of muscle and tendon at wrist and hand level

121

960

1.27

1.75

1.3

1.4

63.08

61.68

mmol/l

0.13

763

Other/unspecified crystal arthropathies

2.20

1.75

1.1

1.2

68.71

55.06

mmol/l

—

Other disorders of cornea

102

794

1.29

1.73

1.5

1.4

58.77

61.06

mmol/l

0.26

646

Other bursal cyst

1.90

1.72

1.5

1.3

91.94

58.08

mmol/l

1.44

Disorder of the sleep-wake schedule

1.93

1.71

1.4

65.67

68.47

mmol/l

0.07

Gonococcal infection

179

1.63

1.70

1.7

1.4

51.05

58.95

mmol/l

0.57

151

Oral lichen planus

203

1.59

1.70

1.4

65.92

57.35

mmol/l

0.48

173

Divergent concomitant strabismus

475

1.38

1.70

1.5

1.4

59.59

62.12

mmol/l

0.18

388

Benign neoplasm: Caecum

124

992

1.26

1.69

1.4

55.20

61.45

mmol/l

1.49

101

806

Malignant neoplasm of stomach

374

1.43

1.69

1.3

1.4

52.98

60.18

mmol/l

1.02

292

Other specified/unspecified hearing loss

744

1.30

1.69

2.1

1.4

59.52

60.71

mmol/l

0.10

598

Stenosis and insufficiency of lacrimal passages

102

797

1.29

1.69

1.4

53.82

60.35

mmol/l

1.03

636

Sudden idiopathic hearing loss

103

806

1.28

1.68

1.3

1.4

63.46

62.83

mmol/l

0.06

654

Convergent concomitant strabismus

308

1.47

1.68

1.2

1.5

70.81

65.30

mmol/l

0.25

256

Poor fetal growth

374

1.42

1.68

1.8

1.6

62.77

68.04

mmol/l

0.39

304

Sulfonylureas

412

2897

1.13

1.68

1.4

55.25

61.33

mmol/l

2.80

323

2344

Typhoid and paratyphoid fevers

2.65

1.68

1.0

1.3

83.88

55.12

mmol/l

—

Bursitis of shoulder

149

1.69

1.68

1.2

1.3

79.15

56.35

mmol/l

1.09

120

Benign neoplasm of brain and other parts of central nervous system

485

1.37

1.67

1.7

1.5

73.87

61.73

mmol/l

1.23

388

Foreign body in ear

119

1.79

1.67

1.6

1.4

80.57

67.94

mmol/l

0.52

106

Retinal haemorrhage

212

1.58

1.67

1.3

77.77

59.47

mmol/l

0.97

173

Nonsuppurative otitis media, including avohilmo

244

1801

1.17

1.66

1.7

1.6

66.22

65.61

mmol/l

0.07

191

1450

Spontaneous abortion

289

2234

0.86

1.66

1.3

1.4

65.80

61.83

mmol/l

0.82

233

1766

Supervision of high-risk pregnancy

565

0.74

1.66

1.5

1.4

75.22

62.47

mmol/l

1.25

415

Carcinoma in situ of other and unspecified digestive organs

368

1.43

1.65

1.6

1.4

55.53

59.72

mmol/l

0.43

298

Ankylosing spondylitis

503

1.36

1.65

1.5

1.4

62.85

63.13

mmol/l

0.02

398

Tongue abnormality

521

1.35

1.65

1.4

58.29

58.75

mmol/l

0.03

422

Primary hyperparathyroidism

132

1068

1.24

1.64

1.3

1.4

54.24

60.77

mmol/l

1.40

108

856

Chronic respiratory disease originating in the perinatal period

3.71

1.63

7.8

2.6

102.60

96.29

mmol/l

—

Respiratory tuberculosis, confirmed and not-confirmed

411

1.40

1.63

1.5

1.3

59.46

60.55

mmol/l

0.08

324

Respiratory tuberculosis

411

1.40

1.63

1.5

1.3

59.46

60.55

mmol/l

0.08

324

Carbimazole or st.post thyroidectomy, condition for graves disease

196

1651

1.19

1.61

1.4

66.08

61.95

mmol/l

0.59

148

1317

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

1.93

1.61

1.1

1.3

75.94

60.11

mmol/l

0.65

Acute laryngitis and tracheitis

565

1.33

1.61

2.5

1.7

71.90

67.36

mmol/l

0.34

450

Malignant neoplasm of pancreas

575

1.33

1.61

1.3

1.4

61.84

59.95

mmol/l

0.13

463

Helminthiases, including avohilmo

238

1.52

1.60

1.5

1.6

47.58

71.00

mmol/l

4.26

205

Melanocytic naevi, other sites/unspecified

550

1.33

1.59

1.4

56.05

62.89

mmol/l

1.01

451

Nontoxic multinodular goitre

218

1857

1.18

1.59

1.3

1.4

59.41

59.90

mmol/l

0.06

164

1478

Bronchitis, not specified as acute or chronic

568

1.33

1.57

1.4

60.38

61.56

mmol/l

0.10

459

Other deformity of hallux (acquired)

2.15

1.57

1.1

1.4

68.00

53.86

mmol/l

—

Secondary malignant neoplasm of respiratory and digestive organs

137

1.70

1.57

1.4

59.47

57.22

mmol/l

0.08

112

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

151

1245

1.22

1.56

1.4

1.5

54.03

64.03

mmol/l

2.86

121

1012

Mesothelioma, including Hilmo

1.91

1.56

1.6

1.5

87.44

57.91

mmol/l

—

Malignant neoplasm of heart, mediastinum and pleura

1.91

1.56

1.5

1.6

87.27

61.30

mmol/l

1.05

Anorexia

1.91

1.56

1.6

1.4

86.09

65.25

mmol/l

0.67

Pregnancy hypertension

295

2298

1.15

1.55

1.4

65.14

62.33

mmol/l

0.51

239

1790

Carcinoma in situ of skin of trunk

298

1.46

1.55

1.2

1.4

67.03

60.34

mmol/l

0.42

239

Chondropathies

129

1050

1.23

1.53

1.3

1.4

65.15

62.87

mmol/l

0.22

100

843

Corneal scars and opacities

209

1.55

1.52

1.3

57.42

60.42

mmol/l

0.18

174

Benign neoplasm: Ascending colon

157

1305

1.21

1.52

1.4

62.73

61.14

mmol/l

0.20

130

1058

Malignant neoplasm of bladder

476

1.35

1.52

1.4

53.70

60.57

mmol/l

0.80

379

Other bursitis of hip

146

1.66

1.52

1.3

55.31

55.10

mmol/l

0.01

115

Other degenerative diseases of the basal ganglia

154

1.65

1.52

1.2

1.3

63.11

60.87

mmol/l

0.10

131

Ectopic pregnancy

128

1042

1.23

1.52

1.4

64.18

62.18

mmol/l

0.19

103

814

Crushed, pushed or stepped on by crowd or human stampede

391

1.39

1.52

1.9

1.4

67.50

69.12

mmol/l

0.10

324

Burns and corrosions confined to eye and internal organs

123

1.72

1.51

1.1

1.3

55.93

63.09

mmol/l

0.34

108

Malignant neoplasm of thyroid gland

460

1.36

1.51

1.2

1.4

65.00

61.86

mmol/l

0.20

378

Vertical strabismus

234

1.51

1.50

1.4

89.32

60.55

mmol/l

1.93

195

Toxic effect of carbon monoxide

101

1.80

1.50

1.3

41.46

57.84

mmol/l

1.51

Abscess of external ear

2.02

1.49

1.7

1.4

57.31

63.98

mmol/l

0.27

Third [oculomotor] nerve palsy

147

1.66

1.49

1.4

1.3

81.82

62.39

mmol/l

0.99

122

Polyp of the female genital tract

296

1461

1.15

1.49

1.4

60.88

59.11

mmol/l

0.28

236

1126

Pedal cyclist injured in noncollision transport accidents

786

1.26

1.47

1.8

1.4

66.99

64.55

mmol/l

0.18

627

Universal erythroderma, KELA reimbursement

1.86

1.47

1.6

1.3

65.67

59.51

mmol/l

—

Other disorders of penis

645

1.29

1.46

1.5

61.48

65.36

mmol/l

0.37

516

Serous carcinoma of ovary, including Hilmo

269

1.46

1.45

1.3

1.4

61.84

59.37

mmol/l

0.15

221

Adult respiratory distress syndrome

1.94

1.45

2.3

1.3

74.71

59.37

mmol/l

0.41

Malignant neoplasm of other connective and soft tissue, including Hilmo

294

1.44

1.3

1.4

58.97

60.14

mmol/l

0.06

236

Recurrent dislocation and subluxation of joint

344

1.40

1.44

1.6

1.4

72.87

66.20

mmol/l

0.37

270

Other arterial embolism and thrombosis

188

1.56

1.44

1.5

1.3

53.67

60.85

mmol/l

0.37

161

Other other unspecified disorders of the circulatory system

271

1.45

1.40

1.2

1.5

58.16

59.67

mmol/l

0.07

224

Recurrent dislocation of patella

165

1.58

1.40

1.1

1.5

58.16

68.77

mmol/l

0.68

140

Pustulosis palmaris et plantaris

288

1.43

1.39

1.4

66.33

59.20

mmol/l

0.34

241

Viral infections of central nervous system, not elsewhere classified/unspecified

2.03

1.39

1.1

1.3

71.08

60.57

mmol/l

0.33

Disorders of puberty

2.09

1.39

7.7

1.7

93.82

77.54

mmol/l

0.58

Benign neoplasm of major salivary glands

776

1.26

1.38

1.3

1.4

55.19

61.44

mmol/l

1.05

632

Diseases of middle ear and mastoid

492

3640

1.10

1.38

1.5

66.88

63.73

mmol/l

0.78

374

2893

Erectile dysfunction

555

1.30

1.38

1.4

67.39

64.75

mmol/l

0.23

452

Postmenopausal atrophic vaginitis

285

1359

1.15

1.37

1.4

59.95

58.41

mmol/l

0.28

230

1042

Contact with sharp glass

174

1.56

1.37

1.4

79.52

64.82

mmol/l

0.47

148

Disorder of external ear, unspecified

231

1.48

1.37

1.3

49.23

60.70

mmol/l

1.16

197

Unspecified abortion

256

1.45

1.36

1.5

1.4

64.37

64.94

mmol/l

0.03

199

Contact with sharp object, undetermined intent

112

1.71

1.36

1.7

1.3

72.77

63.10

mmol/l

0.31

Urolithiasis

245

2804

0.87

1.36

1.4

64.34

63.23

mmol/l

0.15

185

2257

Valgus deformity, not elsewhere classified

2.17

1.35

6.4

1.4

68.80

56.45

mmol/l

—

Benign neoplasm: Anus and anal canal

224

1.49

1.34

1.3

1.4

54.96

62.93

mmol/l

0.76

193

Benign neoplasm: Parotid gland

619

1.28

1.34

1.3

1.4

54.54

61.36

mmol/l

0.96

504

Disorders of vitreous body and globe

585

5067

1.09

1.34

1.4

58.85

61.06

mmol/l

0.74

483

4037

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

515

1.31

1.32

1.4

60.86

59.33

mmol/l

0.12

423

Other juvenile arthritis

176

1.54

1.32

1.5

1.9

58.26

71.69

mmol/l

0.83

147

Arthropathic psoriasis

101

817

1.24

1.31

1.3

1.4

61.89

62.99

mmol/l

0.09

656

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

166

1409

1.18

1.31

1.4

1.5

54.84

63.62

mmol/l

2.48

134

1146

Benign neoplasm: salivary glands, exclude unknown (D119)

693

1.26

1.30

1.3

1.4

54.03

61.42

mmol/l

1.20

563

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

420

1.34

1.30

1.5

1.4

71.74

64.48

mmol/l

0.46

329

Malignant neoplasm of other connective and soft tissue

185

1.53

1.30

1.4

1.5

60.77

60.26

mmol/l

0.02

148

Disorders of vitreous body

567

4942

1.09

1.30

1.4

58.68

61.07

mmol/l

0.82

470

3937

Open wound of hip and thigh

185

1.52

1.29

1.2

1.4

63.47

64.11

mmol/l

0.02

156

Polycystic ovarian syndrome, broad definition

309

1.39

1.29

1.3

1.5

74.78

65.87

mmol/l

0.52

256

Other infestations, including avohilmo

133

0.45

1.29

1.5

1.4

51.83

62.45

mmol/l

—

119

Other congenital malformations of skin

251

1.44

1.29

1.4

1.5

91.11

64.25

mmol/l

1.66

213

Other acquired deformities of musculoskeletal system and connective tissue

310

1.40

1.29

1.3

52.76

61.62

mmol/l

0.81

250

Papillary adenocarcinoma of thyroid gland

344

1.37

1.28

1.2

1.4

67.14

61.44

mmol/l

0.32

282

Benign neoplasm: Other and unspecified parts of small intestine

130

1.64

1.28

1.5

1.3

58.54

58.45

mmol/l

0.00

111

Other retinal artery occlusion

186

1.52

1.27

1.6

1.4

66.39

63.02

mmol/l

0.14

151

Circumscribed brain atrophy

178

1.53

1.27

1.5

1.3

65.50

60.85

mmol/l

0.21

150

Other bullous disorders

186

1.52

1.27

1.2

1.3

73.61

61.27

mmol/l

0.79

155

Ethmoidectomy

107

875

1.23

1.27

1.3

1.4

69.20

62.44

mmol/l

0.99

705

Carcinoma in situ of cervix uteri

431

1.33

1.26

1.2

1.5

67.57

65.08

mmol/l

0.14

351

Ulcerative rectosigmoiditis

475

1.31

1.26

1.5

1.4

57.62

63.62

mmol/l

0.57

389

conjunctival haemorrhage

653

1.26

1.24

1.4

66.02

63.07

mmol/l

0.27

526

Other and unspecified primary disorders of muscles

2.03

1.24

2.6

1.6

77.56

68.08

mmol/l

—

Suppurative and unspecified otitis media

259

2020

1.14

1.24

1.5

1.6

68.52

65.77

mmol/l

0.38

193

1620

FESS (DNB20)

103

842

1.23

1.3

1.4

67.69

62.45

mmol/l

0.68

673

Impacted cerumen

123

1024

1.21

1.23

1.6

1.5

63.10

63.46

mmol/l

0.03

843

Myotonic disorders

2.19

1.22

1.6

1.4

58.88

58.31

mmol/l

—

Sequelae of infectious and parasitic diseases, including avohilmo

522

1.29

1.21

1.3

1.4

64.92

61.16

mmol/l

0.29

420

Other localized connective tissue disorders

140

1.59

1.21

1.3

75.25

61.09

mmol/l

0.47

113

Benign neoplasm: Vulva

148

1.57

1.21

1.4

1.3

67.11

59.79

mmol/l

0.34

119

Hallux rigidus

143

1210

1.19

1.20

1.3

1.4

65.10

61.64

mmol/l

0.45

115

954

Congenital malformations of genital organs

458

1.31

1.20

2.3

1.8

76.40

69.16

mmol/l

0.42

385

Bacterial, viral and other infectious agents

514

1.29

1.20

1.7

1.4

60.60

64.62

mmol/l

0.33

416

Other psoriatic arthropathies

710

1.24

1.20

1.3

1.4

64.18

62.08

mmol/l

0.16

568

Bruxism

1.76

1.19

1.7

1.3

68.27

69.43

mmol/l

0.03

Family history of certain disabilities and chronic diseases leading to disablement

197

1.48

1.19

1.3

1.4

67.52

67.62

mmol/l

0.00

162

Bacterial, viral and other infectious agents, including avohilmo

559

1.27

1.19

1.6

1.5

60.34

64.74

mmol/l

0.40

449

Meralgia paraesthetica

214

1.46

1.18

1.2

1.3

75.00

60.58

mmol/l

0.73

181

Artificial joint operation, meniscal resection

1019

6119

1.07

1.18

1.4

62.71

60.50

mmol/l

1.01

831

4811

Colon adenocarcinoma, helper endpoint

145

1232

1.18

1.17

1.3

1.4

53.80

61.45

mmol/l

1.63

993

Malignant neoplasm of breast, HER-negative

223

1879

1.14

1.17

1.4

66.02

60.03

mmol/l

1.16

180

1505

All dysplastic lesions of the cervix uteri

144

1203

1.18

1.16

1.5

1.4

58.74

64.98

mmol/l

0.99

119

942

Actinomycosis

2.55

1.16

2.6

1.4

68.40

57.93

mmol/l

—

Impacted teeth

681

0.78

1.16

1.6

69.67

70.93

mmol/l

0.07

556

Reactive arthropathies, FINNGEN

438

1.31

1.15

1.5

1.4

56.45

64.76

mmol/l

0.92

343

Tinnitus

230

2025

1.14

1.15

1.4

61.62

62.09

mmol/l

0.06

190

1610

Spinal enthesopathy

182

1.49

1.15

1.4

66.00

54.22

mmol/l

0.88

136

Vascular dementia (undefined)

391

1.33

1.15

1.4

51.11

58.87

mmol/l

1.07

308

Family history of malignant neoplasm

651

1.25

1.15

1.3

1.4

68.06

63.13

mmol/l

0.36

519

Sequelae of other and unspecified infectious and parasitic diseases

300

1.37

1.15

1.2

1.4

69.33

62.78

mmol/l

0.35

247

Crossbite

363

1.32

1.14

4.2

2.4

68.26

72.60

mmol/l

0.28

317

Other and unspecified hypertrophic disorders of skin

2.37

1.13

1.0

1.3

48.29

61.84

mmol/l

—

Disorders of optic nerve, not elsewhere classified

159

1.53

1.13

1.2

1.4

47.89

57.79

mmol/l

0.54

136

Other and unspecified injuries of wrist and hand

250

1.41

1.13

1.6

1.5

58.56

62.17

mmol/l

0.23

203

Sequelae of infectious and parasitic diseases

502

1.28

1.12

1.3

1.4

65.08

61.44

mmol/l

0.27

405

Adhesive capsulitis of shoulder

151

1293

1.17

1.12

1.4

60.66

61.84

mmol/l

0.15

126

1022

Atrophic disorders of skin

155

1331

1.17

1.11

1.5

1.4

65.19

62.16

mmol/l

0.44

130

1051

Other autoimmune haemolytic anaemias

104

1.66

1.11

1.4

1.3

59.09

59.16

mmol/l

0.00

Exposure to excessive natural cold

1.84

1.10

1.5

1.3

35.86

59.52

mmol/l

—

Pustular psoriasis

320

1.35

1.10

1.4

67.63

59.81

mmol/l

0.41

261

Pregnancy examination and test

392

0.76

1.10

1.3

1.5

74.21

62.64

mmol/l

0.71

294

Typhoid and paratyphoid fevers, including avohilmo

1.98

1.10

1.0

1.3

83.88

55.79

mmol/l

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

303

1.36

1.09

1.2

1.4

69.33

62.86

mmol/l

0.34

249

Use of levodopa decarboxylase inhibitor

154

1325

1.17

1.09

1.3

71.57

60.81

mmol/l

2.82

125

1078

Lesion of plantar nerve

478

1.28

1.09

1.3

1.4

61.46

59.58

mmol/l

0.14

387

Gluteal tendinitis

269

1.38

1.09

1.3

61.13

57.93

mmol/l

0.18

215

Non-small cell lung cancer, squamous, helper endpoint

373

1.32

1.08

1.2

1.3

60.77

62.27

mmol/l

0.11

302

Other specified/unspecified disorders of bone/cartilage

161

1.50

1.07

1.4

1.3

50.27

59.17

mmol/l

0.81

136

Atopic conjunctivitis

270

1.38

1.07

1.5

63.07

68.51

mmol/l

0.27

223

Brachial plexus disorders

479

1.28

1.07

1.5

1.4

53.50

63.95

mmol/l

1.40

384

Endometriosis of rectovaginal septum and vagina

560

1.26

1.06

1.5

1.4

56.36

60.31

mmol/l

0.45

443

Foreign body in respiratory tract

357

1.32

1.06

1.2

1.5

58.86

64.37

mmol/l

0.34

288

Contusion of other and unspecified parts of foot

271

1.37

1.04

1.9

1.6

55.45

69.69

mmol/l

1.82

229

Propionic acid derivatives

301

1358

1.12

1.04

1.3

1.6

62.33

62.18

mmol/l

0.02

243

1089

Premenstrual syndrome

1.97

1.04

2.1

1.7

59.11

76.22

mmol/l

—

Malignant melanoma, including Hilmo

166

1443

1.15

1.03

1.2

1.4

64.95

63.12

mmol/l

0.22

137

1165

Infective bursitis

179

1.46

1.03

1.4

1.3

69.25

61.76

mmol/l

0.37

143

Diabetes mellitus in pregnancy

109

825

0.84

1.03

1.4

1.5

66.95

66.87

mmol/l

0.01

640

Carcinoma in situ of colon

230

1.40

1.02

1.3

1.4

60.85

58.51

mmol/l

0.17

187

Puerperal sepsis

887

0.81

1.02

1.4

61.15

63.42

mmol/l

0.16

700

Hypermetropia

518

1.26

1.02

2.1

1.8

66.75

63.64

mmol/l

0.24

421

Benign neoplasm: Long bones of lower limb

188

1.45

1.02

1.3

63.17

64.48

mmol/l

0.04

159

Idiopathic thrombocytopenic purpura

205

1.42

1.01

1.7

1.4

78.26

62.87

mmol/l

0.57

168

Primary open-angle glaucoma, strict

324

2931

1.11

1.01

1.4

61.92

60.32

mmol/l

0.32

262

2333

Mouth breathing

351

3191

1.10

1.00

1.6

1.5

63.84

63.37

mmol/l

0.07

290

2514

Psoriatic arthropathies, ICD10

736

1.21

1.00

1.3

1.4

64.18

62.06

mmol/l

0.16

587

Other inflammation of vagina/vulva

172

1.46

1.00

2.1

1.5

64.55

67.29

mmol/l

0.11

146

Other congenital malformations of skin, including avohilmo

511

1.26

1.00

1.5

73.22

64.40

mmol/l

0.51

418

Juvenile arthritis (FINNGEN)

214

1.41

0.99

1.4

1.7

57.62

69.35

mmol/l

0.79

175

Perforation of tympanic membrane

746

1.21

0.99

1.5

1.4

60.59

63.14

mmol/l

0.25

606

Dislocation, sprain and strain of joints and ligaments of knee

430

4223

0.92

0.99

1.5

1.4

62.30

63.59

mmol/l

0.26

342

3307

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.82

0.99

1.2

1.3

81.00

59.58

mmol/l

0.69

Foreign body or object entering through skin

370

1.30

0.98

1.5

1.4

68.62

63.69

mmol/l

0.18

302

Artificial joint re-operation

666

1.22

0.98

1.4

62.43

60.19

mmol/l

0.20

537

Iron deficiency

140

1.51

0.97

1.1

1.5

62.86

69.50

mmol/l

0.25

125

Pyoderma

116

1.57

0.97

5.8

1.3

62.92

62.96

mmol/l

0.00

102

Ulcerative colitis (strict definition, all Crohn cases excluded)

108

914

1.18

0.96

1.6

1.4

65.83

64.83

mmol/l

0.07

727

Carcinoma in situ of skin, other sites/unspecified

141

1.51

0.96

1.1

1.3

48.82

59.42

mmol/l

0.85

113

Parkinson's disease, strict definition

153

1332

1.15

0.96

1.3

1.4

72.87

60.58

mmol/l

3.47

119

1086

Obstructed labour due to malposition and malpresentation of fetus

907

0.83

0.96

1.4

61.68

67.40

mmol/l

0.53

702

Liposarcoma, including Hilmo

1.80

0.95

1.0

1.4

60.00

59.67

mmol/l

—

Benign neoplasm: Skin of ear and external auricular canal

294

1.33

0.95

1.2

1.3

51.13

61.01

mmol/l

0.98

245

Complications predominantly related to the puerperium

124

1442

0.86

0.94

1.4

1.5

60.20

63.75

mmol/l

0.37

1126

Normal-pressure hydrocephalus

463

1.26

0.93

1.5

1.4

70.94

58.48

mmol/l

1.78

371

Malignant neoplasm of eye and adnexa

1.84

0.93

1.4

73.10

62.65

mmol/l

—

Traction detachment of retina

1.75

0.93

1.4

1.3

53.78

59.70

mmol/l

—

Tooth eruption problems

594

1.22

0.92

2.1

68.18

73.62

mmol/l

0.44

492

Mixed conductive and sensorineural hearing loss

122

1048

1.17

0.92

1.3

1.4

58.92

61.39

mmol/l

0.31

852

Arthropod-borne viral fevers and viral haemorrhagic fevers

662

1.21

0.92

1.3

1.4

52.41

61.21

mmol/l

1.59

529

Dentofacial anomalies [including malocclusion]

620

4534

1.07

0.92

1.6

1.5

64.33

62.68

mmol/l

0.42

515

3539

Malignant neoplasm of other and unspecified parts of biliary tract

110

1.56

0.91

1.2

1.4

54.88

60.49

mmol/l

—

Tarsal tunnel syndrome

1.77

0.91

1.6

1.3

60.18

61.38

mmol/l

0.04

Crowding of teeth, including avohilmo

339

1.27

0.90

3.7

2.3

80.44

77.04

mmol/l

0.17

297

Unattended death

1.71

0.90

1.8

1.3

69.43

63.15

mmol/l

—

Corneal ulcer

161

1415

1.14

0.89

1.5

1.4

63.70

62.43

mmol/l

0.13

129

1124

Other diseases of gallbladder

368

1.28

0.89

1.4

55.15

59.69

mmol/l

0.40

298

Vasomotor rhinitis (mode)

529

1.23

0.88

1.5

1.4

63.58

60.78

mmol/l

0.25

429

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

177

1.42

0.88

1.7

2.2

65.05

74.63

mmol/l

0.58

157

Vascular syndromes of brain in cerebrovascular disorders

386

1.28

0.88

1.3

1.4

65.14

58.76

mmol/l

0.53

310

Childhood allergy (age < 16)

383

1.25

0.88

1.8

3.0

76.61

80.77

mmol/l

0.23

325

Carcinoma in situ of other and unspecified genital organs

144

1.47

0.88

1.4

1.3

59.50

60.83

mmol/l

0.05

119

Chronic diseases of tonsils and adenoids

636

4275

0.94

0.88

1.5

62.33

62.98

mmol/l

0.13

508

3347

Melanocytic naevi of trunk

840

1.18

0.88

1.3

1.4

71.58

62.69

mmol/l

1.28

676

Embedded teeth, including avohilmo

377

1.28

0.88

1.4

1.5

63.46

68.63

mmol/l

0.33

314

Disturbances of smell and taste

288

0.69

0.87

1.1

1.3

73.93

57.84

mmol/l

0.70

232

Acne, including avohilmo

107

738

1.17

0.87

1.4

2.0

76.12

70.56

mmol/l

0.51

617

Other nonthrombocytopenic purpura

1.69

0.86

1.1

1.3

51.92

60.30

mmol/l

0.45

Acute nasopharyngitis (common cold)

717

1.19

0.85

1.4

56.25

62.66

mmol/l

0.85

558

Viral haemorrhagic fevers, not elsewhere classified/unspecified

532

1.23

0.85

1.3

1.4

49.53

61.27

mmol/l

2.48

432

Malignant neoplasm of rectum, including Hilmo

114

982

1.16

0.85

1.5

1.4

61.57

61.17

mmol/l

0.03

789

Medicines for HER+ breast cancer

351

3550

0.92

0.85

1.4

59.51

59.63

mmol/l

0.02

271

2830

Melanocytic naevi of upper limb, including shoulder

137

1.47

0.84

1.6

1.3

63.17

63.90

mmol/l

0.02

115

Other lesions of median nerve

222

1.36

0.84

1.4

1.3

60.05

58.42

mmol/l

0.10

179

Uterine polyps

270

1430

1.10

0.84

1.4

62.01

59.06

mmol/l

0.54

216

1100

Follow-up care involving plastic surgery

222

1.36

0.84

1.4

65.75

63.36

mmol/l

0.11

177

Malignant neoplasm of cervix uteri, including Hilmo

154

1.44

0.84

2.4

1.4

60.41

60.95

mmol/l

0.02

129

Eustachian salpingitis and obstruction

398

1.26

0.83

1.2

1.5

61.06

66.98

mmol/l

0.31

329

Ménière disease

827

1.18

0.83

1.3

1.4

62.17

60.35

mmol/l

0.18

675

Congenital ovarian cysts

171

1.41

0.83

1.1

1.4

86.32

68.64

mmol/l

0.66

143

Benign neoplasm: Skin of lower limb, including hip

197

1.38

0.82

1.5

1.3

54.88

61.47

mmol/l

0.33

165

Vestibular neuronitis

708

1.19

0.82

1.5

1.4

63.66

60.87

mmol/l

0.24

579

Fourth [trochlear] nerve palsy

172

1.41

0.81

1.3

73.83

61.70

mmol/l

0.60

145

Patent foramen ovale

130

1.47

0.81

3.8

1.8

76.16

67.85

mmol/l

0.39

116

Nontoxic diffuse goitre

241

1.34

0.81

1.5

1.4

61.72

57.08

mmol/l

0.23

192

Benign neoplasm: Skin of eyelid, including canthus

157

1390

1.13

0.81

1.4

60.42

61.49

mmol/l

0.11

128

1118

Arthropathy in ulcerative colitis

1.74

0.80

1.2

1.3

49.80

59.58

mmol/l

—

L02BG Aromatase inhibitors

295

3175

0.92

0.80

1.4

59.31

59.56

mmol/l

0.04

224

2538

Other sexually transmitted chlamydial diseases, including avohilmo

294

0.71

0.79

1.1

1.6

80.14

69.86

mmol/l

0.28

240

Combinations of oral blood glucose lowering drugs

276

2522

1.10

0.79

1.3

1.4

58.40

62.45

mmol/l

0.99

215

2037

Malignant melanoma

145

1279

1.14

0.79

1.2

1.3

67.18

63.08

mmol/l

0.52

119

1034

Other acute skin changes due to ultraviolet radiation

242

1.33

0.79

1.5

1.3

52.23

61.27

mmol/l

0.67

193

Embedded and impacted teeth

105

987

0.86

0.79

1.6

1.8

65.63

69.75

mmol/l

0.39

800

L02BX Other hormone antagonists and related agents

429

1.24

0.78

1.3

61.12

63.79

mmol/l

0.19

353

Unspecified lump in breast

150

1329

1.13

0.77

1.4

56.16

61.89

mmol/l

1.22

120

1061

Triptan medication for migraine, min. 3 purchases

408

2832

1.08

0.76

1.5

1.4

66.50

62.56

mmol/l

0.92

330

2206

Postpartum care and examination

333

0.79

0.76

1.1

1.5

75.43

63.66

mmol/l

0.84

249

Other contact dermatitis

512

1.21

0.76

1.4

57.26

63.12

mmol/l

0.52

413

Abdominal aortic aneurysm (AAA)

708

1.18

0.76

1.4

58.90

63.93

mmol/l

0.67

582

Suggestive for eosinophilic asthma

659

1.19

0.76

1.3

72.55

61.98

mmol/l

1.39

532

Hordeolum and other deep inflammation of eyelid

395

1.25

0.75

1.6

1.5

59.95

63.73

mmol/l

0.25

318

Inflammation of lacrimal passages (acute and unspecified)

141

1.43

0.75

1.3

48.93

58.05

mmol/l

0.54

114

Spondylopathies (FG)

854

1.16

0.75

1.6

1.4

61.65

64.72

mmol/l

0.30

671

Varicella [chickenpox], including avohilmo

297

1.28

0.75

1.6

1.8

70.57

71.21

mmol/l

0.03

259

Delayed puberty

2.10

0.75

1.4

2.0

101.40

78.16

mmol/l

—

Other noninflammatory disorders of cervix uteri

387

1.25

0.74

1.5

1.4

58.43

60.54

mmol/l

0.16

301

Undescended testicle

1.61

0.74

6.3

3.2

87.58

81.07

mmol/l

0.15

Malignant neoplasm of breast, HER-positive

328

2254

1.08

0.74

1.4

58.43

60.20

mmol/l

0.35

253

1798

1.66

0.74

1.2

1.3

64.22

61.16

mmol/l

—

Myocardial infarction, unclassifiable

246

2005

1.10

0.74

1.5

1.3

61.52

60.92

mmol/l

0.08

195

1616

Varicella [chickenpox]

245

1.31

0.74

1.6

1.4

69.92

70.51

mmol/l

0.02

209

Peritonsillar abscess

144

1277

1.13

0.74

2.2

1.4

59.34

62.78

mmol/l

0.42

119

996

Hypertrophic disorders of skin

325

1.27

0.73

1.4

51.03

63.92

mmol/l

1.67

260

Spirochaetal infections, other/unspecified

708

1.18

0.73

1.4

59.43

61.71

mmol/l

0.19

573

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

125

1.45

0.73

1.6

1.4

77.69

61.68

mmol/l

0.59

100

Abnormal spermatozoa

106

922

1.15

0.73

1.6

1.4

65.48

63.33

mmol/l

0.24

748

Carcinoma in situ of rectum

1.54

0.73

1.6

1.3

47.71

60.69

mmol/l

0.70

Ankylosing spondylitis, ICD10

552

1.20

0.72

1.6

1.4

63.09

63.10

mmol/l

0.00

447

Benign neoplasm of other and unspecified sites

255

1.30

0.72

1.2

1.3

58.63

61.99

mmol/l

0.19

209

Primary angle-closure glaucoma

389

1.24

0.72

1.2

1.3

55.58

58.95

mmol/l

0.29

314

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

168

1.38

0.72

1.1

1.4

51.77

60.56

mmol/l

0.59

137

Malignant neoplasm of breast, ER-positive, including Hilmo

328

2255

1.08

0.72

1.4

58.43

60.18

mmol/l

0.35

253

1799

Haemorrhage in early pregnancy

149

1622

0.89

0.72

1.3

1.4

69.20

62.15

mmol/l

1.00

121

1267

Foreign body entering into or through eye or natural orifice

544

1.20

0.71

1.4

55.92

65.92

mmol/l

1.09

437

Dysplasia of cervi uteri

163

1024

1.12

0.71

1.4

55.78

61.70

mmol/l

1.12

139

779

Examination and encounter for administrative purposes

535

1.20

0.71

1.4

68.43

62.21

mmol/l

0.59

422

Lichen planus, including avohilmo

191

1727

1.11

0.71

1.4

62.29

61.42

mmol/l

0.11

151

1378

Benign neoplasm: Skin of trunk

291

1.28

0.71

1.2

1.3

57.06

61.05

mmol/l

0.27

239

Anogenital herpesviral [herpes simplex] infection, including avohilmo

480

1.21

0.71

1.4

1.5

58.66

62.58

mmol/l

0.31

405

Malignant neoplasm of gum

1.73

0.70

1.4

75.14

54.11

mmol/l

—

Birth asphyxia

1.73

0.70

2.4

2.6

71.43

92.53

mmol/l

—

Rare circulating lymphoid malignancy

1.73

0.70

1.4

48.00

65.35

mmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

224

2043

1.10

0.70

1.4

60.98

61.21

mmol/l

0.03

175

1633

Adenocarcinoma and ductal carcinoma of pancreas

265

1.29

0.70

1.2

1.4

60.17

60.16

mmol/l

0.00

213

Pedal cyclist injured in other and unspecified transport accidents

795

1.16

0.70

1.4

60.30

63.58

mmol/l

0.34

639

Other puerperal infections

240

0.71

0.70

1.3

1.5

69.27

68.72

mmol/l

0.01

203

Other disorders of pigmentation

355

1.25

0.69

1.5

1.4

55.51

59.74

mmol/l

0.33

286

Nontoxic goitre/thyroid nodule

319

2957

1.08

0.69

1.3

1.4

60.83

60.91

mmol/l

0.01

246

2374

Benign neoplasm of bone and articular cartilage

537

1.20

0.69

1.4

59.74

63.98

mmol/l

0.35

436

Excessive vomiting in pregnancy

364

1.24

0.69

1.3

1.5

58.72

63.21

mmol/l

0.33

291

Deep bite

625

1.17

0.68

3.1

2.0

66.48

70.19

mmol/l

0.28

528

Other otitis externa (chronic)

483

1.20

0.68

1.3

1.4

61.88

62.23

mmol/l

0.03

399

Foreign body on external eye

952

0.86

0.68

1.4

59.94

62.90

mmol/l

0.24

753

Fall on and from ladder

557

1.19

0.67

1.2

1.4

64.56

62.34

mmol/l

0.16

456

Other and unspecified injuries of ankle and foot

232

1.30

0.66

1.5

1.4

56.42

66.46

mmol/l

0.83

196

Inflammatory disease of cervix uteri

514

1.19

0.64

1.3

1.4

59.27

61.32

mmol/l

0.14

409

Use of selegiline

371

0.78

0.64

1.3

65.05

59.45

mmol/l

0.27

296

Chronic iridocyclitis

360

1.23

0.63

1.3

1.5

61.44

62.43

mmol/l

0.07

294

Blepharospasm

1.57

0.63

1.0

1.3

47.27

59.83

mmol/l

0.68

Congenital malformations of ovaries, fallopian tubes and broad ligaments

243

1.28

0.62

1.1

1.5

76.28

66.39

mmol/l

0.40

204

Thyrotoxicosis with toxic multinodular goitre

544

1.18

0.62

1.5

1.4

55.32

60.26

mmol/l

0.50

444

Suppurative otitis media, unspecified

147

1.37

0.61

1.2

1.5

60.00

66.02

mmol/l

0.22

124

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

361

1.22

0.61

1.3

1.4

69.23

63.87

mmol/l

0.27

295

Benign neoplasm of breast

116

1032

1.13

0.61

1.3

1.4

52.99

60.56

mmol/l

1.82

100

817

Injury of muscle and tendon at shoulder and upper arm level

334

3122

1.07

0.60

1.3

1.4

65.15

62.16

mmol/l

0.60

277

2483

Neuroendocrine tumor and carcinoma of small intestine

105

1.44

0.60

1.8

1.4

48.70

59.75

mmol/l

—

Other/unspecified reactive arthropathies

435

1.20

0.60

1.5

1.4

57.98

63.61

mmol/l

0.50

357

Conjunctivitis (acute, non atopic), including avohilmo

1041

6043

1.04

0.60

1.5

60.77

62.60

mmol/l

0.69

848

4757

Explosion of other materials

0.00

0.60

0.0

1.4

—

61.86

—

Disorders of orbit

290

1.25

0.59

1.2

1.3

58.29

59.23

mmol/l

0.05

234

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

330

2673

1.07

0.59

1.4

64.55

62.00

mmol/l

0.49

266

2090

Melanocytic naevi

258

2391

1.08

0.59

1.4

61.79

62.94

mmol/l

0.19

200

1905

Anti-inflammatory and antirheumatic products, non-steroids

291

1359

1.08

0.58

1.3

1.6

63.41

62.21

mmol/l

0.18

235

1090

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

486

0.82

0.58

1.1

1.4

64.76

60.33

mmol/l

0.28

390

Reactive arthropathies

594

1.16

0.58

1.5

1.4

57.00

66.11

mmol/l

1.22

463

Motorcycle rider injured in other and unspecified transport accidents

273

1.25

0.58

1.5

1.4

62.48

65.27

mmol/l

0.14

220

Contact with machinery

754

0.86

0.56

1.2

1.3

70.41

62.22

mmol/l

0.78

618

Anogenital herpesviral [herpes simplex] infection

256

1.25

0.56

1.4

53.08

65.92

mmol/l

1.05

215

Viral meningitis

176

1.31

0.56

1.3

1.4

65.28

64.44

mmol/l

0.03

150

Atrial septal defect, secundum type

211

1.28

0.56

1.5

2.7

73.95

74.98

mmol/l

0.04

188

Other and unspecified acne

1.46

0.56

1.4

2.1

56.63

83.00

mmol/l

—

Iridocyclitis in diseases classified elsewhere

124

1.38

0.56

1.4

78.75

60.82

mmol/l

0.75

106

Hypertrophy of breast in women and men

144

1306

1.10

0.55

1.4

60.21

63.29

mmol/l

0.43

118

1035

Abnormal findings in secretions and smears from cervix uteri vagina vulva

328

2572

0.94

0.55

1.5

1.4

58.69

62.74

mmol/l

0.99

273

2003

Donors of organs and tissues

1.51

0.54

1.3

1.2

66.56

74.37

mmol/l

—

Malignant neoplasm of rectum

805

1.13

0.54

1.5

1.4

64.16

60.32

mmol/l

0.32

649

Injury of muscle and tendon at lower leg level

118

1061

1.11

0.53

1.6

1.4

58.19

62.63

mmol/l

0.70

845

Other disorders of amniotic fluid and membranes

496

0.84

0.53

1.5

59.94

67.49

mmol/l

0.42

386

Struck by thrown, projected or falling objec

313

1.22

0.53

1.7

1.5

75.07

65.82

mmol/l

0.50

262

Malignant melanoma of skin, including Hilmo

129

1167

1.11

0.53

1.3

64.70

62.52

mmol/l

0.24

106

943

Other and unspecified mononeuropathies of lower limb

205

1.27

0.53

1.6

1.3

41.74

58.02

mmol/l

2.61

169

Rheumatic valve diseases

161

1.31

0.52

1.3

1.4

61.07

61.94

mmol/l

0.03

132

Granuloma annulare

100

0.60

0.52

1.8

1.2

49.67

62.66

mmol/l

—

Dermatitis due to ingested food

171

1.29

0.51

5.5

3.8

76.56

84.05

mmol/l

0.27

153

Adenocarcinoma of pancreas

215

1.26

0.51

1.0

1.4

54.58

60.15

mmol/l

0.28

175

Pleural plaque without asbestos

315

1.21

0.51

1.5

1.3

55.10

60.27

mmol/l

0.39

252

Transient global amnesia

873

0.88

0.51

1.4

65.69

59.61

mmol/l

0.54

709

Use of cabergoline

1.50

0.50

1.5

1.3

89.90

61.53

mmol/l

—

Ectropion of eyelid

362

1.19

0.49

1.1

1.3

55.09

61.57

mmol/l

0.59

286

Lichen planus

126

1144

1.10

0.49

1.3

1.4

65.92

61.25

mmol/l

0.63

922

Alzheimer’s disease (Late onset)

307

2377

1.06

0.49

1.3

1.4

61.83

60.10

mmol/l

0.35

248

1921

Felty syndrome

1.54

0.49

2.1

1.3

61.00

61.13

mmol/l

—

Other and unspecified iridocyclitis

326

1.20

0.48

1.3

1.4

60.81

60.85

mmol/l

0.00

264

Exposure to other specified electric current

111

0.63

0.48

1.0

1.3

83.86

66.28

mmol/l

—

Other infective otitis externa

429

1.17

0.47

1.5

1.4

64.29

63.54

mmol/l

0.04

353

Pilonidal cyst

401

1.17

0.47

1.4

63.87

66.67

mmol/l

0.16

319

Unspecified visual impairment (binocular)

111

1.36

0.47

3.4

1.4

68.47

65.80

mmol/l

0.07

Contact with nonpowered hand tool

245

1.23

0.47

1.5

1.3

63.87

62.36

mmol/l

0.06

205

Laparoscopic left hemicolectomy

129

1.33

0.46

1.2

1.3

42.42

56.03

mmol/l

0.80

113

Sacrococcygeal disorders, not elsewhere classified

165

1.28

0.45

1.4

73.13

59.88

mmol/l

0.47

136

Sixth [abducent] nerve palsy

274

1.21

0.45

1.5

1.3

66.37

59.92

mmol/l

0.33

225

Disorders of breast

465

3907

1.05

0.44

1.4

58.12

60.79

mmol/l

0.80

374

3097

Other specified disorders of external ear

275

0.80

0.44

1.5

1.3

63.57

62.53

mmol/l

0.05

234

Plantar fascial fibromatosis

667

1.13

0.44

1.4

1.3

60.65

62.37

mmol/l

0.14

524

Injury of muscle and tendon at hip and thigh level

704

0.88

0.44

1.5

1.4

55.65

61.59

mmol/l

0.66

568

Toxic effect of contact with venomous animals

275

1.20

0.43

1.2

1.5

54.74

62.26

mmol/l

0.63

233

Other disorders of patella

118

1077

1.10

0.43

1.5

1.4

62.35

64.04

mmol/l

0.15

839

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

820

1.11

0.43

1.5

1.4

68.73

60.76

mmol/l

0.74

663

Malignant neoplasm of corpus uteri, including Hilmo

104

945

1.10

0.42

1.3

1.4

56.98

59.53

mmol/l

0.28

763

Acute inflammation of orbit

1.57

0.42

1.6

1.3

59.40

65.37

mmol/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

344

1.17

0.42

2.0

2.2

68.09

73.69

mmol/l

0.36

299

Viral meningitis, including avohilmo

185

1.25

0.42

1.3

1.4

65.28

66.28

mmol/l

0.04

159

Other, unspecified and serous retinal detachments

240

1.21

0.41

1.3

50.21

62.75

mmol/l

1.47

191

Other benign neoplasms of connective and other soft tissue

718

1.12

0.41

1.3

1.4

64.89

62.67

mmol/l

0.18

576

Anomalies of dental arch relationship, including avohilmo

134

1116

1.09

0.41

2.0

1.6

64.14

66.85

mmol/l

0.26

111

893

Chalazion

783

0.89

0.40

1.6

1.4

53.24

63.37

mmol/l

1.41

624

Congenital malformations of ear causing impairment of hearing

0.00

0.40

0.0

2.2

—

57.00

—

Malignant neoplasm of corpus uteri

863

1.10

0.40

1.3

1.4

57.09

59.41

mmol/l

0.25

694

Pregnancy, childbirth and the puerperium

317

1744

0.95

0.40

1.3

1.4

60.30

59.16

mmol/l

0.20

253

1396

Other menopausal disorders

212

1260

0.94

0.40

1.6

1.4

57.57

59.67

mmol/l

0.34

169

958

Hypertrophic scar

306

1.18

0.39

1.4

52.19

64.28

mmol/l

1.41

245

Other disorders of male genital organs

205

1.22

0.39

1.4

1.3

70.56

63.99

mmol/l

0.31

159

Episcleritis

325

1.17

0.39

1.3

68.50

61.16

mmol/l

0.31

271

Caries of enamel

930

5904

1.03

0.38

1.6

1.4

64.31

62.22

mmol/l

0.69

762

4637

Nonspecific lymphadenitis

335

1.17

0.38

1.3

56.88

63.44

mmol/l

0.48

278

Adenomyosis (Endometriosis of uterus)

116

1068

1.09

0.36

1.3

1.4

58.64

59.44

mmol/l

0.08

818

Other keratitis

783

1.10

0.36

1.5

1.4

58.68

62.23

mmol/l

0.33

624

Follicular lymphoma, hilmo

347

1.16

0.36

1.4

1.3

64.29

59.73

mmol/l

0.29

273

Allergic urticaria

546

1.12

0.35

1.5

1.4

67.91

63.91

mmol/l

0.28

444

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

292

1.17

0.34

1.3

1.4

59.32

59.10

mmol/l

0.01

239

Nasal polyp

157

1470

1.07

0.34

1.3

68.96

61.59

mmol/l

1.45

128

1156

Monoarthritis, not elsewhere classified

255

1.18

0.34

1.3

1.4

52.72

64.06

mmol/l

0.74

202

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

209

1.20

0.34

1.1

1.4

80.61

67.57

mmol/l

0.56

174

Erythema nodosum

200

1.20

0.34

1.4

45.44

61.31

mmol/l

2.14

166

Acute appendicitis, with complications

141

1509

0.93

0.33

1.4

67.85

61.58

mmol/l

0.91

113

1202

Internal derangement of knee

319

3020

1.05

0.33

1.4

56.69

61.72

mmol/l

1.48

257

2356

Acute appendicitis, no complications

440

4211

1.04

0.33

1.5

1.4

63.13

62.50

mmol/l

0.11

341

3283

Carcinoma in situ of breast, intraductal

750

0.90

0.33

1.2

1.4

61.02

59.99

mmol/l

0.07

599

Myocardial infarction, with ST-elevation

148

1579

0.94

0.33

1.4

1.3

64.78

60.78

mmol/l

0.70

115

1269

Testicular dysfunction

210

1.19

0.32

1.5

1.3

75.78

62.16

mmol/l

0.69

167

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

592

0.89

0.32

1.4

63.14

62.61

mmol/l

0.03

468

Malignant melanoma of skin

105

972

1.08

0.32

1.3

1.4

66.73

61.51

mmol/l

0.63

789

Retained placenta and membranes, without haemorrhage

780

1.09

0.31

1.4

62.90

64.26

mmol/l

0.11

616

Pterygium

230

0.82

0.31

1.3

48.36

61.32

mmol/l

1.25

191

Nontoxic single thyroid nodule

560

1.11

0.31

1.1

1.4

61.64

60.87

mmol/l

0.05

453

Scleritis and episcleritis

389

1.13

0.31

1.3

67.03

60.08

mmol/l

0.31

318

Benign neoplasm: Skin, unspecified

295

1.16

0.31

1.5

1.4

56.44

60.73

mmol/l

0.24

242

Gestational [pregnancy-induced] hypertension

139

1299

1.07

0.31

1.3

1.5

67.91

63.95

mmol/l

0.47

107

1015

Non-allergic asthma

642

0.90

0.31

1.6

1.5

60.20

64.38

mmol/l

0.30

518

Haemangioma and lymphangioma, any site

666

1.10

0.31

1.4

1.5

63.11

62.93

mmol/l

0.01

539

Biomechanical lesions, not elsewhere classified

390

1.13

0.31

1.3

63.91

59.90

mmol/l

0.26

318

Appendectomy

557

5137

1.03

0.30

1.5

1.4

62.88

62.58

mmol/l

0.06

443

4009

Malignant neoplasm of rectosigmoid junction, including Hilmo

212

1.18

0.30

1.4

68.11

60.91

mmol/l

0.27

171

Cholesteatoma of middle ear

410

0.88

0.30

1.2

1.4

64.19

60.40

mmol/l

0.22

325

L02BA Anti-estrogens

136

1448

0.94

0.30

1.3

1.4

57.51

60.87

mmol/l

0.42

101

1152

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

391

1.13

0.29

1.3

1.5

69.23

64.94

mmol/l

0.21

320

Congenital obstruction of the pelviureteric junction

1.26

0.29

1.4

1.3

39.43

64.06

mmol/l

—

Undescended testis, unilateral

1.23

0.29

8.0

3.6

74.14

80.61

mmol/l

—

Habitual aborter

1.23

0.29

1.0

1.6

125.29

74.33

mmol/l

—

Laparoscopic right hemicolectomy

546

1.10

0.28

1.2

1.4

56.35

59.54

mmol/l

0.36

438

Other and unspecified disorders of vitreous body

417

4213

0.97

0.27

1.4

59.22

60.85

mmol/l

0.42

344

3350

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1062

0.93

0.27

1.2

1.4

56.57

61.15

mmol/l

0.58

852

Procreative management

251

1980

1.04

0.26

1.9

1.6

68.88

63.39

mmol/l

1.04

210

1525

Lumbosacral root disorders, not elsewhere classified

1.31

0.26

1.1

1.2

54.30

58.93

mmol/l

—

Benign neoplasm of thyroid gland

246

0.85

0.26

1.4

1.3

65.21

59.18

mmol/l

0.30

200

Triptan medication for migraine, single purchase ok

609

4231

0.97

0.25

1.5

66.24

62.24

mmol/l

1.33

490

3306

Migraine, single triptan purchase ok & required. ICD-code if available is included

609

4231

0.97

0.25

1.5

66.24

62.24

mmol/l

1.33

490

3306

Cyst of kidney

598

1.09

0.25

1.8

1.4

56.78

60.20

mmol/l

0.35

474

Lesion of sciatic nerve

361

0.88

0.25

1.2

1.4

63.32

59.34

mmol/l

0.22

294

Endometriosis ASRM stages 3,4

181

1727

1.05

0.24

1.4

57.51

61.97

mmol/l

0.81

148

1377

Other disorders of breast

107

1006

1.06

0.24

1.6

1.4

63.17

63.42

mmol/l

0.02

812

Presbyopia

494

1.09

0.24

1.4

59.58

59.41

mmol/l

0.01

399

Mandibular retrognathia

327

0.88

0.23

1.7

2.1

64.96

69.42

mmol/l

0.22

281

Neuroendocrine tumor and carcinoma of stomach

1.32

0.23

1.4

1.3

61.60

66.33

mmol/l

—

Adenocarcinoma and papillary adenocarcinoma of stomach

190

1.16

0.23

1.3

1.4

57.67

62.36

mmol/l

0.26

152

Impotence

380

1.11

0.23

1.2

1.4

61.50

62.26

mmol/l

0.03

306

Calcific tendinitis of shoulder

361

1.11

0.23

1.6

1.3

60.84

61.33

mmol/l

0.02

290

Macular cyst

266

1.13

0.22

1.3

1.4

55.24

59.77

mmol/l

0.30

215

Testicular hypofunction

181

1.16

0.22

1.4

1.3

79.29

62.82

mmol/l

0.73

148

Femoral hernia

352

1.11

0.22

1.2

1.4

62.03

61.41

mmol/l

0.04

284

Prolapse and hernia of ovary and fallopian tube

396

1.10

0.22

1.2

1.3

57.83

56.38

mmol/l

0.10

313

Orthopaedic devices associated with adverse incidents

172

1.17

0.22

1.1

1.3

79.46

58.35

mmol/l

1.54

146

Gender identity disorders

1.22

0.22

1.0

1.5

50.00

65.85

mmol/l

—

Kaschin-Beck disease

0.00

0.22

0.0

1.2

—

46.00

—

Macular pucker, drug-induced

0.00

0.21

0.0

1.6

—

45.36

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.21

0.0

1.2

—

61.64

—

Unspecified hairloss

0.00

0.21

0.0

1.6

—

65.00

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.21

0.0

1.3

—

46.18

—

Traumatic amputation of hip and thigh

0.00

0.21

0.0

1.9

—

55.30

—

Atrophy of thyroid (acquired)

0.00

0.21

0.0

1.5

—

59.00

—

Microtia (small ears)

0.00

0.21

0.0

2.3

—

84.20

—

Abnormalities of ear ossicles

0.00

0.21

0.0

1.5

—

65.45

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

0.21

0.0

2.8

—

58.90

—

Craniosynostosis EXCLUDE syndromes

0.00

0.21

0.0

1.6

—

77.29

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

105

0.76

0.21

1.4

72.25

67.96

mmol/l

—

Alzheimer’s disease (Early onset), excluding more controls

227

0.87

0.21

1.3

76.86

59.11

mmol/l

0.82

175

Use of ropinirole

303

0.89

0.20

1.6

1.4

77.75

60.39

mmol/l

1.17

241

Other specified disorders of kidney and ureter

240

1.13

0.20

1.6

1.4

56.76

61.21

mmol/l

0.27

202

Benign neoplasm: Liver

136

1.18

0.20

1.6

1.3

57.09

66.32

mmol/l

0.32

120

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

240

1.13

0.20

1.4

1.3

74.29

63.07

mmol/l

0.49

191

Carcinoma in situ, bladder

288

1.11

0.20

1.3

51.81

64.03

mmol/l

1.78

238

Carcinoma in situ of other and unspecified sites

317

1.11

0.19

1.3

52.86

63.17

mmol/l

1.47

259

L02BB Anti-androgens

704

1.07

0.19

1.2

1.3

55.97

64.40

mmol/l

1.65

560

Cicatricial alopecia [scarring hair loss]

1.16

0.19

1.3

1.4

34.33

67.68

mmol/l

—

Deep endometriosis

686

1.07

0.18

1.5

1.4

55.57

62.11

mmol/l

0.94

559

Benign neoplasm of eye and adnexa

881

1.06

0.18

1.3

1.4

58.38

62.58

mmol/l

0.49

717

Muscular dystrophy

1.21

0.18

1.3

1.5

93.86

70.29

mmol/l

—

Leiomyoma of uterus

598

3421

0.98

0.18

1.4

58.67

60.09

mmol/l

0.39

470

2721

Endometriosis of ovary

126

1135

1.05

0.17

1.4

58.14

60.75

mmol/l

0.29

100

863

Benign neoplasm: Kidney

281

1.11

0.17

1.4

1.3

63.44

59.38

mmol/l

0.18

224

Dislocation, sprain and strain of joints and ligaments of elbow

378

1.09

0.17

2.2

1.7

57.97

65.31

mmol/l

0.58

319

Female infertility

176

1017

1.04

0.16

1.5

1.4

65.23

62.07

mmol/l

0.46

150

773

Osteitis due to dental implant

1.16

0.16

1.6

1.4

56.75

58.05

mmol/l

—

Tooth agenesis EXCLUDE clefts and syndromes

162

0.86

0.16

3.4

2.3

72.00

79.84

mmol/l

0.20

143

Benign neoplasm: Skin of lip

1.20

0.16

1.4

1.3

59.55

61.46

mmol/l

0.06

Otosclerosis

607

0.94

0.16

1.6

1.4

74.43

60.58

mmol/l

1.16

491

Benign mammary dysplasia

139

1338

1.04

0.16

1.3

1.4

60.58

60.97

mmol/l

0.04

114

1060

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

627

0.94

0.15

1.5

1.4

64.94

61.84

mmol/l

0.25

504

Adenocarcinoma and papilloma adenocarcinoma of rectum

789

1.05

0.15

1.6

1.4

68.78

60.29

mmol/l

0.76

634

Congenital malformations of uterus and cervix

1.13

0.15

1.1

1.5

92.44

75.13

mmol/l

—

Appendicitis, broad definition

625

5693

0.98

0.14

1.5

1.4

64.15

62.32

mmol/l

0.48

492

4464

Labour and delivery complicated by umbilical cord complications

223

0.90

0.14

1.2

1.4

61.79

66.32

mmol/l

0.13

176

MS-disease / Multiple Sclerosis

347

0.92

0.14

1.4

56.33

63.42

mmol/l

0.51

289

Varicose veins of other sites

421

1.07

0.14

1.6

1.4

63.48

64.19

mmol/l

0.03

343

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

106

640

1.04

0.14

1.6

1.5

72.16

68.52

mmol/l

0.31

497

Normotensive glaucoma

871

1.05

0.14

1.4

1.3

60.16

61.11

mmol/l

0.08

704

Endometriosis ASRM stages 1,2

1031

0.96

0.13

1.4

64.43

61.95

mmol/l

0.22

822

Use of anticholinesterases

425

3337

0.98

0.13

1.3

1.4

65.70

59.67

mmol/l

2.57

338

2705

N06DA Anticholinesterases

425

3337

0.98

0.13

1.3

1.4

65.70

59.67

mmol/l

2.57

338

2705

Haemangioma, any site

627

1.05

0.13

1.4

1.5

60.52

62.93

mmol/l

0.17

507

Glucagon-like peptide-1 (GLP-1) analogues

241

2353

1.02

0.13

1.3

1.4

58.29

62.36

mmol/l

0.95

192

1861

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

241

2353

1.02

0.13

1.3

1.4

58.29

62.36

mmol/l

0.95

192

1861

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

123

1.14

0.12

1.1

1.4

50.44

57.96

mmol/l

—

102

Hypertrophy of breast

115

1111

1.04

0.12

1.4

60.21

63.44

mmol/l

0.39

873

Use of galantamine

876

1.04

0.11

1.4

1.3

64.78

60.42

mmol/l

0.59

694

Endometriosis diagnosis and infertility diagnosis occurring together

454

1.06

0.11

1.2

1.5

75.86

65.84

mmol/l

0.74

366

Bicipital tendinitis

308

1.07

0.11

1.7

1.4

71.36

60.75

mmol/l

0.62

244

Other obstetric conditions, not elsewhere classified

109

664

1.04

0.11

1.6

1.5

71.38

68.00

mmol/l

0.29

516

LSIL lesion of the cervix uteri

504

1.05

0.11

1.6

1.4

61.34

66.38

mmol/l

0.39

405

Other/unspecified enthesopathies, not elsewhere classified

622

1.05

0.11

1.5

1.3

61.79

61.73

mmol/l

0.00

492

Caught, crushed, jammed or pinched in or between objects

299

1.07

0.10

1.4

1.5

57.35

65.71

mmol/l

0.46

248

Macular hole

534

1.05

0.10

1.3

1.4

58.88

61.42

mmol/l

0.20

425

Melanoma in situ

393

0.94

0.10

1.1

1.4

64.17

59.57

mmol/l

0.19

318

Alzheimer’s disease, strict definition

317

2513

1.02

0.10

1.3

1.4

62.00

60.15

mmol/l

0.39

256

2028

Other congenital malformations of face and neck

146

0.89

0.10

1.4

58.00

63.41

mmol/l

—

126

Preterm labour and delivery

159

1630

0.97

0.10

1.5

1.4

62.66

62.31

mmol/l

0.03

128

1261

Early lumbar disc prolapse operation

454

0.95

0.10

1.6

1.4

65.06

64.99

mmol/l

0.00

357

Inflammatory disorders of breast

339

1.06

0.10

1.4

1.5

46.20

63.74

mmol/l

2.94

282

Rheumatic fever incl heart disease

222

1.08

0.10

1.3

58.00

60.20

mmol/l

0.09

176

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

310

0.93

0.10

1.3

1.4

68.22

59.66

mmol/l

0.53

256

Contact with other sharp object(s)

349

1.06

0.10

1.4

63.07

66.07

mmol/l

0.15

288

Disorders of globe

203

1.09

0.09

1.6

1.3

57.59

58.59

mmol/l

0.03

164

Dissection of aorta

242

1.08

0.09

1.0

1.3

80.81

61.84

mmol/l

1.57

199

Unspecified threat to breathing

1.04

0.09

1.4

1.5

35.40

65.63

mmol/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

1.14

0.09

1.5

62.82

58.96

mmol/l

0.13

Other and/or unspecified nontoxic goitre

675

1.04

0.09

1.4

1.3

63.40

60.30

mmol/l

0.23

538

Personal history of malignant neoplasm

606

1.04

0.09

1.4

1.5

70.71

61.67

mmol/l

0.82

492

Other appendicitis

553

0.96

0.09

1.6

1.4

60.64

61.78

mmol/l

0.07

449

Systemic sclerosis,strict definition

1.07

0.08

2.5

1.3

61.17

65.47

mmol/l

—

Achilles tendinitis

705

0.96

0.08

1.2

1.4

60.00

60.35

mmol/l

0.03

548

Bitten or struck by other mammals

676

1.04

0.08

1.3

1.5

63.18

63.26

mmol/l

0.00

550

Tibial collateral bursitis [Pellegrini-Stieda]

0.83

0.08

1.0

1.3

47.80

56.15

mmol/l

—

Leiomyosarcoma, including Hilmo

0.78

0.08

1.2

1.4

39.20

62.28

mmol/l

—

Benign neoplasm: Bladder

0.77

0.08

1.8

1.3

74.00

57.90

mmol/l

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

1.08

0.08

1.1

1.4

64.86

61.80

mmol/l

—

LSIL lesion of the cervix uteri, vagina or vulva

746

1.03

0.08

1.6

1.4

57.11

64.41

mmol/l

0.95

589

Female infertility, cervical, vaginal, other or unspecified origin

158

989

1.02

0.08

1.5

1.4

63.76

62.00

mmol/l

0.21

135

754

Benign neoplasm: Choroid

561

0.96

0.07

1.3

1.4

57.66

61.10

mmol/l

0.34

457

Diseases of appendix

636

5734

0.99

0.07

1.5

1.4

64.16

62.33

mmol/l

0.49

499

4498

Disorders of eyelid in diseases classified elsewhere

215

1.07

0.07

1.3

1.4

66.83

61.13

mmol/l

0.29

172

Calcaneal spur

1.05

0.07

1.0

1.3

71.50

57.26

mmol/l

—

Hypersensitivity pneumonitis due to organic dust

108

1.11

0.07

1.4

1.3

63.00

58.79

mmol/l

—

Maternal care for other conditions predominantly related to pregnancy

832

0.97

0.07

1.3

1.5

66.58

66.38

mmol/l

0.01

639

Benign neoplasm: Appendix

0.83

0.07

1.6

1.3

43.43

60.75

mmol/l

—

LSIL lesion of the vagina

1.07

0.07

1.3

1.4

45.89

62.90

mmol/l

—

Muscle strain

167

1.08

0.07

1.4

46.62

63.79

mmol/l

0.79

134

Cervical polyps

710

1.03

0.06

1.2

1.4

68.70

59.83

mmol/l

0.88

541

Other superficial mycoses, including avohilmo

621

1.03

0.06

1.6

1.4

55.49

64.63

mmol/l

1.08

500

Endometriosis of pelvic peritoneum

844

1.02

0.06

1.4

63.89

62.04

mmol/l

0.15

625

Use of rivastigmine

185

1870

0.99

0.05

1.3

65.97

59.73

mmol/l

1.30

155

1503

Cysts of oral region, not elsewhere classified

406

1.04

0.05

1.4

58.26

62.81

mmol/l

0.32

333

Other osteochondropathies

416

1.03

0.05

1.4

61.78

65.28

mmol/l

0.24

345

Pathological resorption of teeth

219

1.05

0.04

1.5

1.3

46.40

61.76

mmol/l

1.33

180

Infections of genitourinary tract in pregnancy

544

0.97

0.04

1.5

55.62

63.09

mmol/l

0.59

433

Acute appendicitis

581

5419

0.99

0.04

1.5

1.4

64.30

62.56

mmol/l

0.44

454

4244

Oral lichen planus, including avohilmo , including avohilmo

564

0.97

0.04

1.5

1.4

62.05

61.75

mmol/l

0.02

461

Early lumbar disc prolapse, operated

398

1.03

0.04

1.6

1.4

62.94

65.81

mmol/l

0.18

298

Retinal breaks without detachment

130

1317

0.99

0.03

1.3

1.4

54.95

62.02

mmol/l

1.78

109

1041

Benign neoplasm of ovary

158

1598

0.99

0.03

1.5

1.4

58.93

60.92

mmol/l

0.28

130

1274

Herpesviral keratitis and keratoconjunctivitis

319

1.04

0.03

1.6

1.3

63.68

60.63

mmol/l

0.21

253

Calculus of lower urinary tract

389

1.03

0.03

1.5

1.3

59.43

63.13

mmol/l

0.27

318

Intrahepatic Cholestasis of Pregnancy (ICP)

241

1.04

0.02

1.1

1.4

80.61

67.96

mmol/l

0.54

200

Maternal care for known or suspected disproportion

152

1.05

0.02

1.3

1.6

51.11

67.70

mmol/l

—

119

Benign lipomatous neoplasm

256

2575

0.99

0.02

1.3

1.4

59.15

61.93

mmol/l

0.56

211

2047

Benign neoplasm: Peripheral nerves and autonomic nervous system

113

1.06

0.02

1.2

1.3

85.71

59.51

mmol/l

—

Congenital deformities of feet

127

0.94

0.01

1.3

1.5

50.33

71.79

mmol/l

0.89

112

Inguinal of femoral hernia, unilateral

227

0.97

0.01

1.3

1.4

67.19

63.12

mmol/l

0.17

180

Inguinal hernia, unilateral

227

0.97

0.01

1.3

1.4

67.19

63.12

mmol/l

0.17

180

Femoral hernia, unilateral

227

0.97

0.01

1.3

1.4

67.19

63.12

mmol/l

0.17

180

Medical treatment for female infertility

725

1.01

0.01

1.4

1.5

80.26

66.89

mmol/l

1.15

561

Other obstructed labour

427

0.98

0.01

1.6

1.4

51.26

65.72

mmol/l

1.75

337

Spermatocele

507

0.99

0.01

1.3

1.4

71.24

62.20

mmol/l

0.64

414

Chronic suppurative otitis media

493

1.01

0.01

1.4

58.32

63.34

mmol/l

0.33

396

Cyst of Bartholin Gland

214

1.03

0.00

1.6

1.4

59.73

65.66

mmol/l

0.35

175

Other blood glucose lowering drugs, excl. Insulins

149

1487

1.00

0.00

1.4

63.35

60.28

mmol/l

0.41

124

1191

Chronic suppurative otitis media, including avohilmo

572

1.00

0.00

1.5

57.77

63.23

mmol/l

0.43

462

Conductive hearing loss, unspecified

578

1.00

0.00

2.6

1.4

72.27

63.48

mmol/l

0.73

462

Lichen sclerosus et atrophicus

101

1012

1.00

0.00

1.6

1.4

67.37

61.74

mmol/l

0.77

801

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

466

3613

1.00

0.00

1.5

1.4

59.97

62.67

mmol/l

0.74

384

2836

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

324

0.99

0.00

1.7

1.3

51.79

64.34

mmol/l

0.97

258

Pregnancy with abortive outcome

613

3191

1.00

0.00

1.3

1.4

60.53

60.10

mmol/l

0.09

501

2546

Benign neoplasm: Cranial nerves

221

1.00

0.00

1.4

1.3

73.65

58.68

mmol/l

0.64

183

Infectious mononucleosis, including avohilmo

306

1.01

0.00

1.3

1.5

86.65

71.03

mmol/l

0.65

256

Infectious mononucleosis

306

1.01

0.00

1.3

1.5

86.65

71.03

mmol/l

0.65

256

Benign leiomyoma with endometriosis

148

1479

1.00

0.00

1.3

1.4

55.23

61.14

mmol/l

1.35

118

1183

Benign neoplasm: Liver/bile ducts

157

1.02

0.00

1.6

1.4

57.09

63.75

mmol/l

0.22

136

Melanocytic naevi of other and unspecified parts of face

403

0.99

0.00

1.6

1.3

63.73

63.38

mmol/l

0.02

329

Complications following abortion and ectopic and molar pregnancy

265

0.98

0.00

1.3

1.4

69.21

59.66

mmol/l

0.51

215

Benign neoplasm of urinary organs

390

1.00

0.00

1.5

1.3

64.58

60.78

mmol/l

0.20

306

Other disorders of diminished melanin formation

0.00

0.0

1.8

—

52.20

—

Functional disorders of polymorphonuclear neutrophils

0.00

0.0

1.1

—

47.50

—

Sclerodactyly

0.00

0.0

2.0

—

42.20

—

Telogen effluvium

0.00

0.0

1.1

—

67.88

—

Brain mixed glioma, helper endpoint

0.00

0.0

1.0

—

67.00

—

Defect, injury or illness of skull

0.00

0.0

1.6

—

72.29

—

Other congenital malformations of male genital organs, including avohilmo

1.02

0.00

5.7

3.9

80.33

85.80

mmol/l

—

Juvenile dermatomyositis

0.00

0.0

1.0

—

77.71

—

Kernicterus

0.00

0.0

1.8

—

67.00

—

Intestinal helminthiases, other/unspecified

0.00

0.0

1.8

—

48.20

—

Xanthelasma of eyelid

0.91

0.00

1.4

1.2

55.60

57.71

mmol/l

—

General autosomal fish scale disease

0.00

0.0

1.3

—

64.56

—

Other disorders of bone development and growth

0.00

0.0

1.9

—

79.71

—

Night blindness

0.00

0.0

1.1

—

70.00

—

Blindness (ICD-9)

0.00

0.0

1.4

—

67.40

—

Mosquito-borne viral encephalitis, including avohilmo

0.00

-0.00

0.0

1.3

—

54.57

—

Mental and behavioural disorders due to cocaine

0.00

-0.00

0.0

1.0

—

76.33

—

Testicular hyperfunction

0.00

-0.00

0.0

1.2

—

67.20

—

Traumatic subcutaneous emphysema

0.00

-0.00

0.0

1.6

—

65.56

—

Traumatic amputation at neck level

0.00

-0.00

0.0

1.8

—

49.40

—

Disorders of multiple cranial nerves

0.00

-0.00

0.0

1.2

—

85.33

—

Pectus carinatum

0.00

-0.00

0.0

5.8

—

91.60

—

Pectus carinatum, including avohilmo

0.00

-0.00

0.0

4.0

—

72.50

—

Need for immunization against combinations of infectious diseases

0.00

-0.00

0.0

2.6

—

49.20

—

Iodine-deficiency-related thyroid disorders and allied conditions

0.00

-0.00

0.0

1.3

—

62.33

—

Myopathy due to other toxic agents

0.00

-0.00

0.0

1.4

—

71.60

—

Crushing injury of shoulder and upper arm

0.00

-0.00

0.0

1.2

—

60.20

—

Malignant neoplasms of independent (primary) multiple sites

0.00

-0.00

0.0

1.5

—

73.83

—

Other disorders affecting eyelid function

0.95

-0.00

1.3

66.00

58.38

mmol/l

—

Other congenital malformations of male genital organs

1.00

-0.00

6.0

4.1

62.20

88.52

mmol/l

—

Cellulitis of external ear

0.87

-0.00

1.0

1.4

73.67

60.02

mmol/l

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.00

-0.00

0.0

1.2

—

63.78

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

-0.00

0.0

1.6

—

60.44

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

-0.00

0.0

1.2

—

68.67

—

Digeorge syndrome

0.00

-0.00

0.0

2.2

—

89.60

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

2.1

—

56.89

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

-0.00

0.0

1.1

—

57.00

—

Indeterminate sex and pseudohermaphroditism

0.00

-0.00

0.0

1.4

—

82.75

—

Liveborn infants according to place of birth

0.97

-0.00

1.2

3.2

95.00

80.65

mmol/l

—

Acquired ichthyosis

0.00

-0.00

0.0

2.0

—

56.00

—

Other histiocytosis syndromes

0.00

-0.00

0.0

1.1

—

89.33

—

Mosquito-borne viral encephalitis

0.00

-0.00

0.0

1.3

—

54.57

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

0.91

-0.00

1.5

2.2

59.67

67.14

mmol/l

—

Family history of other specific disorders

0.98

-0.00

1.2

1.3

77.83

75.74

mmol/l

—

Other benign neoplasm of uterus: Corpus uteri

0.88

-0.00

1.0

1.3

54.80

62.48

mmol/l

—

Carcinoma in situ of lip

0.00

-0.00

0.0

1.1

—

66.88

—

Exposure to high and low air pressure and changes in air pressure

0.00

-0.00

0.0

1.6

—

70.89

—

Irritant contact dermatitis due to drugs in contact with skin

0.00

-0.00

0.0

1.8

—

61.40

—

Other fluke infections

0.00

-0.00

0.0

1.7

—

60.17

—

Explosion and rupture of other specified pressurized devices

0.00

-0.00

0.0

1.5

—

71.67

—

Use of glatiramer acetate

0.89

-0.00

1.0

1.4

53.33

65.59

mmol/l

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

86.00

—

Osteolysis

0.00

-0.00

0.0

1.8

—

49.40

—

Use of tolcapone

0.00

-0.00

0.0

1.0

—

47.40

—

Plague, including avohilmo, including avohilmo

0.00

-0.00

0.0

1.4

—

62.60

—

Niacin deficiency [pellagra]

0.00

-0.00

0.0

1.4

—

58.86

—

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

58.57

—

Other fluke infections, including avohilmo

0.00

-0.00

0.0

1.7

—

60.17

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

-0.00

0.0

1.5

—

88.33

—

Accident to watercraft causing other injury

0.00

-0.00

0.0

1.6

—

40.14

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sodium [Moles/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS